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vSummary
In eukaryotes, membrane protein insertion and asparagine-linked glycosylation (N-
glycosylation) occur co-translationally at the membrane of the endoplasmic reticu-
lum (ER) for the vast majority of substrates. Both events are of critical significance
for membrane protein topogenesis, trafficking of proteins to their final intra- or ex-
tracellular destination and protein functionality. Insertion is performed by the het-
erotrimeric Sec61 complex for most substrates while glycan transfer is catalyzed by
the oligosaccharyltransferase (OST) - a complex of at least eight protein subunits
which exists in two different isoforms (STT3A- and STT3B-OST) in higher eukary-
otes. The transient and highly dynamic nature of the resulting ribosome-translocon
complexes has precluded them from thorough structural characterization so far.
This thesis describes an experimental strategy for the in vitro generation and isola-
tion of mammalian co-translational membrane insertion/N-glycosylation interme-
diates. The routine was used in order to obtain solubilized intermediates of the G-
protein coupled receptor bovine opsin at defined stages of biogenesis for structural
analysis by cryo-electron microscopy (cryo-EM). Preliminary structures of three dif-
ferent intermediates are presented and provide unexpected findings regarding the
functional state of Sec61. It was observed in a so-called ’primed’ rather than an ’in-
serting’ conformation. Besides, the insertion/N-glycosylation substrate could not
be located within the membrane region. Extended analysis of a very early inter-
mediate led to the first high-resolution structure of a mammalian OST-containing
ribosome-translocon complex. It revealed the spatial arrangement of mammalian
OST subunits in the ER membrane. In addition, it explained how only one of the
two naturally occurring paralogs of OST can associate with the ribosome and the
membrane insertion machinery. Besides, the structure enabled building of a molec-
ular model for the catalytic STT3A subunit and the paralog specific DC2 subunit.
Comparison with recent structures of yeast OST confirmed a conserved complex ar-
chitecture but also indicates potential differences among eukaryotic OST complexes.
Moreover, the structural analysis uncovered an unassigned density segment at the
Sec61-OST interface which was tentatively identified as the transmembrane domain
of the in vitro insertion/N-glycosylation substrate.

vii
Contents
1 Introduction 1
1.1 Ribosome architecture . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Co-translational membrane insertion at the ER . . . . . . . . . . . . . 2
1.2.1 Architecture of the Sec61 protein conducting channel . . . . . 3
1.2.2 Biological functions of Sec61 . . . . . . . . . . . . . . . . . . . 4
1.2.3 Accessory translocon factors . . . . . . . . . . . . . . . . . . . 6
1.2.4 Membrane protein terminology . . . . . . . . . . . . . . . . . . 8
1.2.5 Sec61-dependent membrane protein insertion - a thermody-
namic view . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9
1.2.6 TMH topology determinants . . . . . . . . . . . . . . . . . . . 10
1.3 Biogenesis of bovine opsin . . . . . . . . . . . . . . . . . . . . . . . . . 12
1.4 Asparagine-linked glycosylation at the ER membrane . . . . . . . . . 14
1.4.1 Evolution and significance of OST . . . . . . . . . . . . . . . . 14
1.4.2 The oligosaccharide precursor . . . . . . . . . . . . . . . . . . 16
1.4.3 Catalytic mechanism of STT3-type enzymes . . . . . . . . . . 16
1.5 The eukaryotic OST complex . . . . . . . . . . . . . . . . . . . . . . . 20
1.5.1 Complex architecture and distance restraints . . . . . . . . . . 20
1.5.2 The catalytic STT3 subunit . . . . . . . . . . . . . . . . . . . . . 21
1.5.3 Shared accessory subunits . . . . . . . . . . . . . . . . . . . . . 22
1.5.4 The STT3A specific subunits DC2 and KCP2 . . . . . . . . . . 24
1.5.5 The STT3B specific oxidoreductase subunit . . . . . . . . . . . 25
1.6 Aims of this thesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25
2 Materials and Methods 27
2.1 General . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.2 Vectors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.3 Molecular Cloning . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.3.1 Polymerase chain reaction (PCR) . . . . . . . . . . . . . . . . . 27
2.3.2 Degradation of parental DNA . . . . . . . . . . . . . . . . . . . 29
2.3.3 Phosphorylation and Ligation . . . . . . . . . . . . . . . . . . 30
viii
2.3.4 Plasmid transformation . . . . . . . . . . . . . . . . . . . . . . 30
2.3.5 Plasmid isolation . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.4 Preparation of mRNA . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
2.4.1 Template generation by PCR . . . . . . . . . . . . . . . . . . . 30
2.4.2 In vitro transcription . . . . . . . . . . . . . . . . . . . . . . . . 31
2.5 In vitro translation reactions . . . . . . . . . . . . . . . . . . . . . . . . 32
2.6 Protein analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.6.1 Protein precipitation . . . . . . . . . . . . . . . . . . . . . . . . 34
2.6.2 Deglycosylation by Endoglycosidase H (Endo H) . . . . . . . 34
2.6.3 SDS-Polyacrylamide-Gel-Electrophoresis (SDS-PAGE) . . . . 35
2.6.4 Semi-dry western blotting . . . . . . . . . . . . . . . . . . . . . 35
2.6.5 Mass-spectrometry . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.7 Purification of opsin biogenesis intermediates for cryo-EM . . . . . . 37
2.8 Cryo-EM data collection . . . . . . . . . . . . . . . . . . . . . . . . . . 39
2.9 Cryo-EM data analysis and model building . . . . . . . . . . . . . . . 40
3 Results 43
3.1 Expression of C-terminally truncated variants of bovine opsin . . . . 43
3.2 Preparation of solubilized opsin biogenesis intermediates . . . . . . . 47
3.3 Preliminary cryo-EM structures of opsin biogenesis intermediates . . 49
3.4 Cryo-EM analysis of an early opsin biogenesis intermediate . . . . . 52
3.5 Conformation of Sec61 . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.6 Characterizing mammalian ribosome-bound OST . . . . . . . . . . . 56
3.6.1 Evaluating OST-isoform specificity . . . . . . . . . . . . . . . . 56
3.6.2 Positioning of OST subunits . . . . . . . . . . . . . . . . . . . . 58
3.7 Interactions of OST with the ribosome and Sec61 . . . . . . . . . . . . 61
3.7.1 The OST subunit DC2 at the Sec61 interface . . . . . . . . . . . 61
3.7.2 The RPN1-Ribosome interface . . . . . . . . . . . . . . . . . . 62
3.7.3 Conformational dynamics in different functional states . . . . 63
3.8 Tentative positioning of the nascent insertion-glycosylation substrate 64
4 Discussion 69
4.1 A model for OST isoform specificity . . . . . . . . . . . . . . . . . . . 69
4.2 Comparison of eukaryotic OST complexes . . . . . . . . . . . . . . . . 73
4.3 Opsin membrane insertion takes unexpected ways . . . . . . . . . . . 79
5 Future perspectives 83
ix
Appendix 85
A MS analysis of the solubilized OP96 biogenesis intermediate 87
A.1 Hits from the canis lupus familaris database . . . . . . . . . . . . . . . 87
A.2 Hits from the oryctolagus cuniculus database . . . . . . . . . . . . . . . 96
References 109

xi
List of Figures
1.1 Architecture of the heterotrimeric Sec61 channel. . . . . . . . . . . . . 3
1.2 Types of membrane proteins. . . . . . . . . . . . . . . . . . . . . . . . 8
1.3 Topology and structure of bovine rhodopsin. . . . . . . . . . . . . . . 12
1.4 Bovine opsin biogenesis. . . . . . . . . . . . . . . . . . . . . . . . . . . 14
1.5 Composition of eukaryotic OST complexes . . . . . . . . . . . . . . . 15
1.6 The LLO precursor. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
1.7 CET structure of mammalian OST-containing RTCs. . . . . . . . . . . 21
3.1 Construct design and test expression of OP96 in absence or presence
of PKRM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.2 Optimizing PKRM for use in in vitro translation. . . . . . . . . . . . . 46
3.3 Test expression of different opsin NC lengths in absence or presence
of PKRM. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.4 Cryo-EM sample preparation. . . . . . . . . . . . . . . . . . . . . . . . 48
3.5 Purification of solubilized opsin biogenesis intermediates for cryo-EM. 49
3.6 Preliminary cryo-EM structures of thee opsin biogenesis intermediates. 50
3.7 Sec61 conformation in the solubilized opsin biogenesis intermediates. 51
3.8 Classification scheme of the combined cryo-EM datasets from the sol-
ubilized OP96 biogenesis intermediate. . . . . . . . . . . . . . . . . . 53
3.9 Local resolution distribution. . . . . . . . . . . . . . . . . . . . . . . . 54
3.10 Cryo-EM structure of the programmed solubilized RTC. . . . . . . . 55
3.11 Atomic model for Sec61. . . . . . . . . . . . . . . . . . . . . . . . . . . 56
3.12 CET of native RTCs. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
3.13 Atomic model of mammalian STT3A. . . . . . . . . . . . . . . . . . . 59
3.14 Structural conservation of STT3-type proteins. . . . . . . . . . . . . . 60
3.15 Spatial arrangement of mammalian OST subunits. . . . . . . . . . . . 61
3.16 The Sec61-DC2 interface. . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.17 The ribosome-RPN1 interface. . . . . . . . . . . . . . . . . . . . . . . . 62
3.18 Conformational states of different Sec61-OST complexes. . . . . . . . 63
3.19 Additional density at the Sec61-OST interface. . . . . . . . . . . . . . 65
xii
3.20 Putative placement of the NC TMH. . . . . . . . . . . . . . . . . . . . 65
3.21 OP96 NC connectivity. . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.1 Primary sequence alignment for the cytosolic STT3-TMH12/13 loop
in various metazoan organisms. . . . . . . . . . . . . . . . . . . . . . . 72
4.2 Model for OST isoform specificity. . . . . . . . . . . . . . . . . . . . . 73
4.3 Conserved architecture of eukaryotic OST complexes. . . . . . . . . . 74
4.4 Conformation of TMHs in STT3-type proteins. . . . . . . . . . . . . . 76
4.5 Sequence conservation between different eukaryotic OST subunits. . 78
4.6 Superposition of a model for fungal OST and the cryo-EM density of
mammalian STT3A-OST. . . . . . . . . . . . . . . . . . . . . . . . . . . 79
4.7 Expected architecture of opsin biogenesis intermediates. . . . . . . . 80
xiii
List of Tables
1.1 Functionally important residues in STT3-type enzymes of different
organisms. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.1 Primers used for plasmid modification. . . . . . . . . . . . . . . . . . 28
2.2 PCR program used for plasmid mutagenesis and amplification. . . . 29
2.3 PCR program used amplification of opsin constructs. . . . . . . . . . 31
2.4 Reaction mix for in vitro transcription. . . . . . . . . . . . . . . . . . . 32
2.5 Reaction mix for in vitro translation without membranes. . . . . . . . 33
2.6 Reaction mix for in vitro translation in the presence of PKRM. . . . . 34
3.1 Abundance of OST subunits in the solubilized OP96 biogenesis inter-
mediate. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
4.1 Conservation of primary sequences between STT3A and STT3B from
various metazoan organisms. . . . . . . . . . . . . . . . . . . . . . . . 71
A.1 MS analysis of the solubilized OP96 sample - Hits from canis lupus
familiaris (dog). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
A.2 MS analysis of the solubilized OP96 sample - Hits from oryctolagus
cuniculus (rabbit) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 96

1Chapter 1
Introduction
1.1 Ribosome architecture
Ribosomes are the molecular machines which are responsible for protein synthe-
sis. The molecular dimensions of these complexes are often referred to in Svedberg
units (S), according to their sedimentation coefficient. A eukaryotic 80S ribosome
consists of a 60S large ribosomal subunit (LSU) and a 40S small ribosomal subunit
(SSU). They are composed of four different ribosomal RNA (rRNA) and approxi-
mately eighty ribosomal protein species. Ribosomal proteins and rRNA assemble in
a highly complex and regulated way to form different functional sites. The LSU har-
bors the catalytic peptidyl transferase center (PTC) where individual amino-acids
are covalently linked to the growing nascent chain (NC) via an ester bond. Further-
more, it contains the exit tunnel for the nascent polypeptide. The SSU comprises
the messenger RNA (mRNA) tunnel and the decoding center (DC) where triplets
of mRNA codons are sequentially presented to transfer RNA (tRNA) molecules.
tRNAs are the crucial players for converting genetically encoded information from
a nucleic acid sequence into a polypeptide chain format. They bind the ribosome
at defined sites at the intersubunit space, recognizing the mRNA codon on the SSU
and delivering the corresponding amino acid (aa) to the PTC on the LSU. The ribo-
somal tRNA binding positions are referred to as aminoacyl-, peptidyl- and exit sites
(A-, P- and E- site, respectively). (For reviews see for example Melnikov et al., 2012;
Wilson and Cate, 2012)
The structure of ribosomes has been studied extensively (Reviewed in Schmeing and
Ramakrishnan, 2009; Voorhees and Ramakrishnan, 2013; Yusupova and Yusupov,
2014). Initial high resolution information was derived from crystal structures of the
bacterial counterparts (Ban et al., 2000; Wimberly et al., 2000). Atomic-resolution
models of the eukaryotic translation machineries have been described more recently
by several x-ray crystallography and cryo-electron microscopy (cryo-EM) groups
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(Ben-Shem et al., 2011; Anger et al., 2013; Voorhees et al., 2014; Khatter et al., 2015).
The translation cycle in pro- and eukaryotes can be separated into four main stages:
initiation, elongation, termination and recycling. The basic principles of translation
and also many of the protein factors involved are highly conserved. However the
eukaryotic cycle has adapted additional components and evolved to greater com-
plexity.
Approximately 30 aa of an elongating NC are protected by the peptide exit tunnel
of the LSU (Voss et al., 2006). A plethora of factors is known to bind the ribosome in
proximity to the tunnel exit in order to act on the newly synthesized polypeptide as
soon as it emerges from the ribosome (Kramer et al., 2009). In eukaryotes, the ribo-
somal proteins ul23/uL29 and uL22/eL31 which surround the tunnel exit have been
identified as universal adaptor sites for ribosome-associated factors (Kramer et al.,
2009; Pech et al., 2010; Ban et al., 2014). These factors include chaperones and NC
modifying enzymes such as methionine aminopeptidases or N-acetyltransferases.
In addition, this region is the binding platform for several components of the early
secretory pathway, such as the signal recognition particle (SRP), the signal recogni-
tion particle receptor (SR) or the heterotrimeric Sec61 complex.
1.2 Co-translational membrane insertion at the ER
In eukaryotes 20-30 % of all open reading frames are predicted to encode α-helical
integral membrane proteins (Von Heijne, 2011). The majority of these proteins are
integrated into the lipid bilayer co-translationally (Rothman and Lodish, 1977) dur-
ing the early steps of the secretory pathway. The pathway initiates when a ribosome
engaged in translation of a secretory or designated transmembrane protein (TMP) is
recognized by SRP and targeted to the SR in the endoplasmic reticulum (ER) mem-
brane (reviewed in Akopian et al., 2013; Nyathi et al., 2013). NC recognition oc-
curs via SRP binding to a hydrophobic signal sequence (SS) in the translated pep-
tide. GTP hydrolysis by SRP and SR facilitates handover of the ribosome-nascent
chain complex (RNC) to the protein conducting channel (PCC) in the ER membrane.
The PCC is conserved across all three kingdoms of life and can translocate nascent
polypeptide stretches across or insert them into the membrane. In eukaryotes, the
PCC is formed by the heterotrimeric Sec61 complex and is located in the ER mem-
brane. The homologous SecYEG complex in bacteria (SecYEβ in archaea) is embed-
ded in the inner plasma membrane.
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1.2.1 Architecture of the Sec61 protein conducting channel
First direct evidence for a PCC in the ER membrane was obtained by electrophys-
iological experiments (Simon and Blobel, 1991). Shortly after, the channel function
was assigned to the heterotrimeric Sec61 complex (Görlich and Rapoport, 1993).
It consists of the central pore-forming Sec61α subunit and two smaller auxillary sub-
units Sec61β and Sec61γ. The structures of Sec61 and its bacterial and archaeal ho-
mologs (SecYEG and SecYEβ respectively) have been studied extensively (see for
example Van den Berg et al., 2004; Tsukazaki et al., 2008; Zimmer et al., 2008; Egea
and Stroud, 2010; Gogala et al., 2014; Park et al., 2014; Voorhees et al., 2014; Voorhees
and Hegde, 2016). The resulting structural models revealed a number of key struc-
tural elements which are universally conserved (see figure 1.1).
Figure 1.1 – Architecture of the heterotrimeric Sec61 channel. A) Model of the Sec61
channel, views from the membrane plane (left) and cytosol (right). In the cytoplasmic
view, the lateral gate between TMHs 2b and 7 is marked by an arrow in the cytoplasmic
view and the plug helix obstructing the central pore is indicated with a dashed circle. B)
Sec61α TMHs 1-5 and TMHs 6-10 form two pseudosymmetric halves. (Structural model
from Methanococcus janaschii, figure adapted from Van den Berg et al., 2004).
Sec61α (SecY)
The Sec61α subunit is an integral membrane protein with ten α-helical transmem-
brane segments (TMS) forming an hourglass shaped cylinder with a central pore.
Two connecting loops between transmembrane helix (TMH) 6 and 7 (L6/7) as well
as TMH 8 and 9 (L8/9) extend into the cytoplasm. In its idle state, the Sec61α central
pore is blocked by a small helical segment (TMH 2a) therefore known as the plug
domain. The pore ring - a circular arrangement of six hydrophobic residues at the
constriction site - seals the channel against ion-leakage during the translocation pro-
cess (Park and Rapoport, 2011). When viewed from the cytosol, the transmembrane
(TM) portion of Sec61α has a clam-shell like structure with two pseudosymmetric
halves formed by TMH 1-5 and 6-10 respectively. The back side of the channel
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where these two halves are connected by a lumenal loop between TMH 5 and 6
is referred to as the hinge region. In the front the two halves meet at helices 2b
and 7, an interface which has been coined as the channel’s ’lateral gate’. This is be-
cause the N-terminal half of Sec61α can undergo a hinge-like rigid body movement
with respect to the C-terminus. This movement results in opening of the channel to-
wards the lipid bilayer between TMHs 2b and 7. Both, SS as well as TMS of nascent
peptide substrates have been found to be intercalated in the Sec61 lateral gate in
corresponding cryo-EM and crystal structures (Gogala et al., 2014; Park et al., 2014;
Voorhees and Hegde, 2016). Hence this site is currently seen as the canonical region
for hydrophobic stretches to co-translationally partition into the membrane.
Sec61γ (SecE)
The conserved core of Sec61γ forms two α-helical segments. The N-terminal am-
phipathic helix resides perpendicular to the membrane plane on the cytoplasmic
side and contacts the C-terminal half of the Sec61α-subunit. It is connected to the
C-terminal helix via a short hinge region. The C-terminal fragment spans the mem-
brane in a diagonal manner traversing both halves of Sec61α. Overall, this results in
a clamp-like binding to the central channel.
Sec61β (SecG)
Sec61β is a tail-anchored protein and hence consists of a cytoplasmic N-terminal
domain and a single C-terminal TMH. The cytoplasmic region is most likely
disordered and has not been visualized in available structures. The TMH also
appears to be rather dynamic but is in principle located in the vicinity of Sec61α
TMHs 1 and 4.
1.2.2 Biological functions of Sec61
Biochemical as well as structural studies have further provided important mecha-
nistic insights into the co-translational action of Sec61. To date, four different func-
tional states of Sec61 have been characterized: resting, primed, translocating and
inserting.
The resting state most closely resembles the crystal structures of the isolated
(archaea-) bacterial PCC. In this state the plug obstructs the pore and the lateral
gate is completely closed (Van den Berg et al., 2004; Gogala et al., 2014). The main
ribosome-Sec61 interaction is established between the backbone of the 28S rRNA,
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the ribosomal protein eL29 and the uL23/uL29 universal adaptor site on the one
hand and the conserved cytoplasmic L6/7 and L8/9 loops of Sec61α on the other
hand (Becker et al., 2009; Voorhees et al., 2014).
Upon ribosome-binding the channel adopts the primed state, indicated by slight
opening of the lateral gate on the cytoplasmic side. The plug-domain, the pore-ring
residues as well as the lumenal portion of the channel remain unaltered (Voorhees
et al., 2014).
When a nascent chain substrate engages the channel, hydrophilic stretches are
translocated vertically across the ER membrane. This is possible by the plug be-
coming either disordered or being dynamically relocated and by a slight shift of
TMHs 1 and 10 (Gogala et al., 2014; Voorhees et al., 2014).
When the PCC encounters a hydrophobic signal peptide (SP) or a TMS its lateral
gate can open completely to allow direct passage of these segments into the lipid bi-
layer (inserting state, visualized by Voorhees and Hegde, 2016; Gogala et al., 2014).
Two models for partitioning of hydrophobic segments into the membrane have been
proposed. The most prevailing model is the ’in-out’ model, where a helical segment
first fully engages the central Sec61 cavity and then moves laterally into the lipid en-
vironment. In contrast to that stands the ’sliding model’ proposed by the Von Heijne
Lab (Cymer et al., 2015). Here, the hydrophobic segment contacts the lipid phase al-
ready early in the insertion process. This could possibly occur via the crack in the
cytoplasmic face of the channels’ lateral gate which is induced by ribosome binding.
The segment then slides along the outer surface of Sec61 to be fully accommodated
in the membrane. The extent of intercalation into the lateral gate might correlate
to the segments’ hydrophobicity with less hydrophobic segments being more likely
to remain fully intercalated. The considerations behind the sliding model will be
discussed in more detail in section 1.2.5.
The biological roles of the two small PCC subunits are less well characterized.
Sec61γ (SecE) has mostly been studied in the bacterial system. It is essential for
translocation and likely has stabilizing function for the core subunit. The function-
ally important portion lies in the Sec61γ hinge and its C-terminal helix while the
N-terminal amphipathic helix might solely be important for correct localization of
the protein (Lycklama a Nijeholt et al., 2013; Kontinen et al., 1996; Murphy and Beck-
with, 1994; Kihara et al., 1995).
In contrast, Sec61β (SecG) is dispensable for translocation and insertion of PCC sub-
strates (Kalies et al., 1998). Moreover there is apparently no sequence conservation
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between Sec61β and SecG proteins. The protein has been associated with the pro-
cesses involved in handover of the ribosome-nascent-chain-complex (RNC) from
SRP to the Sec61 channel. First, Sec61β has been proposed to act as a guanine nu-
cleotide exchange factor for the β-subunit of the SR (Helmers et al., 2003; Jiang et al.,
2008). Second, delayed translocation upon Sec61β deletion (Kalies et al., 1998) as
well as crosslinking of nascent chains to Sec61β during early translocation events
(Laird and High, 1997; Meacock et al., 2002; MacKinnon et al., 2014; McKenna et
al., 2016) imply a function in inserting the nascent chain into the tunnel pore. Be-
sides, both Sec61β and the prokaryotic SecG have been implicated to be essential for
secretion of certain substrates (Kelkar and Dobberstein, 2009; Sibbald et al., 2010).
1.2.3 Accessory translocon factors
An array of different accessory factors are associated more or less transiently with
the PCC in vivo to form a dynamic assembly, known as the translocon. They are
implicated in different NC modifications or topology determination for nascent
membrane proteins. The core translocon components are the translocating chain-
associating membrane protein (TRAM), the translocon-associated protein complex
(TRAP) and the oligosaccharyltransferase complex (OST).
The translocating chain-associating membrane protein (TRAM)
The integral membrane protein TRAM has been proposed to consist of eight (Tam-
borero et al., 2011) TMS. It is an essential translocon component for many secre-
tory and transmembrane proteins (Görlich et al., 1992; Görlich and Rapoport, 1993).
However, some substrates engage the Sec61 channel in the absence of TRAM. TRAM
has been implicated in early translocation events in a signal-sequence dependent
manner (Görlich et al., 1992; High et al., 1993; Mothes et al., 1994; Voigt et al., 1996).
Furthermore, it has been proposed to have a functional role during membrane pro-
tein biogenesis, possibly chaperoning TMS with charged or hydrophilic residues
(Görlich and Rapoport, 1993; Saurí et al., 2007; Heinrich et al., 2000; Meacock et al.,
2002; McCormick et al., 2003; Devaraneni et al., 2011).
The translocon-associated protein complex (TRAP)
TRAP is a heterotetrameric complex in the ER membrane, formerly known as the
signal sequence receptor complex (SSR) (Hartmann et al., 1993). The α- β- and δ-
subunits have a single TMS whereas TRAPγ adopts a four-fold membrane spanning
topology. The complex has been crosslinked to NCs upon translocation to the ER
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lumen (Wiedmann et al., 1987; Görlich et al., 1990). More recently it has also been
indicated to be involved in topology determination of membrane proteins (Som-
mer et al., 2013). Moreover, mutations in the TRAPδ-subunit result in defects in
asparagine-linked glycosylation due to skipping of some glycosylation sites in the
nascent chain (Losfeld et al., 2014). Low resolution cryo-EM structures as well as
cryo-electron tomography (CET) followed by subtomogram averaging have identi-
fied TRAP as a stoichiometric component of mammalian translocon complexes and
have revealed its positioning with respect to Sec61 and the ribosome (Ménétret et al.,
2005; Ménétret et al., 2008; Pfeffer et al., 2014; Pfeffer et al., 2015; Pfeffer et al., 2017).
The TRAP transmembrane region is flanking the C-terminal half of the PCC. The
complex makes contact to the large ribosomal subunit via its cytoplasmic domain.
On the other side of the membrane the TRAP complex harbors a large lumenal lobe,
which resides below the Sec61 central pore and in close proximity to the Sec61 hinge
region and the lumenal segment of the OST. The complex has been unamenable to
high resolution analysis by single-particle cryo-EM, likely because of its tendency to
be disordered or partly dissociate upon detergent solubilization.
The oligosaccharyltransferase complex (OST)
The eukaryotic oligossacharyltransferase complex (OST) is a multisubunit complex
and an integral part of the ER membrane. It is responsible for the most abundant
post-translational modification of nascent secretory proteins: asparagine-linked gly-
cosylation (N-glycosylation). OST scans the emerging polypeptide for glycosylation
sequons (Asn-X-Ser/Thr(/Cys), where X is any aa except proline, Gavel and Heijne,
1990) and covalently links a preassembled oligosaccharide to the side chain nitrogen
of the Asn residue by an N-glycosidic bond (Helenius and Aebi, 2004; Mohorko et
al., 2011; Shrimal et al., 2015). The enzyme’s catalytic center is located in the ER
lumen (Hanover and Lennarz, 1980; Welply et al., 1983). N-glycosylation has been
shown to be an important determinant for protein topology, since it prevents retro-
translocation of the modified peptide stretch, thereby constraining it to the lumenal
compartment (Welply et al., 1983). Furthermore, naturally occurring as well as ge-
netically engineered glycosylation motifs can be used diagnostically, to probe the
location of a certain protein region (Nilsson and Von Heijne, 1993). This is possi-
ble because successful modification results in a detectable shift of molecular weight
(MW) of approximately 2-3 kilodalton (kDa). The shift can be reversed by treating
the sample with endoglycosidase H (Endo H) to enzymatically remove the oligosac-
charide.
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1.2.4 Membrane protein terminology
Different concepts are used to classify membrane proteins which are inserted into
the bilayer in a Sec61-dependent manner. First, they can be separated into bitopic
versus polytopic (also: single-spanning vs. multi-spanning) proteins (Blobel, 1980).
A bitopic protein has only a single TMH in its mature form whereas several TMH
traverse the membrane multiple times in polytopic substrates.
Another classification approach clusters TMPs into type I, II or III, based on the fi-
nal orientation of the most N-terminal TMH as well as the presence or absence of a
cleavable N-terminal signal peptide (Figure 1.2) (Von Heijne and Gavel, 1988; Spiess,
1995).
Type I TMPs harbor such a signal and the subsequent TMH anchors the mature pro-
Figure 1.2 – Types of membrane proteins. Membrane proteins are be classified accord-
ing to their number of TMS (single- vs. multispanning) or based on the orientation of
the most N-terminal TMS in the mature protein in combination with the presence or
absence of a cleavable N-terminal signal peptide (SP) (Adapted from Spiess, 1995).
tein in the membrane with its N-terminus in the lumen and its C-terminus in the
cytosol (Nlum-Ccyt) once the signal sequence is cleaved off.
Type II TMPs lack a cleavable SS and are instead targeted via their most N-terminal
TMH which then serves as a signal-anchor (SA) in the ER membrane. In type II
proteins, the N-terminus resides in the cytoplasm while the SA-C-terminal-region is
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translocated into the lumen (Ncyt-Clum).
Some type II TMP initially expose their N-terminus to the lumen (head-first inser-
tion) and subsequently reorient the N-terminal TMH in the membrane plane to
obtain their mature topology (Devaraneni et al., 2011). Others are more likely to
retain their N-terminus on the cytoplasmic site, resulting in a looped (hairpin) con-
formation during the insertion process (MacKinnon et al., 2014). Both, hairpin and
head-first insertion followed by reorientation also seem to be possible trajectories for
cleavable signals of type I TMP to reach their looped pre-cleavage orientation (Shaw
et al., 1988; Rösch et al., 2000; Rutkowski et al., 2001; Goder and Spiess, 2003; Ver-
meire et al., 2014). Hairpin vs. head-first insertion has been proposed to be a func-
tion of the number of aminoacids preceding the targeting signal at the N-terminus,
with longer N-terminal stretches promoting the looped insertion (Kocik et al., 2012;
MacKinnon et al., 2014; McKenna et al., 2017).
Finally, type III TMP also do not contain a cleavable signal. In contrast to type II
proteins, they always insert in a head-first manner and do not reorient in the mem-
brane. Thus, their N-terminus is being translocated across the membrane and the
C-terminus of the SA points towards the cytosol (Nlum-Ccyt).
1.2.5 Sec61-dependent membrane protein insertion - a thermody-
namic view
The sliding model for TMS insertion described in 1.2.2 was derived by evaluating
the insertion process from a thermodynamic perspective (Cymer et al., 2015). Ther-
modynamically, a reaction is favorable, when it is connected with a negative differ-
ence in free energy (ΔG). According to the Gibbs equation (Equation 1.1), contri-
butions to ΔG include changes in enthalpy ΔH as well as entropy ΔS for a certain
temperature T.
∆G = ∆H − T∆S (1.1)
For insertion of polypeptides into the lipid bilayer, ΔG is influenced by partitioning
of the peptide backbone as well as the aa side chains. In an extended conformation,
backbone contributions are very unfavorable due to dehydration of hydrophilic
peptide bonds. These ΔG penalties can be tremendously reduced, albeit not en-
tirely abolished by intramolecular saturation of hydrogen bonds through adapting
an α-helical conformation (Ladokhin and White, 1999; Almeida et al., 2012). Parti-
tioning of hydrophobic side-chains on the other hand is beneficial for ΔG of peptide
insertion. In a simplified model, a polypeptide segment is preferentially inserted
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into the bilayer if the hydrophobic effect from the side-chains can outbalance the
unfavorable contributions from insertion of the α-helical peptide backbone. Hence,
the exact ΔG for lipid-bilayer insertion depends on the aa sequence of a given pep-
tide stretch. A biological hydrophobicity scale has been derived to rank amino acids
according to their contributions to ΔG depending on their position in a peptide seg-
ment (Hessa et al., 2005). Factors which influence a residue’s contribution include
its hydrophobicity, charge as well as helix-forming propensity.
Assuming a negative ΔG, it should in principle be possible for a TMS to insert
into the bilayer spontaneously, without the help of the PCC. Therefore, the pri-
mary role of the channel in the insertion might be to facilitate initial contact with
the hydrophobic membrane core. The lateral gate could then open gradually as the
TMS slides along the PCC surface and provide a protected environment for less
hydrophobic faces of TMS or α-helical signal sequences. In addition, the PCC as
well as other translocon factors could impact the topology and tertiary structures of
membrane proteins.
1.2.6 TMH topology determinants
Several determinants have been identified to influence the topology of transmem-
brane helices (For review see for instance Higy et al., 2004; Lee and Kim, 2014).
The first important factor is the charge distribution along the THM. Usually the
TMH terminus with the more positive net charge preferentially locates to the cy-
toplasmic face of the membrane (’positive inside rule’, Von Heijne, 1986). Charges
of immediate flanking residues also contribute to this rule. Another topogenic di-
mension is given by the segment’s hydrophobicity. This includes overall hydropho-
bicity, length of the hydrophobic region as well as the distribution of hydrophobic
residues along the TMS. More hydrophobic segments seem to integrate more readily
whereas marginally hydrophobic segments have been proposed to have longer re-
tention times at the PCC. In some cases hydrophobicity is in direct competition with
the positive inside rule. It has for example been shown that increased hydropho-
bicity prevented the reorientation of a type II SA after headfirst insertion, despite
a net positive N-terminal charge (Goder and Spiess, 2003). Furthermore, folding of
N-terminal domains will prevent a downstream segment from adopting a Nlum-Ccyt
topology. The reason for this is that the PCC is only capable of translocating ex-
tended polypeptides but not stably structured regions across the membrane.
For polytopic transmembrane proteins, the situation is even more complex and by
far less well understood. Initially, it was believed that the orientation of the most
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N-terminal TMH determines the topology of the entire protein (Blobel, 1980). How-
ever more recent data shows that topogenic signals can be present in several regions
of the nascent chain and integration of TMHs can be interdependent or strongly in-
fluenced by adjacent sequences. Recently, up to 100 residues C-terminal of a TMS
have been indicated to influence the topology of this segment (Junne and Spiess,
2017). Similarly, it is still poorly understood at what point a helix disengages from
the PCC. TMHs can be released one-by-one in a series of alternating translocation
and membrane integration steps (linear insertion model, Blobel, 1980; Mothes et al.,
1997). Alternatively, some TMS have been proposed to be retained in the vicinity of
Sec61 and interact with more C-terminal TMS prior to final release (Borel and Simon,
1996; Meacock et al., 2002; Ismail et al., 2006; Cross and High, 2009). Finally, certain
TMH might even transiently disengage the PCC, only to return to the lateral gate
region later during their biogenesis to aid insertion of more C-terminal segments
(Heinrich and Rapoport, 2003).
An example for a class of TMHs which often fail to successfully and stably integrate
into the lipid bilayer themselves are marginally hydrophobic segments. Instead,
they can depend on properties of flanking loops and insertion of neighboring he-
lices (Hedin et al., 2010; De Marothy and Elofsson, 2015). In accordance with this,
helices can be repositioned during the insertion process (Lu et al., 2000; Kanki et al.,
2002; Kauko et al., 2010; Watson et al., 2013).
Another feature of more complex transmembrane proteins are segments which
adopt non-standard topologies in the mature protein. Examples for these are extra-
long TMS which span the membrane diagonally, re-entrant or very short TMS which
only traverse the membrane incompletely, or amphipathic helices, which lie perpen-
dicularly on one face of the membrane (Von Heijne, 2006; De Marothy and Elofsson,
2015; Tsirigos et al., 2018).
Moreover, some proteins exist in multiple topogenic forms and it has even been
shown for a bacterial polytopic substrate that topology can be reversed completely
upon exchange of a single residue (Seppälä et al., 2010).
The exact role of the Sec61 complex and other translocon factors during the topo-
genesis of TMPs remains unclear. Also, the topogenic signals within polytopic TM
proteins and the translocon mediated responses remain only vaguely characterized.
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1.3 Biogenesis of bovine opsin
Bovine opsin is a prototypical G-protein coupled receptor (GPCR). This class of in-
tegral membrane proteins adopts a multispanning topology with seven TMS. Opsin
is highly conserved across organisms and serves as a photon receptor in the retina
after binding to its essential co-factor 11-cis-retinal.
The crystal structure of bovine rhodopsin (i.e. opsin in covalent linkage to the chro-
mophore) provided detailed insights into the protein’s conformation and topology
(see figure 1.3) (Palczewski et al., 2000; Palczewski, 2006).
Opsin is a polytopic type III membrane protein and hence adopts a Nlum-Ccyt topol-
Figure 1.3 – Topology and structure of bovine rhodopsin. A) Schematic depiction of
bovine rhodopsin topology. Functionally important residues (grey, blue, purple) as well
as residues carrying post-translational modfications (orange, red, yellow, light and dark
green) are highlighted. B) Crystal structure of bovine rhodopsin. (Adapted from Pal-
czewski et al., 2000; Palczewski, 2006).
ogy during insertion with the first TMS serving as a SA. This topology has been
confirmed in its native location in the rod cell disk membrane and when translated
in vitro in the presence of canine microsomal ER membranes (Goldman and Blobel,
1981; Hargrave et al., 1983). Its N-terminal tail harbors two N-glycosylation sites at
N2 and N15 (Hargrave, 1977).
Opsin has a long standing tradition as a model substrate for studying both co-
translational membrane protein insertion as well as N-glycosylation (Hargrave,
1977; Goldman and Blobel, 1981). It has been demonstrated, that opsin TMHs 1-
3 as well as 5-7 constitute stable individually folded subdomains (Ridge et al., 1995;
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Ridge et al., 1996). In line with that, crosslinking experiments suggest that these
groups of TMH form independent Sec61-adjacent bundles prior to release into the
bilayer (Ismail et al., 2006; Ismail et al., 2008). In contrast, opsin TMH 4 rapidly
leaves the PCC independent of sequence context. These and earlier studies use in
vitro translated cys-null variants of opsin with a single cystein residue at a central
position within one of the seven TMS. Crosslinking of this cysteine to adjacent pro-
teins is used to explore the interactions of the crosslinked segment with different
translocon components upon varying nascent chain length (Laird and High, 1997;
Meacock et al., 2002; Ismail et al., 2006; Ismail et al., 2008).
Based on crosslinks to Sec61α and Sec61β a two-phase interaction model has been
suggested. In phase I, when a TMH first encounters the PCC, it can be simulta-
neously crosslinked to both Sec61 subunits. With longer chain lengths, crosslinks to
the same position in the opsin chain can only be detected with Sec61α indicating that
the corresponding TMS has now moved to a different environment in the translo-
con region. Furthermore, the authors discovered a protein associated with the ER
translocon of 10 kDa, therefore named PAT-10, which interacts stably with opsin
TMH 1 and 5 throughout the biogenesis of the protein (Meacock et al., 2002; Ismail
et al., 2006; Ismail et al., 2008). Also, they show that TMH 2 undergoes transient
interactions with the TRAM protein (Meacock et al., 2002). Based on these data, the
authors have developed a model for the translocon interactions during opsin bio-
genesis (see Figure 1.4).
The crosslinking experiments serve as a solid basis for understanding the processes
involved in the insertion process of the polytopic opsin substrate. However, they
can only provide very limited spatial information on the position of individual TMS
during the biogenesis. Besides, the authors did not investigate the role of OST which
performs N-glycosylation on two sites in the opsin N-terminal region at the same
time as the protein is being inserted co-translationally.
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Figure 1.4 – Bovine opsin biogenesis. Schematic depiction of opsin biogenesis includ-
ing interactions with specific translocon components (Adapted from Ismail et al., 2006;
Ismail et al., 2008).
1.4 Asparagine-linked glycosylation at the ER mem-
brane
1.4.1 Evolution and significance of OST
The vast majority of proteins which enter the secretory pathway are N-glycosylated
by the OST enzyme. Homologs of the catalytic subunit can be found in all three
kingdoms of life (STT3 proteins in eukaryotes, see Kelleher et al., 2003; AglB in
archaea, see Spirig et al., 1997; PglB in bacteria, see Szymanski et al., 1999). The
bacterial species can be found in the inner leaflet of the plasma membrane, while
the eukaryotic enzyme is located in the ER membrane. An evolutionary perspective
reveals that the number of N-glycosylation-sites in an organism’s proteome has in-
creased drastically from bacteria over fungi to humans (Dell et al., 2010; Zielinska et
al., 2012). Likewise, the complexity of the modifying enzyme has increased dramat-
ically. In bacteria, OST is a single subunit enzyme. In Saccharomyces cerevisiae it is a
heterooctameric complex consisting of the following subunits (homologs in higher
eukaryotes with corresponding abbreviations in parentheses) (Karaoglu et al., 1997;
Spirig et al., 1997; Cherepanova et al., 2016):
• Oligosaccharyltransferase protein 1, Ost1p (ribophorin I, RPN1)
• Oligosaccharyltransferase protein 2, Ost2p (defender against apoptotic cell-
death 1, DAD1)
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• Oligosaccharyltransferase protein 3 or 6, Ost3p or Ost6p (magnesium trans-
porter 1/implantation-associated protein, MagT1/IAP; Tumor suppressor
candidate 3, TUSC3/N33; DC2)
• Oligosaccharyltransferase protein 4, Ost4p (OST4)
• Oligosaccharyltransferase protein 5, Ost5p (transmembrane protein 258,
TMEM258)
• Wheat germ binding protein 1, Wbp1p (Ost subunit of 48 kilodalton, OST48)
• Supressor of Wbp1 protein, Swp1p (ribophorin 2, RPN2)
• Stt3p (staurosporin and temperature sensitive mutant 3, STT3A and STT3B).
Five of the subunits are encoded by essential genes in S. cerevisiae (OST1, OST2,
WBP1, SWP1 and STT3).
By gene duplication metazoans have evolved a second paralog of the catalytic sub-
unit. The resulting STT3A and STT3B proteins assemble with a partially overlap-
ping set of auxiliary factors (RPN1, RPN2, OST4, TMEM258, DAD1, OST48). In
addition, the STT3A- and B complexes incorporate paralog specific subunits (DC2
and KCP2 [keratinocyte associated protein 2] for STT3A; MagT1/IAP or Tusc3/N33
for STT3B) (Figure 1.5).
N-glycosylation has been shown to play a pivotal role in glycoprotein quality con-
Figure 1.5 – Composition of eukaryotic OST complexes. Eukaryotic OST consists of
eight to nine different subunits. Higher eukaryotes express two complex isoforms which
assemble around paralogous versions of the catalytic STT3A/STT3B subunits (names of
S. cerevisiae homologs in parentheses) (Adapted from Braunger et al., 2018).
trol, protein folding as well as -trafficking (Sato et al., 2012; Tannous et al., 2015;
Caramelo and Parodi, 2015). Concomitantly, defects in N-glycosylation in humans
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result in a class of diseases called congenital disorders of glycosylation (Reviewed
for example in Hennet and Cabalzar, 2015).
1.4.2 The oligosaccharide precursor
The oligossacharide precursor is assembled in a series of glycosyltransferase reac-
tions. They are catalyzed by alg-family proteins (alg = asparagine-linked glycosyla-
tion). Via a pyrophosphate (PPi) bond the precursor is linked to a dolichol molecule
(Dol), which anchors it to the ER membrane. The first seven sugar residues are as-
sembled on the cytoplasmic face of the rough ER. The partially assembled precursor
is then flipped across the membrane by Rft1 (Helenius et al., 2002) and its synthesis
is completed in the ER lumen. The final lipid-linked oligosaccharide (LLO) adopts a
branched structure and consists of two N-acetyl-glucosamines, nine mannose units
and three glucose moieties (Glc3Man9GlcNAc2-PP-Dol) (Figure 1.6).
Once the preassembled oligosaccharide has been transferred to the substrate pep-
Figure 1.6 – The LLO precursor. Schematic depiction of the lipid-linked oligosaccha-
ride precursor (LLO) including the types of glycosydic linkage between monosaccha-
ride components (Adapted from Stanley et al., 2015).
tide, it undergoes several trimming and modification steps. These lead to a great
variety of N-linked glycans which play crucial functional and structural roles.
1.4.3 Catalytic mechanism of STT3-type enzymes
The crystal structures of bacterial PglB (protein glycosylation B) and archaeal AglB
(archaeal glycosylation B) single-subunit OST enzymes have been solved in different
functional states (Igura et al., 2008; Maita et al., 2010; Lizak et al., 2011; Matsumoto et
al., 2013; Matsumoto et al., 2017; Napiórkowska et al., 2017). A high degree of struc-
tural conservation has been observed despite low levels of sequence conservation,
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in particular for the transmembrane region and the functionally important core of
the C-terminal domain. Moreover, the acceptor sequon requirements (N-X-S/T(/C),
see Gavel and Heijne, 1990; extended to E/D-X-N-X-S/T in bacteria, see Kowarik et
al., 2006) as well as the chemical nature of the LLO (an isoprenoid membrane an-
chor and a pyrophosphate leaving group coupled to the preassembled glycan) are
conserved widely across all kingdoms of life. This suggests that mechanistic im-
plications from the PglB and AglB structures also apply to the catalytic STT3-type
subunits of eukaryotic OST.
Overall, the structures are composed of a large N-terminal transmembrane domain
and a slightly smaller C-terminal soluble domain which could also be crystallyzed
separately (Igura et al., 2008; Maita et al., 2010). Furthermore, the OST crystal struc-
tures reveal two groves at the membrane interface on opposite sides of the enzyme.
They serve as binding regions for the two types of substrates which need to be han-
dled by OST in a coordinated manner: the acceptor peptide and the LLO. The two
cavities are connected by a tunnel (also referred to as the enzyme’s "loophole") to
allow for covalent substrate linkage. The acceptor sequon must be localized in a
flexible loop in order to accommodate in the active site, thus precluding modifica-
tion of folded peptide regions.
Hence, the structures defined three spatially separated functional sites for binding of
the peptide sequon, accomodation of the LLO donor as well as an active site region.
Individual residues at each of these sites which have been shown to be important
for OST functionality are listed in table 1.1 for different organisms.
In more detail, the N-terminus of the enzyme adopts a unique fold of thirteen trans-
membrane segments. Most connecting cytoplasmic and external loops (EL) are rel-
atively short. Exceptions to this are EL1 (between TMS 1 and 2) and EL5 (between
TMS 9 and 10). EL1 is well structured in all available models and contains two α-
helical stretches.
In contrast, EL5 adopts different conformational states depending on absence or
presence of LLO and peptide substrates in the crystal structures. The loop is com-
pletely structured in the enzyme’s apo state (absence of peptide and LLO, pdb 3wak)
(Matsumoto et al., 2013) or when both, an acceptor peptide and a synthetic, nonhy-
drolyzable LLO analog are tightly bound (pdb 5ogl) (Napiórkowska et al., 2017).
In these structural models, it forms a short helical segment in the N-terminal half
(N-EL5). In contrast, the C-terminal region does not contain defined secondary
structural elements despite being rigid enough to be visualized in the crystal struc-
tures. When bound to a substrate peptide but not the glycan donor (pdb 3rce, 5gmy)
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Table 1.1 – Functionally important residues in STT3-type enzymes of different or-
ganisms. Residues which have been shown to be involved in crucial interactions for
substrate binding or catalysis in crystal structures of single subunit OST enzymes (PglB,
AglB) (Igura et al., 2008; Maita et al., 2010; Lizak et al., 2011; Matsumoto et al., 2013;
Matsumoto et al., 2017; Napiórkowska et al., 2017) and corresponding residues in eu-
karyotic STT3-type enzymes (Stt3p, STT3A, STT3B). Conserved motifs are underlined.
Ser/Thr = serine/threonine residues in +2 position of the acceptor sequon, PPi = py-
rophosphate, NAc = N-acetyl group of the reducing-end GlcNAc moiety, M2+ = diva-
lent metal ion (Mn2+ in vivo), Asn = acceptor asparagine.
Function Binding C. lari A. fulgidus S. cerevisiae H. sapiens H. sapiens
partner (PglB) (AglB) (Stt3p) (STT3A)* (STT3B)*
WWD
Ser/Thr W463 W550 W516 W525 W604
Peptide Ser/Thr W464 W551 W517 W526 W605
binding Ser/Thr D465 D552 D518 D527 D606
DK/MI
Ser/Thr I572 K618 K586 K595 K674
LLO PPi Y196 W215 W208 W209 W263
binding PPi R375 R426 R404 R405 R459
NAc Y468 H555 Y521 Y530 Y609
M2+/Asn D56 D47 D47 D49 D103
Active M2+ D154 D161 D166 D167 D221
site M2+ D156 H163 E168 E169 E351
TIXE/SVSE
M2+/Asn E319 E360 E350 E351 E405
*residue numbers are identical to Canis lupus familiaris STT3A/B which is used in the present study
(Lizak et al., 2011; Matsumoto et al., 2017), N-EL5 appears flexible and cannot be vi-
sualized. Finally, the loop is completely disordered in an archaeal structure which
did not contain any substrates or analogs but showed extra density for a sulfate-ion
which was proposed to mimick the pyrophosphate group of the LLO precursor (pdb
3waj) (Matsumoto et al., 2013). Besides, tethering of N-EL5 to the transmembrane re-
gion by crosslinking to the C-terminal, lumenal end of TMH 11 has significantly re-
duced turnover of a fully assembled oligosaccharide precursor while leaving trans-
fer of a minimal monosaccharide substrate unaffected. Based on these finding it
was proposed that N-EL5 immobilization impairs LLO binding (Napiórkowska et
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al., 2017). Hence, EL5 has been assigned a prominent role in the catalytic mecha-
nism.
TMS 1-4 as well as 10-13 form the most prominent contact sites to the well-structured
C-terminal periplasmic domain.
The periplasmic domain contains the conserved WWD and DK/MI motifs which
form the binding pocket for the +2 threonine/serine residue in the acceptor peptide
via hydrogen bonds (WWD motif) or van der Waals interactions (DK/MI motif)
(Igura et al., 2008; Maita et al., 2010; Lizak et al., 2011). This ensures spatial separa-
tion from the modified asparagine which can in turn accommodate in the loophole.
The catalytic pocket is also highly conserved. Four acidic residues (D56, D154, D156,
E319 in C. lari, for other organisms see table 1.1), coordinate a divalent metal ion
(M2+) which is required for catalysis and has been proposed to have a post-catalysis
stabilizing role for the lipid-pyrophosphate (Lizak et al., 2011; Napiórkowska et al.,
2017). D56 and E319 also interact with the acceptor asparagine, resulting in activa-
tion of its nitrogen and facilitating nucleophilic attack on the LLO. E319 is located in
the C-terminal half of EL5 and is part of the widely conserved TIXE (Thr-Ile-X-Glu)
motif in archaea and eubacteria, or the corresponding SVSE (Ser-Val-Ser-Glu) motif
among eukaryotes (Matsumoto et al., 2013).
Based on the structures in different functional states the following catalytic cycle has
been proposed (Matsumoto et al., 2013; Napiórkowska et al., 2017):
• Step 1: apo-state
• Step 2: polypeptide-bound- or LLO-bound-state
• Step 3: ternary complex OST-polypeptide-LLO
• Step 4: transition state, catalysis, glycopeptide release
• Step 5: lipid-pyrophosphate-bound state
Napiorkowska et al. have set up the hypothesis that LLO binding is likely to occur
prior to peptide binding (Napiórkowska et al., 2017). The reasoning is that EL5-C
engagement upon peptide binding might limit the access of the bulky oligosaccha-
ride precursor to its binding site.
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1.5 The eukaryotic OST complex
1.5.1 Complex architecture and distance restraints
Structural data on eukaryotic OST and its subunits remains scarce. Therefore, do-
main assignments and assumed topologies rely almost exclusively on structure pre-
dictions and biochemical characterization, for example by protease protection stud-
ies or glycosylation mapping assays. Also, the arrangement of OST subunits with
respect to each other remains elusive.
However, biochemical studies on the yeast OST complex have indicated existance
of three OST subcomplexes (Karaoglu et al., 1997). Subcomplex I is formed by
Ost1p and Ost5p. Subcomplex II contains the catalytic Stt3p subunit, Ost4p as
well as Ost3p or Ost6p respectively. Subcomplex III encompasses Swp1p, Wbp1p
and Ost2p. In metazoans these subcomplexes would correspond to RPN1 and
TMEM258 (Subcomplex I); STT3A/B, OST4 and the paralog specific subunits (Sub-
complex II); RPN2, OST48 and DAD1 (Subcomplex III).
In higher eukaryotes, distinct functions of the OST complexes assembling around
STT3A or STT3B (from now on referred to as STT3A-OST and STT3B-OST respec-
tively) have also been inferred from biochemical studies. These data have indicated
that STT3A-OST but not STT3B-OST associates with the ribosome-Sec61-complex
(Shibatani et al., 2005; Ruiz-Canada et al., 2009). The overall spatial arrangement of
the mammalian OST-containing ribosome-translocon-complex (RTC) has been es-
tablished by moderate resolution cryo-electron tomography structures (see figure
1.7) (Pfeffer et al., 2014; Pfeffer et al., 2015; Pfeffer et al., 2017). They revealed that
the OST TM region is localized proximal to the N-terminal half of Sec61 and the
PCC’s hinge region. In addition, OST has a large lumenal extension, protruding
approximately 90 Å into the ER lumen (Pfeffer et al., 2014). Ribosome associated
nascent chains first have access to the OST active site when the distance between
the PTC and the acceptor asparagine is 65-75 aa (Whitley et al., 1996). With respect
to the membrane, the minimal distance for sucessful glycosylation between a signal
sequence or TMD and the acceptor arginine has been shown to be 10-14 aa, cor-
responding to 20-30 Å, depending on the peptide conformation (Nilsson and Von
Heijne, 1993; Nilsson et al., 1994).
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Figure 1.7 – CET structure of mammalian OST-containing RTCs. Subtomogram av-
erage of the mammalian OST-containing RTC filtered to 9.0 Å resolution reveals the
spatial arrangement of translocon components (Adapted from Pfeffer et al., 2015).
1.5.2 The catalytic STT3 subunit
For a long time the number of TMH in eukaryotic STT3-type enzymes was not un-
ambiguously known, ranging from 11 to 13 according to hydropathy plots and gly-
cosylation mapping assays (Kim et al., 2005). However, recent evidence could con-
firm thirteen membrane spanning stretches in the eukaryotic enzyme (Lara et al.,
2017) in analogy to the archaeal and bacterial homologs. Despite their shared topol-
ogy and very high degree of sequence conservation (60% sequence identity), STT3A
and STT3B display certain differences in their cellular roles (Kelleher et al., 2003;
Ruiz-Canada et al., 2009). Functional analyses of the complex isoforms rely on se-
lective purification of either STT3A- or STT3B-OST (Kelleher et al., 2003), siRNA me-
diated knock-down (Wilson and High, 2007; Ruiz-Canada et al., 2009) or CRISPR-
mediated knock-out of either one of the catalytic STT3 paralogs (Cherepanova and
Gilmore, 2016).
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STT3A
The 81 kDa STT3A paralog forms the catalytic core of the STT3A-OST complex
which acts purely co-translationally and is responsible for the majority of all N-
glycosylation events (Ruiz-Canada et al., 2009). It has very stringent substrate re-
quirements for both, the acceptor peptide as well as the LLO donor. This leads to
skipping of glycosylation consensus sites under certain circumstances. First, se-
quons in close proximity to a signal sequence cleavage site have been observed
to be unamenable to glycosylation by STT3A-OST (Ruiz-Canada et al., 2009). Se-
quon skipping can also be caused by closely spaced NXS acceptor sites (Shrimal
and Gilmore, 2013). Besides, glycosylation by STT3A is very limited when the cor-
responding motif is found in a very C-terminal region of the substrate polypep-
tide (Shrimal et al., 2013). Finally, sub-optimal sequons, including those with inter-
nal cysteine residues are omitted at a high frequency by STT3A-OST (Malaby and
Kobertz, 2014; Cherepanova et al., 2014).
STT3B
The OST complex containing STT3B can act co- and post-translationally (Kelleher et
al., 2003; Ruiz-Canada et al., 2009). The major role proposed for STT3B-OST is glyco-
sylation of substrates which have been skipped by STT3A-OST to ensure maximum
coverage (Ruiz-Canada et al., 2009). In line with that, STT3B-OST is more active
than STT3A-OST and more promiscuous in substrate and donor selection (Kelleher
et al., 2003). STT3B has been shown to be more similar to yeast Stt3p than the STT3A
paralog (Shrimal and Gilmore, 2013; Zielinska et al., 2010; Zielinska et al., 2012). In
contrast to the yeast enzyme and the STT3A paralog, the 94 kDa STT3B features ad-
ditional N- and C-terminal extensions as well as a significantly longer loop between
TMH 12 and 13 (L12/13) (Kelleher et al., 2003).
Interestingly, STT3B-mediated hyperglycosylation of misfolded protein substrates
at consensus sites which are neglected in the correctly folded proteins can target
these substrates for ER-associated degradation (Sato et al., 2012; Cherepanova et al.,
2016).
1.5.3 Shared accessory subunits
The majority of metazoan OST subunits form part of both complex isoforms.
RPN1 (Ost1p)
Ribophorins were originally named based on their localization to ribosome-binding
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sites in the rough ER (Kreibich et al., 1978). RPN1 (68 kDa) was among the first
three identified OST subunits, together with RPN2 and OST48 (Kelleher et al., 1992).
RPN1 has been predicted to consist of a large lumenal domain, a single trans-
membrane helix and a C-terminal cytoplasmic domain of approximately 150 aa
(Crimaudo et al., 1987; Mohorko et al., 2011). Antibodies against the cytoplasmic
domain inhibit protein translocation by preventing ribosome targeting to the mem-
brane (Yu et al., 1990). RPN1 is crucial for glycosylation in a substrate dependent
manner. Certain secretory and polytopic substrates can be successfully glycosylated
in absence of RPN1 whereas the subunit plays an important role for modification of
single-spanning substrates (Wilson et al., 2005; Wilson and High, 2007; Wilson et al.,
2008).
RPN2 (Swp1p)
Primary structure analyses indicate that the RPN2 protein has a large lumenal do-
main followed by three transmembrane helices at the C-terminus (Crimaudo et al.,
1987). Notably, mammalian RPN2 displays a large difference in molecular weight
compared to the homologous yeast protein (67 kDa RPN2, 32 kDa Swp1p) which is
not true for any of the other OST subunits (Shibatani et al., 2005).
OST48 (Wbp1p)
OST48 is a type I single-spanning TMP with a substantial N-terminal lumenal por-
tion and only very few cytoplasmic residues downstream of the TMH. The protein
has been suggested to act as a bridge between the ribophorin subunits via its lume-
nal domain (Fu et al., 1997). Besides, the yeast homolog Wbp1 (Te Heesen et al., 1992;
Silberstein et al., 1992) has been implicated in LLO precursor binding (Pathak et al.,
1995). This suggestion is in line with the finding of a homology search which has
identified a GIFT domain (for GldG/IFT = Gliding motility protein G/intraflagellar
transport) in the Wbp1p and OST48 lumenal domains which was proposed to have
sugar binding function (Beatson and Ponting, 2004). However, confirmatory data
for the LLO-binding hypothesis is lacking (Mohorko et al., 2011).
DAD1 (Ost2p)
Together with the catalytic subunits and the initially identified RPN1, RPN2 and
OST48 subunits, DAD1 - a small 12 kDa protein - constitutes the fifth essential com-
ponent of eukaryotic OST (Kelleher and Gilmore, 1997; Fu et al., 1997). Is is also the
OST subunit with the highest degree of sequence conservation between mammalian
species (100% identity between human, mice, rat, and hamster; 99% among human,
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canine and bovine DAD1) (Mohorko et al., 2011). Structure predictions suggest two
TMDs with both termini located in the cytosol. Functionally, DAD1 is important for
OST complex stability (Sanjay et al., 1998; Roboti and High, 2012b).
TMEM258 (Ost5p)
While yeast Ost5p had long been known as an OST component (Reiss et al., 1997),
its mammalian homolog was only recently identified (Parnas et al., 2015; Blomen
et al., 2015). It is a 9 kDa protein with two TMH but its orientation in the membrane
remains unclear. An interaction with the RPN1 homolog Ost1p has been proposed
in S. cerevisiae (Reiss et al., 1997) but functional data on the mammalian homolog is
not available to date.
OST4 (Ost4p)
Similar to OST5, Ost4p was first identified as a OST component in yeast (Karaoglu
et al., 1997) and OST4 has later been confirmed as a component of the mammalian
OST complexes (Kelleher and Gilmore, 2006; Dumax-Vorzet et al., 2013). It is the
smallest OST subunit, with a molecular weight of only 4 kDa. Notably, this sin-
gle TMH protein (Ccyt-Nlum topology) is the only mammalian OST component for
which high-resolution structural data is available to date (Zubkov et al., 2004; Gayen
and Kang, 2011). The yeast homolog Ost4p has been implicated in stabilizing the in-
teraction between Stt3p and Ost3p as well as regulating the incorporation of Ost3p
or Ost6p respectively (Kim et al., 2003; Spirig et al., 2005).
1.5.4 The STT3A specific subunits DC2 and KCP2
STT3A-OST has been shown to incorporate two paralog specific subunits, DC2 (17
kDa) and KCP2 (Keratinocyte-associated protein 2, 14 kDa) (Shibatani et al., 2005).
DC2 shows weak homology to the C-terminal domain of yeast Ost3p/Ost6p and
has a predicted three-TMH topology. Noteworthy, it is lacking its homologues’ N-
terminal thioredoxin-like domain. KCP is a small 14 kDa protein with a predicted
4-TMH topology (Roboti and High, 2012a). It is the only OST component without
any known homolog in the yeast complex. KCP2 may facilitate the glycosylation of
selected substrate proteins (Roboti and High, 2012b). Functional analyses are ham-
pered by the fact that KCP2 displays a tendency to be lost upon OST solubilization
in detergent (Roboti and High, 2012b; Kelleher et al., 2003). Recent biochemical
evidence indicates that DC2 and KCP2 are required for stable interaction of STT3A-
OST with the PCC (Shrimal et al., 2017). However, loss of KCP2 results in a less
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severe phenotype than knockout of DC2. The latter resembles a deletion mutant of
the STT3A paralog of the catalytic subunit.
1.5.5 The STT3B specific oxidoreductase subunit
Instead of DC2 and KCP2, the STT3B complex associates with one of two other
mammalian homologs of the yeast Ost3/6p, namely TUSC3 (tumor suppressor can-
didate protein 3, also known as N33, 36 kDa) or MagT1 (magnesium transporter
1, also known as implantation-associated protein - IAP, 35 kDa) (MacGrogan et al.,
1996; Kelleher et al., 2003; Cherepanova et al., 2014).
In contrast to DC2, TUSC3 and MagT1 harbor a common thioredoxin fold in their
lumenal domain (Fetrow et al., 2001; Schulz et al., 2009) and likely acquire a four-
fold membrane spanning topology (Karaoglu et al., 1995). The proteins have been
proposed to compete with naturally occurring intramolecular disulfide bridge for-
mation by forming transient mixed disulfides with a free thiol in a glycoprotein
substrate. The current model suggests that this prevents these substrates from
obtaining their mature, folded conformation, hence keeping them accessible for
modification by OST (Schulz et al., 2009; Cherepanova et al., 2014). Furthermore,
TUSC3 or MagT1 might be needed for peptide substrate recognition by STT3B-OST
(Cherepanova et al., 2016).
1.6 Aims of this thesis
This dissertation aims to elucidate the mechanisms of co-translational membrane
protein insertion and to characterize the coupling of translation, translocation and
N-glycosylation at the mammalian endoplasmic reticulum.
The events occurring at the PCC during the biogenesis of secretory substrates are
fairly well understood. In contrast, many open questions prevail with regard to the
processes involved in the Sec61 mediated insertion of integral transmembrane pro-
teins.
How do individual TMS partition into the membrane? The existing structural data
show that a TMH can occupy the lateral gate of Sec61 (Gogala et al., 2014; Park et al.,
2014). However, they represent post-accommodation states and cannot explain how
the substrate has reached its final position. When did it get into contact with the
lipid phase? Did it pass though the central pore or slide along the outer surface of
Sec61?
Besides, there is no structural data on the insertion of polytopic transmembrane
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proteins in eukaryotes. Do individual TMHs stay close to the channel or even form
Sec61-proximal bundles prior to full release into the bilayer as it has been indicated
by crosslinking studies? Where do they reside with respect to different translocon
factors? And what is the exact role of the PCC and other translocon accessory fac-
tors in membrane protein topogenesis?
Moreover, since the majority of Sec61 substrates are N-glycosylated co-
translationally at the ER membrane, it is important to understand how the OST
cooperates with the ribosome and the PCC to accomplish this task.
Therefore, the first goal of this thesis was to establish a protocol for the purification
of defined biogenesis intermediates of polytopic transmembrane proteins. More-
over, the chosen approach should be suitable to account for the additional layer of
complexity which OST-involvement adds to the process for many naturally occur-
ring substrates. Therefore, in contrast to available protocols (Voorhees et al., 2014;
Voorhees and Hegde, 2016; Gogala et al., 2014) the strategy should enable recovery
of OST-containing RTCs.
To that end, we designed different C-terminally truncated variants of the well-
studied polytopic glycoprotein bovine opsin (see section 1.3) with a C-terminal ri-
bosome stalling sequence. In vitro translation of these constructs in the presence
of mammalian microsomal ER membranes was performed to obtain homogeneous
and stable biogenesis intermediates at different insertion stages. A fast and mild
isolation strategy was developed to allow for biochemical and structural character-
ization.
The second aim was to perform in depth structural analysis on the resulting com-
plexes. For that purpose, the biogenesis intermediates were isolated biochemically
and subjected to cryo-EM followed by single-particle analysis.
We set out to obtain high-resolution structures of defined steps along the co-
translational insertion and N-glycosylation pathway which can provide new in-
sights into the process of membrane protein insertion at the mammalian ER. More-
over, they can unravel the complex interplay between the molecular machineries
involved in protein translation, translocation and N-glycosylation. Finally, a high-
resolution structure of the mammalian OST complex can offer unprecedented in-
sight into the architecture of this multisubunit enzyme.
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Materials and Methods
2.1 General
Autoclaved glassware and sterile laboratory material was used in all experiments.
Buffers and stock solutions were prepared using deionized water and were sterile
filtered before use. Nuclease-free H2O was used for all in vitro transcription and
translation reactions.
2.2 Vectors
All constructs are based on a pEXK4 vector (eurofins) coding for full-length (FL)
bovine opsin. The gene was under a T7 promoter and flanked by a high transla-
tion initiation efficiency 5’ UTR region as described in Beckmann et al. (Beckmann
et al., 2001) and contained an N-terminal hemagglutinin-tag (HA-tag). Vectors cod-
ing for truncated opsin variants with a C-terminal ribosome stalling sequence from
the human cytomegalovirus (CMV) gp48 upstream open reading frame 2 (uORF2)
(Degnin et al., 1993; Bhushan et al., 2010; Matheisl et al., 2015) were generated by
polymerase chain reaction (PCR, see section 2.3.1).
2.3 Molecular Cloning
2.3.1 Polymerase chain reaction (PCR)
PCR was used in order to generate vectors coding for C-terminally truncated opsin
variants with a CMV stalling sequence. The forward primer (F_ pEXK4) was de-
signed to anneal in the pEXK4 backbone downstream of the opsin FL coding se-
quence. Reverse primers (R_ OP96-HA, R_ OP109, R_ OP130, R_ OP164, R_ OP204)
were designed such that they contain a region which overlaps with the opsin ORF
28 Chapter 2. Materials and Methods
21 aa upstream of the desired final number of aa. In addition the reverse primers
contained an overhang coding for the reverse complement sequence of the 21 aa
CMV stalling peptide including a UGA stop-codon triplett. The OP96 construct
was initially designed to include a C-terminal HA-Tag between the opsin coding
sequence and the CMV stalling sequence. The tag was later replaced with the cor-
responding opsin aa using the primers F_ replaceHA and R_ replaceHA. All primer
sequences are listed in table 2.1.
Table 2.1 – Primers used for plasmid modification. Primary sequence of the forward
(F_) and reverse (R_) primers. The sequence coding for the reverse complement of the
inserted CMV stalling sequence is underlined.
Name Sequence
F_ pEXK4 CCGCTCACAATTCCACACAACATAC
R_ OP96-HA TCAGGGAGGGATATACTTGCATGTAAGCAGGCTGCT
CAGTTTCTTGGCGGACAACACCAAGGGCTCGGC
GTAATCTGGGACGTCATACGGGTACTTGTGCTG-
GACTGTGACGTAC
R_ OP109 TCAGGGAGGGATATACTTGCATGTAAGCAGGCTGCT
CAGTTTCTTGGCGGACAACACCAAGGGCTCGAA
GACCATGAAGAGGTCGGCCACGGC
R_ OP130 TCAGGGAGGGATATACTTGCATGTAAGCAGGCTGCT
CAGTTTCTTGGCGGACAACACCAAGGGCTCGCC
CGTGGGCCCAAAGACGAAGTACCC
R_ OP164 TCAGGGAGGGATATACTTGCATGTAAGCAGGCTGCT
CAGTTTCTTGGCGGACAACACCAAGGGCTCCAT
GGGCTTGCACACCACCACGTACCG
R_ OP204 TCAGGGAGGGATATACTTGCATGTAAGCAGGCTGCT
CAGTTTCTTGGCGGACAACACCAAGGGCTCCAT
GCCCTCCGGGATGTACCTGGACCA
F_ replaceHA AAGCTGCGCACACCCCTCAACTACATCGAGCCCTT
GGTGTTGTCCGC
R_ replaceHA CTTGTGCTGGACTGTGACGTAC
The reactions were prepared using the Thermo Scientific Phusion Flash High-
Fidelity PCR Master Mix according to the manufacture’s protocols. PCR was per-
formed in a two-phase protocol. Initially, reactions were prepared to contain either
the forward or one of the reverse primers (F-mix and R-mix respectively). There-
fore, this first phase serves for amplification of the full-length plasmid including
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the primer-encoded overhangs. Subsequently, one F-mix was pooled with one R-
mix and the PCR was resumed in order to obtain linearized plasmids coding for the
desired opsin construct. The two step program for whole plasmid amplification is
shown in detail in table 2.2.
Table 2.2 – PCR program used for plasmid mutagenesis and amplification. A two-
phase program was used in order to amplify plasmids of different C-terminal trunca-
tions of bovine opsin and to introduce a C-terminal CMV stalling sequence.
Phase Step Purpose Temperature Duration Repetitions
I
1 Initial DNA denaturation 98°C 180s 1x
2 Iterative DNA denaturation 98°C 20s
4x3 Primer annealing 62°C 25s
4 Iterative Elongation 72°C 210s
5 Final Elongation 72°C 600s 1x
6 Finish 12°C 600s 1x
Pool F-mix and R-mix
II
1 Initial DNA denaturation 98°C 30s 1x
2 Iterative DNA denaturation 98°C 180s
11x3 Primer annealing 52°C 20s
4 Iterative Elongation 72°C 210s
5 Final Elongation 72°C 600s 1x
6 Finish 12°C 600s 1x
2.3.2 Degradation of parental DNA
After whole plasmid amplifications parental DNA was degraded using the restric-
tion endonuclease Dpn1 (NEB). Dpn1 exclusively digests methylated DNA, hence
preserving the DNA amplified by PCR. The digestion was performed at 37°C for
one hour after adding 5.7 µL 10× CutSmart buffer (NEB) and 1.3 µL Dpn1 (NEB)
to 40 µL of PCR product. Dpn1 treated amplified plasmids were purified using the
QUIAquick PCR purification kit (QUIAGEN) according to manufacturer’s instruc-
tions. DNA was eluted into 30-40 µL nuclease free water.
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2.3.3 Phosphorylation and Ligation
After plasmid amplification vectors were phosphorylated and re-ligated. The Dpn1
digested PCR products were mixed in a 1:10 ratio with 10x T4 ligase buffer (NEB)
and incubated for 1 h at 37°C with T4 polynucleotide kinase (NEB) in order to gen-
erate 5’phosphorylated DNA ends. Subsequently T4 ligase (NEB) was added to the
reaction and the mix was incubated for 1 h at 37°C or over night at 16°C.
2.3.4 Plasmid transformation
Plasmids were transformed immediately after ligation into competent E. coli DH5α
cells. The cells were thawed on ice and 10 µL of DNA were added and mixed with
the cells by a quick flip of the tube. After 10 min incubation on ice the cells were heat-
shocked for 90 s at 42°C in a waterbath prior to addition of 900 µL of LB medium.
Cells were recovered by incubation at 37°C for 45 min in a shaker and subsequently
plated onto LB-Agar plates containing kanamycin as a selection marker (LB-Agar-
Kan) for positive clones.
2.3.5 Plasmid isolation
2 mL LB medium containing 50 µg/mL Kanamycin were inocculated with a posi-
tive clone from an LB-Agar-Kan plate. Cultures were grown for 8-9 h. Subsequently
plasmid DNA was isolated using the QUIAprep Spin Miniprep Kit (QUIAGEN)
according to the manufacturers instructions. Final DNA concentrations were mea-
sured using a Nanodrop 1000 device. Isolated DNA was sent for sequencing at eu-
rofins, using the pEXK-forward and pEXK-reverse primers to confirm the primary
sequence of the coding region.
2.4 Preparation of mRNA
2.4.1 Template generation by PCR
In order to generate a template for subsequent in vitro transcription, the region cod-
ing for the desired opsin construct was amplified from the corresponding plasmid
by PCR. Used primers were a 5’ T7 forward primer (TAATACGACTCACTATAG)
and a 3’ reverse CMV-STOP (TCAGGGAGGGATATACTTGCATG) primer. Linear
DNA for subsequent use as template DNA in in vitro transcription reactions were
amplified by PCR using the Thermo Scientific Phusion Flash High-Fidelity PCR
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Master Mix and the PCR program given in table 2.3.
Table 2.3 – PCR program used amplification of opsin constructs. Linear DNA frag-
ments coding for the T7 promoter region, the 5’UTR and the truncated opsin-ORF with
a C-terminal CMV stalling sequence were amplified as templates for in vitro transcrip-
tion.
Step Purpose Temperature Duration Repetitions
1 Initial DNA denaturation 98°C 30s 1x
2 Iterative DNA denaturation 98°C 20s
30x3 Primer annealing 52°C 20s
4 Iterative Elongation 72°C 210s
5 Final Elongation 72°C 600s 1x
6 Finish 12°C 600s 1x
The products were purified using the QUIAquick PCR purification kit and concen-
trations were measured using a Nanodrop 1000 device. Prior to further use they
were analyzed by agarose gel electrophoresis in order to confirm the correct size
and rule out contaminations by secondary products. Separation of PCR fragments
was done using a 2% agarose gel in TAE buffer (40 mM Tris, 20 mM acetic acid, 1mM
EDTA). Agarose was resuspended in buffer and heated until it was completely dis-
solved. The gel was poured with 3:50000 SybrSafe DNA stain and left to polymerize
for 30-45 min. For sample preparation DNA was mixed in a 1:10 ratio with 10x
DNA loading dye (50% glycerol, 1 mM EDTA, 0.25% bromophenol blue,0.25% xy-
lene cyanol FF). A DNA molecular weight standard (100 bp or 1 kb ladder, Thermo
Scientific) was loaded next to samples for size estimation. Electrophoresis was per-
formed for 30-45 min at 125 V. Fragments were detected using a Multi Gel Jet (IN-
TAS) system.
2.4.2 In vitro transcription
In vitro transcription recations were performed in order to generate mRNA tem-
plates for in vitro translation. The reaction mix was prepared in the order given in
table 2.4 at RT.
The mix was incubated for 1 h at 37°C, the first 15 minutes shaking slightly. Then,
additional 4 µL of T7 polymerase were added and the incubation was continued for
1 h. 3 µL of TURBO DNase (from the T7 mMESSAGE mMACHINE kit, Ambion)
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Table 2.4 – Reaction mix for in vitro transcription. The reaction mix was prepared in
the given order of components at room temperature.
Component c(stock) V or c(final)
T7 Transcription Buffer 10x 1x
DTT 1 M 0.5 mM
ATP 125 mM 6.25 mM
GTP 125 mM 6.25 mM
CTP 125 mM 6.25 mM
UTP 125 mM 6.25 mM
Template DNA 100-300 ng/µL 30 ng/µL
Anti-RNase (Ambion) 20 U/µL 0.4 U/µL
Nuclease free H2O ad 96 µL
T7 RNA Polymerase (pre-
pared in-house)
4 µL
Total Volume ∑ 100 µL
were added and the mix was incubated on a shaker for 15 min at 37°C.
For precipitation of mRNA 100 µL of nuclease free H2O and 120 µL of saturated LiCl
solution were added and the resulting mix was incubated over night at -80°C. The
RNA was pelleted by centrifugation, the supernatant was sucked away carefully
and the pellet was washed once with 70% Ethanol in order to remove salt contam-
inations. After a final pelleting step, the pellet was dried at RT and resuspended
in 100-200 µL nuclease free water. mRNA concentration was determined on a Nan-
odrop 1000 device.
Quality of the resulting mRNA was evaluated by agarose gel electrophoresis. These
experiments were performed in analogy to DNA analysis experiments but samples
were prepared using a 2x RNA loading dye (95% formamide, 0.025% xylene cyanol
FF, 0.025% bromophenol blue, 0.025% SDS, 18 mM EDTA).
2.5 In vitro translation reactions
All in vitro translation assays were performed using the rabbit reticulocyte lysate
(RRL) cell free in vitro translation system (Promega). In vitro translation was per-
formed either in absence or presence of puromycin/high-salt treated microsomal
membranes from dog pancreas (PKRMs). In absence of PKRMs, the expression
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level was analysed and optimized for all constructs. Translation reactions were sup-
plemented with PKRMs (prepared by Marko Gogala, Gene Center Munich, as de-
scribed before, see Walter and Blobel, 1983) in order to evaluate the targeting and
glycosylation efficiencies of the constructs used.
Before use in the reaction, mRNA was heated to 75°C for 3 min in a shaker and
cooled down quickly on ice for 2 min in order to resolve any secondary structure. If
PKRMs were used in the reaction, they were pre-treated with 7.5 U/µL Anti-RNase
(Ambion) for 10 min on ice prior to addition to the reactions, unless specifically
stated otherwise. This pre-treatment serves to minimize deleterious effects from
RNases present in the microsome preparations.
Tables 2.5 and 2.6 give an overview on the reaction mix for assays without and with
pre-treated PKRM, respectively.
Table 2.5 – Reaction mix for in vitro translation without membranes.
Component c(stock) V or c(final)
RRL 21 µL
Aminoacid mix 1 mM 1.2 µL
Anti-RNase (Ambion) 20 U/µL 0.4 U/µL
mRNA 1000-2000 ng/µL 100 ng/µL
Nuclease free H2O ad 30 µL
Total Volume ∑ 30 µL
Translation was performed at 28°C for 30 min in total, including the time before
addition of PKRM for membrane-containing reactions. The time was adjusted to
45 min for constructs with more than 150 aa. The reactions were stopped by addition
of 1 µl 1 mg/mL cycloheximide. Afterwards, each sample was immediately loaded
on 100 µL sucrose cushion (30 mM HEPES/KOH pH 7.5, 10 mM Mg(OAc)2, 100 mM
KOAc, 1 mM DTT, 1 µg/mL cycloheximide, 500 mM sucrose) in a TLA 100 tube.
Samples were centrifuged for 10 min at 33 k rpm/4°C in order to pellet microsomes
and membrane bound ribosomes (MB). Supernatants were quickly transferred to
a fresh TLA 100 tube and free ribosomes which did not bind to the microsomes (F)
were pelleted for 30 min at 100 k rpm/4°C. Immediately after the spin, supernatants
were quickly removed. The pellets from both spins (MB and F) were resuspended in
20 µL 1x SDS-sample buffer (1x SDS-SB; 50 mM tris(hydroxymethyl)aminomethane
(Tris) / HCl pH 6.8, 2% (w/v) SDS, 10% (v/v) glycerol, 0.1% (w/v) bromophenol
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Table 2.6 – Reaction mix for in vitro translation in the presence of PKRM.
Component c(stock) V or c(final)
RRL 21 µL
Aminoacid mix 1 mM 1.2 µL
Anti-RNase (Ambion) 20 U/µL 0.4 U/µL
mRNA 1000-2000 ng/µL 100 ng/µL
Nuclease free H2O ad 26.8 µL
After 5 min incubation:
pre-treated dog PKRM
0.56 eq/µL 0.05-0.06 eq/µL
Total Volume ∑ 30 µL
blue, 100 mM 1,4-dithiothreitol). The resuspended pellets were either used imme-
diately for analysis by SDS-PAGE and semi-dry western blotting (WB) or stored at
-20°C until analysis was performed.
2.6 Protein analysis
2.6.1 Protein precipitation
For analysis by SDS-Polyacrylamide-Gel-Electrophoresis (SDS-PAGE) all protein
samples with volumes larger than 25 µL were precipitated with trichloroacetic acid
(TCA). To that end samples were filled to 1 mL with H2O and 100 µL sodium-
desoxycholate as well as 100 µL 72% TCA were added. The precipitation mix was in-
cubated on ice for 20 min and pelleted in a pre-cooled tabletop centrifuge for 20 min
at 14 k rpm/4°C. The supernatant was sucked away carefully. The pellets were
washed with 1 mL ice-cold acetone, re-pelleted under the same conditions as before
and left to dry under the hood at RT. Finally they were resuspeded in 15 µL 1x SDS
SB.
2.6.2 Deglycosylation by Endoglycosidase H (Endo H)
Endo H reverts N-glycosylation by hydrolyzing the chitobiose core of the oligosac-
charide, leaving only a single N-acetylglucosamine residue attached to the peptide
(Maley et al., 1989). For this purpose an aliquot (6-10 µL, depending on concentra-
tion) of a membrane-bound sample was treated with Endo H (500000 U/mL, NEB).
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To do so, the aliquot was mixed with 2 µL glycoprotein denaturation buffer (NEB)
and filled to 20 µL with H2O. The mix was incubated for 5 min at 95°C and cooled
down to room temperature (RT) prior to addition of 3 µL 10x deglycosylation buffer
(NEB), 3 µL EndoH and 4 µL H2O. Deglycosylation was performed for 1 h at 37°C.
Subsequently the sample was frozen in liquid N2 and stored at -20°C until used for
further analysis.
2.6.3 SDS-Polyacrylamide-Gel-Electrophoresis (SDS-PAGE)
SDS-PAGE for separation of proteins according to their molecular weight was per-
formed using standard protocols (Laemmli, 1970). Separation was performed either
on 15% SDS-polyacrylamide (SDS-PAA) gels or on 12% Bis-Tris-PAA gels. All sam-
ples were prepared with 1x SDS-SB. Samples were denaturated prior to loading for
5 min at 65°C in order to preserve the peptidyl-tRNA bond. Electrophoresis was
performed for 1 h at 200 V in SDS running buffer (25 mM Tris, 192 mM glycine,
0.1% (w/v) SDS) for SDS-PAA gels and for 1 h at 180 V in MOPS running buffer
(50 mM MOPS, 50 mM Tris Base pH 7.7, 0.1% SDS (w/v), 1 mM EDTA) for Bis-Tris-
PAA gels.
Gels were used for western blot (WB) transfer immediately after electrophoresis.
After transfer, gels were stained with Simply Blue Coomassie staining solution
(Novex) to evaluate transfer efficiency. Gels were boiled in H2O twice to remove
SDS. Subsequently, gels were heated in Simply Blue staining solution and incubated
on a shaker for 5-10 min at RT to visualize bands.
2.6.4 Semi-dry western blotting
Semi-dry western blotting was used in order to transfer proteins to a polydivinylflu-
oride (PVDF) membrane. Methanol-based blotting buffer was used (20% (v/v)
methanol, 48 mM Tris/HCl, 39 mM glycine, 0.037% (w/v) SDS) and blots were per-
formed at 75-120 mA/gel (constant current) for 1 h in a standard semi-dry blotting
apparatus (BioRad).
Membranes were stained with amido-black (0.1% (w/v) naphthol blue black,
7.5% (v/v) acetic acid, 20% (v/v) ethanol) for 2 minutes on a shaker at RT and
destained (40% (v/v) ethanol, 10% (v/v) acetic acid) until clear bands were visi-
ble on a light background.
Prior to antibody detection, the membranes were incubated in TBS (20 mM Tris HCl
pH 7.6, 150 mM NaCl)/5% (w/v) milk-powder for 30-60 min at RT or over night
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at 4°C in order to reduce unspecific binding. Subsequently the blots were rinsed
with TBS. Antibody detection of the HA-tag in the nascent chain was performed
with either a single-step αHA-HRP antibody (rat anti-HA-Peroxidase, High affinity
3F10, Roche) or in a two-step procedure using the αHA-probe-antibody (mouse-
αHA, Santa Cruz) with a suitable secondary antibody (goat-α-mouse-HRP, Santa
Cruz) according to the following protocols:
• α-HA-HRP
1. incubate 1 h at RT in TBS/5% (w/v) milk-powder, 1:5000 αHA-HRP
2. wash 3× 10 min with TBS-T (20 mM Tris HCl pH 7.6, 150 mM NaCl,
0.1% (v/v) Tween)
• αHA-probe
1. incubate over night at 4°C in TBS/2% Bovine serum albumin, 1:1000
αHA-probe
2. wash 3× 10 min: TBS-T, TBS, TBS
3. block for 10 min at RT with TBS/5% (w/v) milk-powder
4. incubate 1 h at RT in TBS/5% (w/v) milk-powder, 1:5000 goat-αmouse-
HRP
5. wash 3× 10 min with TBS-T
For detection, the membranes were incubated with ECL substrate (Thermo Fisher)
or super signal ECL substrate (Thermo Fisher). Chemiluminescence was visualized
either on LucentBlue X-ray film (advansta) which was fixed using a developing de-
vice (Optimax Type TR, PROTEC) or alternatively by using a AI600 imaging device
(GE Healthcare). Exposure times were adjusted according to signal strength.
2.6.5 Mass-spectrometry
In order to learn about the protein composition of the OP96-cryo-EM sample, it was
subjected to mass spectrometry (MS) analysis. Therefore, the sample was subjected
to SDS-PAGE and exised from the gel. Gel extraction, proteolytic digest, MS and
data analysis was performed by Thomas Fröhlich (Gene Center, LMU). Proteins
were identified by screening against peptide libraries from canis lupus familiaris (dog)
for membrane components and libraries from oryctolagus cuniculus (rabbit) for cy-
tosolic components. Hits with very high (≥100) and high (≥30) confidence scores
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were combined and rated according to abundance. To that end, the exponentially
modified protein abundance index (emPAI) was used as a label free quantitative
measure to estimate relative protein amounts in the sample (Ishihama et al., 2005).
2.7 Purification of opsin biogenesis intermediates for
cryo-EM
The purification stategy was optimized to preserve the very transient OST-
containing RTC intermediates. Hence, the final protocol did not contain an affinity
purification step via the nascent chain in contrast to previous studies (Gogala et al.,
2014; Voorhees and Hegde, 2016). This greatly reduces the time window between
in vitro translation and vitrification and minimizes shearing forces on the complexes
of interest. The resulting increase in sample heterogeneity was compensated for by
extensive classification during cryo-EM data analysis (see section 2.8).
Buffers
The following buffers were used during the purification:
• Compensation Buffer (CB): 150 mM HEPES/KOH pH 7.5, 50 mM Mg(OAc)2,
2.5 M KOAc, 5 mM DTT, 5 µg/mL cycloheximide
• High-Salt Sucrose Cushion (HS-Suc): 30 mM HEPES/KOH pH 7.5, 10 mM
Mg(OAc)2, 500 mM KOAc, 1 mM DTT, 1 µg/mL cycloheximide, 500 mM Su-
crose
• Ribosome buffer (RB): 30 mM HEPES/KOH pH 7.5, 10 mM Mg(OAc)2,
100 mM KOAc, 1 mM DTT, 1 µg/mL cycloheximide
• Solubilization Buffer (SB): 30 mM HEPES/KOH pH 7.5, 10 mM Mg(OAc)2,
100 mM KOAc, 1 mM DTT, 1 µg/mL cycloheximide, 1.5 % Digitonin
• Digitonin Sucrose Cushion (DSuc): 30 mM HEPES/KOH pH 7.5, 10 mM
Mg(OAc)2, 100 mM KOAc, 1 mM DTT, 1 µg/mL cycloheximide, 500 mM Su-
crose, 0.3 % Digitonin
• Digitonin Grid Buffer (DGB): 30 mM HEPES/KOH pH 7.5, 10 mM Mg(OAc)2,
100 mM KOAc, 1 mM DTT, 1 µg/mL cycloheximide, 0.3 % Digitonin
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In vitro translation and high-salt treatment
Six 50 µL in vitro translation reactions with PKRMs were prepared as described in
section 2.5 including pretreatment of PKRM and denaturation of mRNA secondary
structure.
After stopping each reaction with 1 µL cycloheximide (c=1 mg/mL), 12.5 µL CB
was added to each reaction and the resulting mix was incubated for 30 min at 25°C,
shaking slightly. For the OP204 sample, the addition of cycloheximide was omitted
and in vitro translation was immediately followed by incubation under high-salt
conditions.
Solubilization and isolation of membrane bound ribosomal complexes
Unless stated otherwise, all resuspension steps were performed on ice and all cen-
trifugation steps were carried out at 4°C.
All samples were pooled and applied to 600 µL HS-Suc in a TLA120.2 tube. Pelleting
of membranes was performed for 10 min at 45 k rpm (spin 1). The supernatant (SN1)
was removed immediately and transferred to a fresh TLA120.2 tube. The membrane
pellet was rinsed immediately with 100 µL RB (saved for analysis = W) and 400 µL
SB were added. SN1 was spun at 100 k rpm for 45 min in order to pellet free ribo-
somes, which had not bound to the PKRM (spin 2). The supernatant from spin 2 was
quickly discarded and the ribosome pellet was carefully resuspended in 60 µL RB
over 2 h by pipetting up and down every 15 min. Meanwhile, solubilization of the
membrane pellet was carried out for 1 h by carefully mixing the sample by pipetting
every 10 min. The resulting solubilization mix was loaded on 600 µL DSuc in a fresh
TLA120.2 tube and spun at 100 k rpm for 45 min to pellet solubilized RTCs (spin 3).
The supernatant (SN2) was quickly removed and saved for analysis and the pellet
was resuspended in 60 µL DGB for 90 min, carefully pipetting up and down every
10 min. The solubilized sample was transferred to an eppendorf tube and spun for
30 s in a tabletop centrifuge to remove large aggregates. The supernatant was trans-
ferred to a fresh tube and adjusted to a final concentration of 5.0-5.5 A260/mL with
DGB. An overview on the sample preparation is given in figure 3.4 of section 3.2.
Aliquots were taken at different steps during the purification and analyzed by SDS-
PAGE and WB.
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2.8 Cryo-EM data collection
Cryo-EM data collection
Carbon coated holey grids (2 nm, R3/3, Quantifoil) were glow discharged at
0.2 mbar for 30 s. For each grid, 3.5 µL of sample were applied to the grids at a con-
centration of 5.0-5.5 A260/mL. Subsequent vitrification was performed by plunge
freezing in liquid ethane using a Vitrobot mark IV (FEI Company, Netherlands) with
a blotting time of 3 s at 4°C. Cryo-EM data was collected semi-automatically using
the acquisition software EM-TOOLS (TVIPS, Germany) on a Titan Krios transmis-
sion electron microscope (FEI Company) at a defocus range between 0.9 and 3.5 µm.
All data were recorded on a Falcon II detector upgraded with a Falcon III detector
chip under low dose conditions with a nominal pixel size of 1.084 Å/pixel (px) on
the object scale. All micrographs experienced a total exposure of 28 electrons/Å2
fractionated into 10 frames. Grid preparations were performed by Susanne Rieder
and cryo-EM data collection was performed by Dr. Otto Berninghausen.
In total five different cryo-EM datasets were collected from three different samples:
OP96 (dataset I, 7120 micrographs; dataset IV, 13087 micrographs), OP109 (dataset
II, 9758 micrographs; dataset V, 12656 micrographs) and OP204 (dataset III, 8563 mi-
crographs).
Contrast transfer function (CTF) estimation was performed on-the-fly with
CTFFIND4 (Mindell and Grigorieff, 2003; Rohou and Grigorieff, 2015) and micro-
graphs with an estimated resolution limit of below 4.5 Å were automatically dis-
carded.
Original image stacks were summed up and aligned at micrograph level using Mo-
tionCor2 (Zheng et al., 2017).
Cryo-EM data processing
The CTF parameters were re-estimated via GCTF (Zhang, 2016). All micrographs
were screened manually for ice quality prior to automated particle picking with
Gautomatch (http://www.mrclmb.cam.ac.uk/kzhang). All classifications and re-
finements were performed using Relion-2.1 (Kimanius et al., 2016).
Two distinct classification routines were used. Initial structural models from
datasets I-III (see section 3.3) were obtained by the following classification scheme:
1. 2D classification
2. selection of good classes with ribosomal particles
3. initial 3D refinement with an undecimated box size of 420 px, resized to 100 px
4. 3D classification, 10 classes
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5. Optional (for partial OST occupancy): 3D classification of P-site peptidyl-
tRNA class
6. 3D refinement of P-site peptidyl-tRNA containing class with an undecimated
box size of 420 px
7. post-processing
Data obtained by extended data collection for OP96 was processed according to a
slightly modified routine. The two datasets collected for the OP96 sample (I and
IV) were joined after automated particle picking and reference-free 2D classification
resulting in 1.343.416 ribosomal particles. After an initial round of 3D refinement
these were subjected to extensive 3D classification. Differences between the result-
ing eleven classes comprised the presence or absence of the SSU, OST and eEF2 as
well as different tRNA states. Also conformational differences in the L1 stalk and
the relative arrangement of ribosomal subunits were found. A clean class with den-
sities for both P-site peptidyl-tRNA and OST (188.900 particles; 14.1 %) was refined
to high resolution (reconstruction A1) using a box size of 550 px, resized to 500 px.
Two further classes (13.6 %) were lacking density for tRNAs and instead had strong
occupancy of eEF2 as well as partial occupancy of the OST complex. These were sub-
jected to another round of 3D classification using a mask on the translocon region
where they clearly separated into populations with or without OST. OST-containing
particles (90.895 particles, box size 550 px, resized to 500 px) were refined to high
resolution (reconstruction B1). The final refinement was continued for reconstruc-
tions A1 and B1 including a mask on the ligand region, resulting in reconstructions
A2 and B2. All final reconstructions were subjected to post-processing using a wide
soft-edge mask. This resulted in final resolutions of 3.2 Å (Reconstruction A1), 4.2 Å
(Reconstruction A2), 3.3 Å (Reconstruction B1) and 4.7 Å (Reconstruction B2) ac-
cording to the FSC 0.143 criterion following the Relion gold-standard refinement.
Local resolution was calculated using the ResMap option implemented in Relion.
Data from the second collection of the OP109 sample (dataset V) was processed by
Robert Buschauer (Gene Center, LMU Munich) identically to the extended OP96
routine but without combining it with the first OP109 collection.
2.9 Cryo-EM data analysis and model building
The post-processed maps were low-pass filtered at several defined resolutions for
model building and refinement in order to account for differences in local resolution.
All existing pdb structures used as starting points for model building were docked
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into the maps as a rigid body using UCSF Chimera (Pettersen et al., 2004). Since the
programmed population displayed higher resolution than the corresponding non-
programmed map both before and after masked refinement, manual adjustments to
pdbs were performed in Coot based on the A1 and A2 maps respectively (Emsley
and Cowtan, 2004).
Models for the LSU and the P-site tRNA (pdb 3jah, Brown et al., 2015) were fitted
into the A1 map. The region contacting the cytosolic RPN1 domain was manu-
ally adjusted by Dr. Thomas Becker (Gene Center, LMU Munich). Namely, the
C-terminus of eL28 was remodeled and extended by 11 aa and the rRNA H19/H20
was rearranged to fit the electron density.
Sec61 was modeled in the A2 map based on the structure of the ‘primed’ state (pdb
3j7q, Voorhees et al., 2014). Minor adjustments were made in the plug region (res.
58-66) and TMH10 (res. 436-465). The hinge region (res. 196-242) as well as the N-
terminus (res. 1-27) were modeled de novo.
Homology models (HMs) for the STT3A TM and lumenal domains were created
using the PHYRE2 server (Kelly et al., 2015) based on the crystal structure of the
archaeal homolog AglB (pdb 3waj, Matsumoto et al., 2013) by Thomas Becker (Gene
Center, LMU Munich). The initial models for the TM and soluble domains were
combined and unambigously placed in the OST density of the locally refined A2
map. The resulting HM was manually adjusted in Coot based on electron density
features and the recent high resolution yeast OST structure (pdb 6ezn, Wild et al.,
2018).
The TMHs of the non-catalytic OST-subunits were initially assigned based on the
following criteria:
• predicted number of TMHs for different subunits using the jPred4 secondary
structure prediction (Drozdetskiy et al., 2015) as well as the ΔG prediction
server (Hessa et al., 2007)
• connectivity of electron densities between putative TMHs
• electron densities for bulky sidechains
• biochemical prediction of subcomplexes
The assignment was later confirmed by the high resolution cryo-EM structures of
the S. cerevisiae OST complex (see section 4.2) (Wild et al., 2018; Bai et al., 2018).
The cytosolic four-helix bundle of RPN1 which does not form part of the S. cerevisiae
complex was assigned by Dr. Stefan Pfeffer (Max Planck Institute for Biochemistry,
Martinsried) based on secondary structure prediction using the jPred4 server.
For the well-resolved metazoan-specific DC2 subunit (local resolution ranging from
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3.5-4.2 Å) an atomic model of the three TMH was built based on the jPred4 sec-
ondary structure prediction and positioning of bulky side chains. Homology mod-
els for the OST4 and RPN1 TMDs were created using the PHYRE2 server based on
the yeast OST structure (Wild et al., 2018) and manually adjusted in Coot. When
local resolution did not allow to build an atomic model, namely for the TMHs of
TMEM258 and Subcomplex III (DAD1, OST48, RPN2), for STT3A-TM9 as well as
the loop regions in DC2, poly-alanine segments were placed instead. The entire
translocon model was refined using PHENIX (Afonine et al., 2012).
The final models of the LSU, Sec61 and the OST complex were fitted as individual
rigid bodies into the maps of the non-programmed population (B1 and B2). More-
over, they were docked individually into an improved cryo-electron tomography
structure of the native OST-containing RTC (Dr. Stefan Pfeffer, Max Planck Insti-
tute, Martinsried). Since this structure contains Sec61 with an open lateral gate, the
N-terminal region of Sec61α was adjusted separately. Vectors representing the con-
formational rearrangements among the three resulting translocon states (see figure
3.18) were visualized using PyMol (The PyMOL Molecular Graphics System, Ver-
sion 2.0 Schrödinger, LLC.).
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Results
3.1 Expression of C-terminally truncated variants of
bovine opsin
In vitro translation in presence of rough microsomal membranes (RM) or
puromycin/high-salt treated microsomal membranes (PKRM) from dog pancreas
has a long standing tradition as a model system for studying membrane protein
biogenesis (Blobel and Dobberstein, 1975; Walter and Blobel, 1983). In addition,
it has been shown to represent a suitable system for generation of defined transla-
tion/translocation intermediates for structural studies (Gogala et al., 2014; Voorhees
and Hegde, 2016). We chose the rabbit reticulocyte lysate (RRL) cell-free in vitro
translation system in combination with dog PKRM to produce defined intermedi-
ates of bovine opsin. Conditions for the use of non-pre-treated dog PKRMs in com-
bination with the RRL translation system were tested with a construct coding for an
N-terminal HA-tag, the first 75 opsin aa as well as a C-terminal CMV stalling se-
quence (see figure 3.1, panels A and B, from now on referred to as OP96). The CMV
stalling peptide was introduced to stall ribosomes at a specific point with a mini-
mal extent of subsequent nascent chain (NC) release, thereby allowing enrichment
of defined ribosome nascent chain complexes (RNCs).
Expression in absence of PKRM was performed as a negative control for glycosyla-
tion and to confirm that the conditions used for microsome pelleting do not result in
pelleting of ribosome species which are not bound to the membranes. Results were
analyzed by SDS-PAGE and WB (see figure 3.1, panel C).
In general two different types of signals can be expected for WB detection of a
NC after in vitro translation. First, there should be a signal corresponding to the
peptidyl-tRNA representing intact tRNA-NC species. However, partial hydrolysis
of the peptidyl-tRNA bond usually leads to a second population of free peptide
which can be detected at lower molecular weight (MW). For samples which have
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Figure 3.1 – Construct design and test expression of OP96 in absence or presence
of PKRM. A) Schematic depiction of the OP96 construct used for expression tests, N-
glycosylation sites are marked with fletched arrowheads B) Illustration of the expected
architecture of the glycosylated OP96-RNC-complexes C) Anti-HA WB detecting NC
species in the membrane bound (MB) and free (F) ribosome populations after translation
without (-PKRM) or with (+PKRM) dog PKRM, samples correspond to 1/2 of the prod-
ucts of a 30 µL in vitro translation reaction (Gel: 12% Bis-Tris; WB: PVDF, 75 mA/gel,
1 h; Antibody: αHA-probe/goat-α-mouse-HRP; Detection: Super ECL, film, 1 min ex-
posure).
been translated in presence of PKRM one can furthermore expect glycosylated vari-
ants of both NC populations which experience a shift to higher MW due to the mod-
ification as soon as the RNCs have been sucessfully targeted to the membranes and
engaged the translcation and glycosylation machineries. Here, when in vitro transla-
tion was performed in absence of PKRM, chemiluminescence signal on the anti-HA
WB could only be detected in the free ribosome fraction but not in the pellet fraction
of the microsome-pelleting step. The two signals visible in the free ribosome pellet
correspond to the non-glycosylated peptidyl-tRNA and non-glycosylated free pep-
tide, respectively. Partial hydrolysis of the peptidyl-tRNA bond is due to the basic
pH of the 1x SDS-SB. Upon addition of PKRM, both signals could be detected in the
membrane-bound fraction and experienced a shift to higher MW, indicating sucess-
ful glycosylation. Non-glycosylated free peptide in the membrane bound sample
could either be a contamination from the supernatant or represent NCs which failed
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to be glycosylated and were released from the membrane-bound ribosomes. Sig-
nal for the free peptide was also detected in the free ribosome pellet of the PKRM-
containing reaction, indicating ribosome species which failed to be targeted to the
membranes and lost their NC during analysis. The experiment demonstrates that
the chosen centrifugation conditions are suitable for selective isolation of membrane
bound ribosomes.
The efficiency of targeting and glycosylation was estimated by comparing intensi-
ties of the corresponding signals. For this specific test experiment targeting was esti-
mated to 60% (MB vs. F signal in +PKRM sample). Glycosylation efficiency was esti-
mated by comparing glycosylated and non-glycosylated species in the +PKRM/MB
fraction. Assuming that the non-glycosylated free peptide is not due to a super-
natant contamination but rather due to incomplete modification, glycosylation effi-
ciency amounted to approximately 50%. Finally, it became apparent that the overall
translation efficiency is decreased in the presence of PKRM (Total signals -PKRM vs.
+PKRM). This was due to contaminations of microsome preparations with endoge-
neous RNase species.
A recent study by Vermeire et al. suggests that pre-treating PKRMs of different
species with RNase inhibitor can reduce these deleterious effects (Vermeire et al.,
2015). Also, it was in principle desirable to increase the amount of PKRM present
in the in vitro translation reaction to obtain higher targeting and glycosylation ef-
ficiencies. Therefore, two different amounts of dog PKRM were tested in in vitro
translation assays of OP96 with and without anti-RNase pre-treatment prior to use
in the experiment. The efficiency of targeting and glycosylation was analyzed by
SDS-PAGE and WB (see figure 3.2).
In contrast to the test expression analyzed in figure 3.1, no signal was present in
the free ribosome fraction indicating highly efficient targeting. However all reac-
tions showed signals representing the glycosylated forms of peptidyl-tRNA and free
peptide in the membrane-bound populations. The fact that no additional signal was
detected at the MW of the non-glycosylated species suggested a very high glycosyla-
tion efficiency. Moreover, it could be seen that pre-treatment increases the efficiency
for both PKRM concentrations. The strongest signals were observed for the reaction
with 0.06 eq PKRM/µL (equal to 1.8 eq PKRM in a 30 µL translation reaction) after
anti RNase pre-treatment. Therefore, these conditions were used for all subsequent
translation experiments.
The next step was to expand the analysis to opsin constructs of varying NC lengths
in order to mimic different stages of biogenesis. Truncation sites were chosen such
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Figure 3.2 – Optimizing PKRM for use in in vitro translation. Anti-HA WB detect-
ing NC species in the membrane bound (MB) and free (F) ribosome populations, "pre"
indicates PKRM pre-treatment with anti RNase prior to use in the assay, samples corre-
spond to 1/2 of the products of a 30 µL in vitro translation reaction and PKRM amounts
are indicated per µL reaction (Gel: 12% Bis-Tris; WB: PVDF, 75 mA/gel, 1 h; Antibody:
αHA-probe/goat-α-mouse-HRP; Detection: Super ECL, film, 8 min exposure).
that - without the N-terminal HA-tag - the NC including the CMV stalling sequence
had the same number of aa as constructs used for existing crosslinking studies on
opsin biogenesis (Laird and High, 1997; Meacock et al., 2002; Ismail et al., 2006;
Ismail et al., 2008). Since these studies have revealed an increasing number of in-
completely translated products for long NC lengths (Ismail et al., 2008), constructs
coding for more than the N-terminal four opsin TMS were excluded from the anal-
ysis. Opsin-CMV constructs with NC lengths of 96, 109, 130, 164 and 204 aa were
expressed in absence and presence of pre-treated dog PKRMs. Reactions without
PKRMs were performed for each construct as a positive control for translation and
as a control for the MW of the non-glycosylated NC. As an additional control for
each construct, one reaction was performed in presence of PKRM and the MB pellet
was subsequently treated with Endo H to revert glycosylation. Analysis was per-
formed by SDS-PAGE and WB and is visualized in figure 3.3.
All constructs were expressed in vitro and were targeted and glycosylated sucess-
fully in the presence of pre-treated dog PKRMs. However, the expression efficiency
varied considerably when comparing different constructs. Since all constructs had
an identical 5’UTR and start codon environments it was unlikely that they displayed
entirely different expression efficiencies. Instead, it had been observed that transla-
tion efficiency for one construct can vary significanty between mRNA preparations
which was likely causing these differences.
For the OP204 construct, the signal for the PKRM containing samples was signifi-
cantly reduced. Since the same batch of PKRM was used for all reactions, this vari-
ation is rather due to sample handling than actual negative effects of the PKRMs.
3.2. Preparation of solubilized opsin biogenesis intermediates 47
Figure 3.3 – Test expression of different opsin NC lengths in absence or presence of
PKRM. Anti-HA WB detecting NC species for the OP96, OP109, OP130, OP164 and
OP204 constructs in the membrane bound (MB) and free (F) ribosome populations after
translation without (-) or with (+) dog PKRM and including a MB sample after EndoH
treatment (E), samples correspond to 1/2 of the products of a 30 µL in vitro translation
reaction (Gel: 12% Bis-Tris; WB: PVDF, 120 mA/gel, 1 h; Antibody: αHA-HRP; Detec-
tion: ECL, Imager, 3 min exposure).
3.2 Preparation of solubilized opsin biogenesis inter-
mediates
The OP96, OP109 and OP204 constructs were chosen for analysis by cryo-EM.
The OP96 construct represents a very early intermediate and was selected to gain
insights into the initial Sec61 gating process. OP109 reflects a NC length, which
should enable full accommodation of the signal anchor-helix (SA-helix). The OP204
construct was chosen based on the findings that the TMHs 1-3 constitute an indi-
vidually folding opsin subdomain. The construct was therefore considered suitable
to challenge the hypothesis of TMH retention and Sec61-proximal bundling.
The preparation of samples for cryo-EM analysis is described in detail in the
methods section (section 2.7) and is visualized in figure 3.4. In summary, after in
vitro translation, samples were subjected to a high-salt (HS) incubation prior to
pelleting of PKRM and solubilization of membrane bound ribosomal complexes
using digitonin. Finally, the solubilized ribosome-translocon complexes (RTCs)
were purified and concentrated by another pelleting step and resuspended in
detergent-containing grid buffer (DGB). In contrast to previously established
protocols, the preparation does not include an affinity purification via the nascent
chain, thereby minimizing sample preparation time, in order to preserve fragile
assemblies. The cryo-EM preparations of the OP96, OP109 and OP204 constructs
were analyzed by SDS-PAGE and WB. For simplicity, only the lanes giving signal
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Figure 3.4 – Cryo-EM sample preparation. Schematic depiction of the sample prepa-
ration for cryo-EM analysis of the OP96, OP109 and OP204 constructs. CHX = cyclo-
heximide (* omitted for the OP204 sample), HS-Suc = high-salt sucrose cushion, SB =
solubilization buffer, D-Suc = digitonin sucrose cushion, DGB = digitonin grid buffer,
RB = ribosome buffer.
in the anti-HA WB are depicted in figure 3.5.
All final solubilized samples showed a strong signal for the glycosylated NC species
indicating sucessful isolation of defined biogenesis intermediates.
For OP96, glycosylated free peptide which has lost its tRNA during the preparation
was detected in the wash fraction after membrane pelleting (W) and the supernatant
after solubilization (SN2). In addition, minor amounts of non-glycosylated species,
which have failed to stably bind the PKRMs were detected in the free ribosome
pellet.
The anti-HA-WB from the OP109 and OP204 preparations also showed bands at the
expected molecular weight for the final cryo-EM sample (OP109), or the pelleted
free ribosomes and the final sample (OP204). However, signal could not be detected
in any other fractions. This was likely due to differences among the three analyses
with respect to gel type (15% SDS-PAA vs. 12% Bis-Tris-PAA), blotting current
(75-120 mA/gel), choice of antibody (αHA-probe vs. αHA-HRP) as well as the
detection method (film vs. imaging device). Conditions used are indicated in the
figure legend.
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Figure 3.5 – Purification of solubilized opsin biogenesis intermediates for cryo-EM.
Anti-HA WB detecting NC species in different fractions during the preparation of sol-
ubilized RTCs.(A) OP96 construct, Cryo = Final cryo-EM sample, E = Endo H-treated
aliquot of final sample, F = Free ribosomes pelleted from the supernatant after mem-
brane pelleting (spin 1, see section 2.7), W = membrane pellet wash, SN2 = supernatant
after pelleting of solubilized complexes (spin 3); (Gel: 15% SDS; WB: PVDF, 100 mA/gel,
1 h; Antibody: αHA-HRP; Detection: Super ECL, film, 10 s exposure) (B) OP109 con-
struct (Gel: 12% Bis-Tris; WB: PVDF, 120 mA/gel, 1 h; Antibody: αHA-probe/goat-α-
mouse-HRP; Detection: Super ECL, Imager, 1 min exposure) (C) OP204 construct (Gel:
12% Bis-Tris; WB: PVDF, 120 mA/gel, 1 h; Antibody: αHA-HRP; Detection: ECL, Im-
ager, 5 min exposure). A clear signal for peptidyl-tRNA is visible for all cryo-EM sam-
ples.
3.3 Preliminary cryo-EM structures of opsin biogenesis
intermediates
Initial cryo-EM datasets of the OP96, OP109 and OP204 constructs were collected
(datasets I-III) and processed as described in section 2.8.
In silico 3D classification revealed considerable sample heterogeneity for all con-
structs. This was expected due to the lack of an affinity purification step or a su-
crose gradient separation of different ribosomal species in the preparation protocol.
While the precise class distributions varied among the constructs, the general popu-
lations observed in the preparations were similar. All classes contained either 80S or
60S ribosomes with close-to-complete occupancy of Sec61. In addition, some classes
had extra density for several translation- or translocon factors like eEF2, eIF5A, eIF6,
different tRNA species, OST and TRAP. eIF6 was exclusively observed on the 60S
particles, likely representing intermediates of ribosomal quality control pathways
which are initiated upon ribosome stalling at the ER membrane. It is known from
previous studies that eEF2, which is functionally required during the translocation
step of translation elongation, also has a high affinity to non-translating ribosomes
(Voorhees et al., 2014; Liu and Qian, 2016). In line with these results, presence of
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Figure 3.6 – Preliminary cryo-EM structures of thee opsin biogenesis intermediates.
Cryo-EM structures of the programmed solubilized RTCs programmed with three dif-
ferent opsin NC lengths, low-pass filtered to 5.5 Å.
eEF2 was mutually exclusive with tRNA binding in the A- or P-site, but was in some
classes observed together with eIF5A (OP96, OP109) or E-site tRNA (OP204). eIF5A
has previously been shown to be enriched on pull-out samples containing cyclohex-
imide (Schmidt et al., 2015), therefore it is not surprising that it could not be detected
in the OP204 sample which was prepared without the antibiotic. Notably, it was
also absent from all classes containing a P-site peptidyl-tRNA in the cycloheximide-
containing OP96 and OP109 preparations. Binding of accessory translocon factors
appeared to be independent of translation factor occupancy. TRAP appeared de-
localized or substoichiometrically bound in all classes. In contrast, the majority of
otherwise identical populations (60S-Sec61-eIF6, 80S-P-Site-NC, 80S-eEF2-±eIF5A)
separated into two distinct classes with or without OST.
Since our main goal was to investigate membrane insertion and N-glycosylation of
the opsin model substrate, we limited our analysis of each cryo-EM dataset to the
class containing a peptidyl-tRNA in the P-site and OST. These classes were refined
to highest possible resolution.
The final resolutions according to the gold-standard criterion employed by the Re-
lion 2.1 post-processing routine were 3.7 Å (OP96), 3.5 Å (OP109) and 4.1 Å (OP204)
respectively. They all showed well-defined electron density for the programmed
ribosome (see figure 3.6). However, the signal decreased rapidly in the Sec61 and
surrounding membrane region and the translocon components could only be visu-
alized at lower contour levels and after low-pass filtering. Therefore, these initial
reconstructions only allowed for limited interpretation.
Surprisingly, the PCC conformation appeared identical for all three opsin constructs
3.3. Preliminary cryo-EM structures of opsin biogenesis intermediates 51
and most closely resembled the primed state (Voorhees et al., 2014) when compared
to existing structural models (see figure 3.7). In this state the lateral gate of Sec61α is
almost entirely closed, with just a slight opening at the cytosolic face. Moreover,
in contrast to other structures of Sec61 in an inserting state (Gogala et al., 2014;
Voorhees and Hegde, 2016), no additional α-helical densities corresponding to an
inserting substrate TMH were detected in the lateral gate region in the opsin bio-
genesis intermediates.
These findings were contrasting our expectations, which included varying degrees
Figure 3.7 – Sec61 conformation in the solubilized opsin biogenesis intermediates.
Zoom onto the Sec61 lateral gate region in the preliminary cryo-EM structures of the
OP96, OP109 and OP204 biogenesis intermediates, low-pass filtered to 7 Å. A model of
Sec61 in the primed state (PDB 3j7q, Voorhees et al., 2014) with the lateral gate forming
helices TMH2b and TMH7 colored in dark blue and green provides a good overall fit
for all three constructs.
of lateral gate opening as well as extra densities representing different numbers of
opsin TMH in proximity of the lateral gate based on available crosslinking data
(Laird and High, 1997; Meacock et al., 2002; Ismail et al., 2006; Ismail et al., 2008).
The lack of NC density in the lateral gate region can be explained by different sce-
narios:
• Location of TMHs in vicinity of the lateral gate, but low signal-to-noise ratio
due to conformational and/or positional flexibility of the TMHs
• Release of the TMHs into the lipid bilayer
• Stable positioning of TMHs at a position different from the lateral gate envi-
ronment
Since the preliminary reconstructions remained inconclusive regarding the mem-
brane insertion process, we then focused on the RTC-OST interactions. The OP96
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construct had the highest occupancy for a P-site peptidyl-tRNA and OST contain-
ing class (55786 particles, 17.3% of ribosomal particles). For OP109 this class repre-
sented only 12.0% of ribosomal particles (25275 particles). The OP204 dataset did
not yield a clean class with high occupancy of both peptidyl-tRNA and OST but in-
stead showed only partial OST occupancy in the final class (32802 particles, 17% of
ribosomal particles). Unfortunately, this class could not be sub-classified any further
due to low particle numbers. For all constructs, the density in the OST region was
too weak to draw conclusions on the architecture of the complex or its interactions
with Sec61 and the ribosome.
Taken together, the preliminary cryo-EM reconstructions allowed only very limited
conclusions regarding the Sec61 functional state and the integration of OST into the
RTC. Hence, in order to improve the signal-to-noise ratio and potentially enable
further in silico classification of different conformational states we decided to collect
more data on the most promising sample. The OP96 construct was prioritized for
extended analysis because it had the highest percentage of OST-bound translating
ribosomes.
3.4 Cryo-EM analysis of an early opsin biogenesis in-
termediate
Classification of the combined OP96 data (datasets I and IV) confirmed the high
degree of heterogeneity observed for the preliminary reconstruction. The data
contained both, programmed and non-programmed 80S populations as well as
two translocon-bound 60S classes with and without extra density for OST. The
processing scheme was focused on isolation of OST-containing RTCs harboring 80S
ribosomes and led to two final classes (A and B, see figure 3.8).
Class A was programmed with a P-site tRNA and showed clear density for the NC
in the ribosomal tunnel whereas class B did not contain any tRNA populations but
was instead bound to the translational GTPase eEF2.
When employing the unsupervised refinement approach implemented in Relion,
the signal for the translocon components was still considerably weaker than the
ribosome signal (Classes A1 and B1). Besides, in contrast to Sec61 and OST, TRAP
appeared to be disordered or bound in substoichiometric amounts as already
observed in the preliminary reconstruction. By using a mask around the ligand
region during refinement, the alignment was now based on the signal within
the mask rather than on the otherwise dominating signal from the rRNA. This
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Figure 3.8 – Classification scheme of the combined cryo-EM datasets from the solu-
bilized OP96 biogenesis intermediate. Non-ribosomal particles were excluded after
2D classification. Well-resolved classes after initial 3D classification represent eight dif-
ferent translocon bound 80S classes and two translocon bound 60S classes. The class
with strong density for both, P-site tRNA and OST was selected (14.1 %) and refined
to high resolution (Reconstruction A1). The two 80S classes lacking density for tRNA
species but instead displaying high occupancy of eEF2 and partial OST occupancy were
combined (13.6 %) and subjected to a second round of 3D classification with a mask on
the translocon region. This resulted in a class with high OST-occupancy (6.8 % of all
ribosomal particles) which was selected and refined to high resolution (Reconstruction
B1). The final reconstructions for programmed and non-programmed OST-containing
RTCs (A1 and B1) were further refined with a mask on the membrane components to
enhance the signal-to-noise in this region (Reconstructions A2 and B2). The translocon
region of A2 was used for model building and structural analysis of Sec61 and OST. It
was combined with the ribosome region of A1 to evaluate the OST-LSU interface. A
composite map of reconstructions B1 (ribosome) and B2 (translocon region) was used
for rigid body fitting of the final models and comparison of conformational states.
technique revealed that the weaker signal in the membrane components was largely
due to flexibility of the ribosome with respect to the membrane. Concomitantly,
the masked refinement approach led to a significant improvement of the local
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resolution for the translocon components Sec61 and OST (see figure 3.9).
For the transmembrane region of the programmed population local resolution now
ranged between 3.5 Å in the Sec61 region to 4.5 Å for the most distal OST TMH. The
local resolution in the non-programmed OST containing class was slightly worse in
this region and varied from 4.2 Å (Sec61) to 5.5 Å (OST peripheral helices) in the
membrane. Besides, a drastic resolution drop for the lumenal OST segment was
observed. As a consequence, certain regions in the lumenal OST domain could not
be resolved beyond ≥7.5 Å, limiting map quality to rigid, alpha helical features.
The locally refined electron density for the translocon region allowed to assign the
Figure 3.9 – Local resolution distribution. Maps of programmed and non-programmed
particles before (left) and after (right) refinement on the ligand region colored accord-
ing to local resolution. Local refinement significantly improved local resolution in the
translocon region.
TMS of all OST components and to build a homology model of the catalytic subunit
(described in detail in section 3.6). It was combined in a composite map with the
high resolution electron density of the ribosome prior to masked refinement in order
to visualize the general architecture of the OP96 biogenesis intermediate (see figure
3.10).
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Figure 3.10 – Cryo-EM structure of the programmed solubilized RTC. Ribosome and
p-site tRNA are shown before focused refinement, low-pass filtered to 4 Å; the mem-
brane region including Sec61, TRAP, and OST is shown after. Horizontal lines indicate
membrane boundaries prior to solubilization.
3.5 Conformation of Sec61
Analysis of the density corresponding to Sec61 confirmed our unexpected findings
from the preliminary cryo-EM reconstruction. Despite being in complex with a ri-
bosome translating a membrane insertion substrate, the PCC was very similar to the
primed state (Voorhees et al., 2014) (see figure 3.11).
The lateral gate was in a closed position and the plug largely obstructed the cen-
tral pore of the channel. In addition, no extra density corresponding to an inserting
substrate TMH was visible in proximity of the lateral gate. We therefore decided to
focus our analysis on additional density components which were present in the OST
region.
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Figure 3.11 – Atomic model for Sec61. A) Overlay of the Sec61 model for the primed
state (light grey, pdb 3j7q, Voorhees et al., 2014) with the adjusted model on basis of
the high-resolution cryo-EM structure of the OP96 biogenesis intermediate (light blue);
lateral gate TMHs are colored in dark blue (TMH 2) and green (TMH 7). Views perpen-
dicular to the membrane plane (left) and from the cytosol (right) are shown B) Adjusted
model of Sec61 as in A) in overlay with the corresponding cryo-EM density low-pass
filtered to 4 Å according to local resolution.
3.6 Characterizing mammalian ribosome-bound OST
3.6.1 Evaluating OST-isoform specificity
We performed MS analysis of the OP96 cryo-EM sample in order to evaluate its
protein composition prior to vitrification. The analysis identified a large number
of ribosomal proteins and several factors involved in protein translocation and co-
translational modification processes (See appendix A for a full list of identified pro-
teins). Detected protein species include Sec61α and β, SRα and β, TRAM, TRAPγ
and δ, signal peptidase subunits (Sec11, 25 kDa subunit) as well as components of
the ER membrane protein complex (EMC1, 2, 3 5, 7 and 10; see Jonikas et al., 2009;
Christianson et al., 2012). Finally, full sets of OST subunits for both complex iso-
forms were identified except for the OST4 component (see table 3.1).
Lack of OST4 could be explained by its small size, preventing it to be digested into
peptide fragments suitable for MS detection. We were then wondering whether the
MS analysis can provide information about the relative abundance of the two iso-
forms in our cryo-EM structure. Both OST isoforms are capable of co-translational
N-glycosylation. However, biochemical data indicates that only STT3A-OST is as-
sociated with the ribosome (Shibatani et al., 2005; Ruiz-Canada et al., 2009). In line
with this, the STT3B-OST specific subunits, STT3B and MAGT1 were detected at
lower abundance than all other OST components. However, relative amounts of
Sec61α were even lower according to the emPAI value (0.13), in contrast to the find-
ing that cryo-EM analysis revealed a nearly complete occupancy of the PCC on ribo-
somal complexes (see figure 3.8). Therefore, apparent abundance according to MS
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Table 3.1 – Abundance of OST subunits in the solubilized OP96 biogenesis inter-
mediate. OST subunits in the OP96 cryo-EM sample by mass spectrometry, ranked
according to their abundance by their emPAI values (exponentially modified protein
abundance index, see Ishihama et al., 2005, Full range of observed values: 0.00-8.91).
Protein Accession emPAI
RPN1 gi|73984484 2.88
DAD1 gi|73962567 0.61
RPN2 gi|73991908 0.52
STT3A gi|545496900 0.43
OST48 gi|164038 0.38
TMEM258 gi|345783280 0.38
KCP2 gi|226732647 0.22
DC2 gi|226739213 0.20
MAGT1 gi|345807587 0.16
STT3B gi|73989883 0.15
analysis did not appear to be a suitable tool to evaluate which OST variant forms
part of the structure.
Thus, in order to evaluate, whether the electron density which was observed in
the high-resolution cryo-EM structure of the OP96 intermediate could be clearly as-
signed to one of the two paralogs we collaborated with the groups of Prof. Friedrich
Förster (Utrecht University, Netherlands) and Prof. Reid Gilmore/Prof. Elisabet
Mandon (University of Massachusetts, USA). Shiteshu Shrimal from the Mandon
group isolated microsomal membranes from three different HEK-cell lines which
were either wild-type (wt) or CRISPR-knockout mutants of STT3A or STT3B re-
spectively (Shrimal et al., 2017). Subsequently Stefan Pfeffer from the Förster Lab
performed CET in combination with subtomogram averaging on the wild-type
HEK293, ΔSTT3B and ΔSTT3A microsomes. The data showed that wt and ΔSTT3B
had equal OST-occupancy for ER-associated ribosomes (see figure 3.12). In contrast
ΔSTT3 resulted in a loss of OST-containing complexes.
These results provided a structural proof that OST-containing RTCs harbor exlu-
sively the STT3A-isoform of OST.
The CET data therefore also unambiguously identified the OST complex present
in the high-resolution cryo-EM structure of the OP96 biogenesis intermediate as
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Figure 3.12 – CET of native RTCs. Ribosome-bound translocon populations observed
by CET and subtomogram averaging for microsomes from wild-type HEK293 (top),
ΔSTT3B (center), and ΔSTT3A (bottom) cell lines after in silico sorting. The absolute
number and percentage of subtomograms contributing to each class are indicated. All
densities were low-pass filtered to 30 Å(CET/subtomogram analysis and figure by Ste-
fan Pfeffer).
STT3A-OST. This finding was not necessarily in contrast with detection of STT3B-
OST specific components in the MS analysis. As metioned previously, MS analysis
also identified a range of additional other factors which were not accounted for by
distinct density features (e.g. TRAP, EMC, SR). It is possible that these proteins were
associated in the periphery, possibly in low amounts or rather transiently and there-
fore fell apart during the vitrification process. Being associated in proximity but
not directly interacting with translocon-bound ribosomes is also in agreement with
STT3B-OST’s proofreading function for sites which have been skipped by STT3A.
3.6.2 Positioning of OST subunits
Having resolved potential ambiguity regarding the OST isoform present in the high
resolution cryo-EM structure of the OP96 biogenesis intermediate we set out to iden-
tify the positions of OST subunits in the electron density region corresponding to
the complex. The density envelope of the OST region was approximated from the
known, medium-resolution CET structure of native, OST-bound RTCs (Pfeffer et al.,
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2015). In our cryo-EM reconstruction of the OP96 biogenesis intermediate, 28 ad-
ditional TMHs packed against Sec61, within the predicted OST-region. According
to secondary structure predictions 31 TMHs would be expected for STT3A-OST in-
dicating that at least one of the subunits was lost during preparation. We could
unambiguously place a homology model of the catalytic STT3A subunit in the cen-
tral region of the OST density (see figures 3.13 and 3.14). The model confirmed
Figure 3.13 – Atomic model of mammalian STT3A. A model for canine STT3A was
derived from a homology model based on existing crystal structures of the archaeal
homolog and could be placed unambiguously in the electron density correspinding to
OST.
the enzyme’s 13 TMH topology and showed high similarity to the existing crystal
stuctures of its homologs (see figure 3.14).
The most prominent rearrangements were observed in TMHs 8 and 9. In line with
conformational flexibility in this region, TMH 9 was also the least resolved and no
clear connectivity to the N-terminal part of EL5 was observed. Weak density for an
α -helical segment was present in the region which likely represents the N-terminal
end of EL5, but the residues involved could not be identified due to resolution re-
straints. In contrast, the C-terminal end of EL5 was relatively well structured start-
ing from a conserved SVSE motif (TIXE in bacteria, with the glutamate constituting
one of the residues of the active-site acidic cluster, see section 1.4.3). No density
for the peptide substrate was observed whereas density corresponding to the pyro-
phosphate moiety of the LLO was present in the final reconstruction.
The remaining OST subunits assembled around the catalytic core and form clus-
ters according to their affiliation with the three predicted subcomplexes (see figure
3.15).
A three-TMH bundle resolved at the distal side of the OST complex facing away
from Sec61 and in close proximity to STT3A TMH1 corresponded to subcomplex
I comprising RPN1 (1 TMH) and TMEM258 (2 TMHs). Subcomplex II comprises
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Figure 3.14 – Structural conservation of STT3-type proteins. A) Model for mammalian
STT3A viewed from the cytosol (left, order of TMS is indicated by Arabic numbering:
TMS1-7 orange, TMS8/9 light red, TMS10-13 dark red) and superposition with crys-
tal structures of archaeal (pdb 3waj, Matsumoto et al., 2013) and bacterial (pdb 3rce,
Lizak et al., 2011; pdb 5ogl, Napiórkowska et al., 2017) homologs. B) Overlay of the
models from A) with the corresponding electron density in the high-resolution cryo-
EM structure of the OP96 construct. Despite limited levels of sequence conservation a
high degree of structural conservation can be observed.
STT3A (13 TMs), DC2 (3 TMHs), OST4 (1 TMH) and KCP2 (4 TMHs) and was lo-
cated in immediate vicinity of the PCC. No extra density for the four TMHs of KCP2
was observed. The subunit has a known tendency to dissociate during solubiliza-
tion (Shrimal et al., 2017) and could in addition have been lost during sample vitrifi-
cation. Subcomplex III is composed of RPN2 (3 TMHs), DAD1 (3 TMHs) and OST48
(1 TMH) and was covered by the seven-TMH bundle on the distal side of STT3A.
The large soluble extensions of subcomplexes I (RPN1) and III (OST48 and RPN2)
enclosed the C-terminal domain of STT3A from opposite sides and approached each
other below the catalytic subunit in the ER lumen. However the local resolution did
not allow to build structural models for these domains.
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Figure 3.15 – Spatial arrangement of mammalian OST subunits. A) Schematic depec-
tion of STT3A-OST subunits and predicted affiliation with subcomplexes I-III; KCP2 in
parenthesis since no corresponding density could be identified in the OP96 cryo-EM
reconstruction B) Cytosolic view of the Sec61-OST region in the OP96 cryo-EM map
revealed a spatial organisation of STT3A-OST into the three biochemically predicted
subcomplexes. The paralog specific components cluster in proximity to Sec61 whereas
other subunits occupy more peripheral regions C) Arrangement of STT3A-OST subcom-
plexes when viewed parallel to the membrane plane.
3.7 Interactions of OST with the ribosome and Sec61
OST was integrated into the RTC via interactions through its RPN1 and DC2 sub-
units. The composite map as shown in figure 3.10 was used in order to draw con-
clusions on the interactions between the translation, translocation and glycosylation
machineries.
3.7.1 The OST subunit DC2 at the Sec61 interface
The isoform specific DC2 subunit formed the interface to the Sec61 complex (see fig-
ure 3.16). The resolution in this area was sufficient to built an atomic model de novo
for the three TMHs of DC2 based on excellent agreement between features resolved
62 Chapter 3. Results
Figure 3.16 – The Sec61-DC2 interface. Magnified view of the Sec61-OST interface with
a fitted model for the DC2 TMHs.
in our map and the predicted length and connectivity of DC2 TMHs. The amphi-
pathic DC2 N-terminus projected toward Sec61 on the micelle surface, whereas the
lumenal loop of DC2 interacted with the C-termini of Sec61β and Sec61γ . DC2
contacted STT3A via its lumenal C-terminus (to STT3A TMH13), the cytosolic L2/3
loop (to STT3A L12/13), and TM2 (close proximity to STT3A L9/10, also referred
to as EL5). In the programmed population we observed an additional helical seg-
ment intercalated between Sec61 and DC2 which will be discussed in more detail in
section 3.8.
3.7.2 The RPN1-Ribosome interface
The C-terminal region of RPN1 formed a four-helix bundle on the cytosolic face of
the membrane and was intercalated between OST and the 60S ribosomal subunit.
This metazoan-specific extension reached towards the linker between rRNA helix
Figure 3.17 – The ribosome-RPN1 interface. Magnified view of the cytosolic RPN1
four-helix bundle binding to the ribosome.
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H19 and H20, rRNA expansion segment ES7a (H25), and the tail of ribosomal pro-
tein eL28 which was unstructured in previous LSU models (Brown et al., 2015). Pre-
cise contact regions could not be defined since the LSU and the RPN1 bundle form
part of two different density segments of the composite map.
3.7.3 Conformational dynamics in different functional states
The translocon is capable of dealing with a very broad range of substrates with dif-
ferent requirements regarding NC modifications, membrane insertion and topology
determination. To gain insights into different functional states of the assembly we
compared the conformation of Sec61 and OST in our model of the programmed
OP96 biogenesis intermediate (maps A1 and A2) with their arrangement in the non-
programmed counterpart (see B1 and B2 in figure 3.8) and in the native translocon
(CET by Stefan Pfeffer, MPI of Biochemistry, Martinsried, improved processing rou-
tine for the data published in Pfeffer et al., 2015) (see figure 3.18).
The general translocon architecture in the non-programmed reconstruction was
Figure 3.18 – Conformational states of different Sec61-OST complexes. Top: Rigid
body fitted models for Sec61 and OST in the cryo-EM densities of the OP96 biogen-
esis intermediate (left, programmed; center, non-programmed) with laterally closed
Sec61 and the native translocon from CET/subtomogram averaging with opened Sec61
(right). Bottom: Movement trajectories of α-carbon atoms connecting the observed con-
formational states with color-coded length (Figure by Stefan Pfeffer with small adapta-
tions).
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very similar to the P-site peptidyl-tRNA–containing complex, and models for lat-
erally closed Sec61 and OST fitted well as separate rigid bodies (see figure 3.18,
center). Comparison with the model of the programmed RTC revealed a tilt be-
tween Sec61 and OST, with the more lumenal regions approaching each other. In
this movement, the cytosolic loops of Sec61 and the cytosolic RPN1 domain served
as hinge points on the LSU.
In the native RTC with laterally opened Sec61, the Sec61α N-terminal domain and
Sec61β approached DC2. This induced a repositioning of the entire OST complex to
accommodate the conformational change of the PCC.
Although the relative arrangement of OST and Sec61 differed substantially between
the three observed conformational states, DC2 always mediated stable interactions
with Sec61.
3.8 Tentative positioning of the nascent insertion-
glycosylation substrate
Notably, after positioning of all OST subunits one additional helical density segment
was observed intercalated between Sec61 and DC2 in the P-site peptidyl-tRNA
bound OP96 sample (see figure 3.19, undisplayed for clarity in figure 3.18). The
density was absent from the non-programmed population and its position was
partially occupied as a result of the conformational rearrangements described in
section 3.7.3.
This observation led to the idea that the density might represent TMH1 of the opsin
in vitro translation/N-glycosylation substrate. To test this hypothesis, residues
35-59 of bovine opsin were tentatively modelled into the density (see figure 3.20).
The model showed good agreement with electron density features for some bulky
side-chains (e.g. W35, F56). Furthermore, there were no electron densities which
immediately contradict the molecular model. However side-chain density could
not be observed for all aa.
Since we isolated a co-translational biogenesis intermediate, the NC should still
be connected to the p-site tRNA. Therefore, we evaluated the connectivity of the
additional density segment in map A2 to the density observed in the ribosomal
exit tunnel of the electron density map A1 obtained before masked refinement (see
figure 3.21).
The NC displayed a flexible behavior, especially towards the lower part of the exit
tunnel. Therefore, initially no connection between the two densities was observed.
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Figure 3.19 – Additional density at the Sec61-OST interface. An additional, unas-
signed helical density segment (cyan) is intercalated between Sec61 and OST in the pro-
grammed population of the OP96 cryo-EM sample on the opposite side of the lateral
gate, view from the cytosol.
Figure 3.20 – Putative placement of the NC TMH. Close-up view on the unassigned
density at the Sec61-OST interface, filtered to 3.5 Åand superposition with a model for
opsin TMH1; sidechains correspond to opsin W35-L59.
However, upon decreasing the contour level for the isolated NC density in the
ribosomal tunnel it could be traced to the tip of Sec61 TMH10. Additional density
protruded from this connection point to the putatively identified substrate TMH.
The above-mentioned results provided strong indication that the additional density
segment could in fact be attributed to the first TMH of the in vitro insertion/N-
glycosylation substrate opsin. However, for a PCC substrate, the density was
positioned at a highly unexpected position. All known structures of insertion
intermediates, both for the eukaryotic and the bacterial system display additional
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Figure 3.21 – OP96 NC connectivity. The electron density corresponding to the NC
(cyan) connects to the putative opsin helix at low contour levels
density for the NC substrate intercalated at the Sec61α lateral gate (Bischoff et al.,
2014; Park et al., 2014; Gogala et al., 2014; Voorhees and Hegde, 2016). In contrast,
the density segment in this study was observed almost on the opposite side of the
channel, in the vicinity of Sec61β. Remarkably, this position would result in a clash
with Sec61α TMH1 upon opening of the lateral gate. The OP96 construct contained
only a fairly short linker between the C-terminal end of opsin TMH 1 (V64) and
the PTC (32 aa). In order to rule out that the unusual positioning of the putative
substrate helix was simply a result of distance restraints imposed by NC length,
we decided to perform extended cryo-EM analysis on the OP109 construct. The
construct has additional 13 aa and should therefore enable to relax potential strains
affecting NC positioning. Hence, a second, larger cryo-EM dataset (dataset V, 12656
micrographs) was recorded for the OP109 construct and was processed by Robert
Buschauer (Gene Center, LMU Munich) in analogy to the large OP96 dataset.
However, NC elongation did not result in any structural changes and thus the data
is not discussed in more detail. Therefore, it was concluded that the unexpected po-
sition of the tentatively identified opsin TMH is not an artefact caused by NC length.
In summary, we were able to derive a protocol for the isolation of bona fide mam-
malian membrane insertion intermediates of different nascent chain length, suitable
for structural analysis. We solved the structure of a very early bovine opsin biogen-
esis intermediate representing the first high-resolution structure of a mammalian
OST-bound RTC. We unambiguously identified the STT3A-isoform of OST and posi-
tioned the TMDs of all corresponding OST subunits, except for KCP2 which did not
form part oft he reconstruction. The arrangement revealed clustering of subunits ac-
cording to three subcomplexes which had previously been proposed for S. cerevisiae
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OST. Moreover, we derived a homology model for the catalytic STT3A subunit, de
novo built an atomic model for the DC2 TMDs forming the interface with the Sec61
complex, and gained insights into OST ribosome binding via the RPN1 C-terminus.
Finally, we surprisingly observed Sec61 in a near-primed state with a closed lateral
gate and no additional insertion substrate density in the lateral gate region. Instead,
we putatively identified the TMH of the opsin insertion/N-glycosylation substrate
at an unexpected position between the PCC and OST.
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Discussion
A major goal of this work was to investigate the membrane insertion process of the
chosen model substrate bovine opsin. We sucessfully established a protocol which
enables the isolation of opsin biogenesis intermediates at different stages during the
insertion process. In contrast to other structural studies of eukaryotic, solubilized
RTCs, the purification routine is suitable to enrich for the oligosaccharyltransferase
complex (OST), one of the translocon components which previously could only be
observed in substoichiometric amounts (Gogala et al., 2014; Voorhees et al., 2014;
Voorhees and Hegde, 2016). This provided the unique opportunity to investigate
the intimate coupling of membrane protein insertion and asparagine-linked glyco-
sylation (N-glycosylation) in a single structural study on functional opsin biogenesis
intermediates.
4.1 A model for OST isoform specificity
N-glycosylation is a highly abundant, universally conserved modification of newly
synthesized proteins, with great functional importance for protein folding, intra-
cellular trafficking and stability. The modifying enzyme OST is a single subunit
enzyme in prokaryotes and archaea but has evolved into a multisubunit assembly
with at least eight different proteins in eukaryotes. Furthermore, gene duplication
of the gene coding for the catalytic STT3 subunit in metazoans has yielded two com-
plex isoforms, STT3A-OST and STT3B-OST. The majority of subunits are present in
both variants and are complemented with either STT3A or STT3B and one or two
paralog-specific subunits. Current models suggest based on biochemical data that
only STT3A-OST associates with translocon-bound ribosomes for co-translational
N-glycosylation. However, in addition to performing post-translational modifica-
tions, STT3B-OST can also act co-translationally. As part of this study, CET data
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by Stefan Pfeffer provided the first structural proof, that ribosome-translocon bind-
ing is an exclusive feature of STT3A-OST in mammalian cells. We used cryo-EM
and single-particle analysis to solve the first high resolution structure of an OST-
containing RTC and obtained detailed insights into the STT3A-OST interfaces with
Sec61 and the ribosome.
The PCC interaction is mediated by the isoform specific DC2 subunit as recently
suggested by biochemical data (Shrimal et al., 2017). DC2 extends towards the
Sec61β and Sec61γ subunits. Comparison of different functional RTC states demon-
strated that DC2 acts as a versatile module which provides robust integration of OST
into the translocon complex, even under vastly differing conformational states of the
translocon complex. This is an important prerequisite for sucessful N-glycosylation
of a very broad substrate range. Not only do OST substrates have vastly different se-
quon environments regarding their primary aminoacid sequence. In addition they
potentially require transient association not only with Sec61 and OST but also other
accessory factors for nascent chain processing (signal peptidase), topogenesis (e.g.
TRAM, TRAP) or covalent modification (e.g. protein disulfide isomerase). With re-
gard to OST, DC2 is positioned adjacent to the most C-terminal helices of the STT3A
TM region (TMH 10-13). This posed the question how DC2 is able to discriminate
between the STT3A and STT3B paralogs. STT3A and STT3B show high overall se-
quence conservation (60% sequence identity in humans). However, more thorough
investigation of pairwise alignments of STT3A and STT3B paralogs from different
organisms revealed that conservation is significantly reduced for the DC2 binding
region (see table 4.1).
Therefore, STT3A potentially presents a binding surface clearly distinct from the
STT3B surface and hence preferably integrates DC2 which modulates Sec61 interac-
tion. On the contrary, the interface presented by STT3B is presumably more suitable
for binding of TUSC3 or MagT1. In comparison to DC2, these factors contain an
additional TMH as well as a lumenal thioredoxin-domain. It cannot be excluded
that these features might even have a repulsive effect on Sec61 binding, for example
due to steric hinderance. However, due to the lack of high resolution structures of
STT3B-OST this remains rather speculative.
Towards the cytosol, STT3A-OST interacts with the ribosome via the C-terminal
four-helix bundle of RPN1 according to our cryo-EM reconstruction. This meta-
zoan specific domain protrudes from the TM region in direct vicinity of the STT3A
N-terminus. Notably, the soluble N-terminal region is significantly longer in mam-
malian STT3B (41 vs. 17 aa in Homo sapiens, Canis lupus familiaris, Mus musculus, 66
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Table 4.1 – Conservation of primary sequences between STT3A and STT3B from
various metazoan organisms. Sequence identity between STT3A and STT3B par-
alogs for the sequence ranges covering TMHs 1-9 (residues 7-346 of reference sequence
NP_689926.1) or TMHs 10-13 (residues 347-501 of reference sequence NP_689926.1) are
shown. TMHs 1-9 have a significantly higher degree of conservation ( 60% identity
between paralogs) than the DC2-interacting TMHs 10-13 ( 39% identity between par-
alogs)(Pairwise alignment performed by Stefan Pfeffer).
Organism Sequence IDs Sequence Sequence
STT3A/B Identity Identity
TMH 1-9 TMH 10-13
Mammalia
Homo sapiens NP_689926.1/
NP_849193.1
60.70% 39.34%
Mus musculus NP_032434.3/
NP_077184.2
60.70% 39.34%
Bos taurus NP_001039445.1/
NP_001091039.1
60.70% 39.34%
Sus scrofa NP_001230781.1/
XP_003132136.3
60.41% 39.34%
Aves Gallus gallus NP_001305920.1/
XP_015137059.1
59.82% 38.80%
Reptilia Chrysemys picta XP_005294744.1/
XP_005299331.1
59.82% 39.34%
Amphibia Xenopus laevis NP_001083986.1/
XP_018124788.1
60.11% 39.34%
Osteichthyes Astyanax mexicanus XP_007244780.1/
XP_022529444.1
58.94% 39.89%
vs. 17 aa in Bos taurus, 69 vs. 15 aa in Sus scrofa). Hence, it is possible, that the
extended STT3B N-terminus disturbs the interaction between RPN1 and the ribo-
some. This hypothesis is in agreement with results which demonstrate that binding
of a Fab fragment from an anti-RPN1-C-terminus antibody can abolish ribosome
translocon binding (Yu et al., 1990).
Interestingly, insects lack the C-terminal cytoplasmic domain of RPN1 despite ex-
pressing two paralogs of the catalytic subunit (Kelleher and Gilmore, 2006). There-
fore it can be speculated, that the ribosome/RPN1 interaction rather plays a com-
plementary role in anchoring OST to the RTC while DC2 acts as the primary binding
partner. Alternatively, a tight RTC-OST interaction might be dispensable in organ-
isms lacking the cytoplasmic RPN1 domain.
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A third potential interface between OST and the RTC is present in STT3A loop L12-
13 which extended towards the ribosome in our cryo-EM structure but was not suf-
ficiently resolved to unambigously determine its location.
The loop is considerably longer in STT3B and harbours a number of negatively
Figure 4.1 – Primary sequence alignment for the cytosolic STT3-TMH12/13 loop
in various metazoan organisms. Residues 404-498 of human STT3A were chosen
as a reference and aligned to corresponding STT3A (black) and STT3B (blue) re-
gions of various organisms (Homo sapiens: NP_689926.1, NP_849193.1, Mus musculus:
NP_032434.3, NP_077184.2, Bos taurus: NP_001039445.1, NP_001091039.1), Sus scrofa:
NP_001230781.1, XP_003132136.3, Gallus gallus: NP_001305920.1, XP_015137059.1,
Chrysemys picta: XP_005294744.1, XP_005299331.1, Xenopus laevis: NP_001083986.1,
XP_018124788.1), Astyanax mexicanus: XP_007244780.1, XP_022529444.1.) (Sequence
alignment performed by Stefan Pfeffer).
charged residues (see figure 4.1) which might cause repulsion from the negatively
charged rRNA backbone.
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Taken together, our findings lead to a model which could explain how metazoan
Figure 4.2 – Model for OST isoform specificity. Isoform specific features and compo-
nents determine paralog specificity.(Figure adapted from Braunger et al., 2018).
RTCs selectively integrate the STT3A isoform of OST. It schematically summarized
in figure 4.2 and represents a combination of positive determinants in STT3A-OST
(DC2 integration) and negative determinants in STT3B-OST (N-terminal extension,
L12/13).
4.2 Comparison of eukaryotic OST complexes
Prior to this study, the structural knowledge of the eukaryotic OST has been limited
to moderate-resolution cryo-EM and CET structures (Li et al., 2008; Pfeffer et al.,
2014; Pfeffer et al., 2015; Pfeffer et al., 2017) prohibiting a profound understanding
of its subunit arrangement and interplay with the translation and translocation ap-
paratus. The results presented in this dissertation provide the first high resolution
model for the mammalian STT3A-OST in complex with Sec61 and the ribosome. In
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addition, very recently, two other groups could sucessfully solve isolated cryo-EM
structures of S.cerevisiae OST in the apo-state at 3.3 Å (Wild et al., 2018) and 3.5 Å
resolution (Bai et al., 2018) respectively. They are very similar and provide molec-
ular models for all yeast OST subunits except for the lumenal domain and TMH1
of Ost3p and EL5 of Stt3p which were proposed to be mobile due to the absence of
substrates.
In direct comparison the yeast and mammalian structures reveal a conserved ar-
chitecture among eukaryotic OST complexes with an identical spatial division into
subcomplexes in the TM region (see figure 4.3). Because of the high similarity of
the S. cerevisiae structural models, only the one which is based on the slightly better
resolved cryo-EM structure is shown (pdb 6ezn, Wild et al., 2018).
The fungal and metazoan complexes differ with regard to a few compositional el-
Figure 4.3 – Conserved architecture of eukaryotic OST complexes. A) Cryo-EM den-
sity for the OST complex from S.cerevisiae, reconstituted into nanodiscs (adapted from
Wild et al., 2018), view in the membrane plane. B) Atomic model for the OST com-
plex from S.cerevisiae based on the density shown in A), view rotated by 180° around
the y-axis. C) Comparison of structural models for mammalian (pdb 6fti; DC2 in yel-
low, STT3A in red, RPN1 in magenta, other subunits in pale pink; Braunger et al., 2018)
and yeast OST (pdb 6ezn; shown in white; Wild et al., 2018) demonstrates a conserved
subunit organization in the membrane plane (view from the cytosol).
ements. DC2 engages the mammalian STT3A complex at the same position that is
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occupied by the yeast Ost3p (TMHs 2-4), in agreement with the fact that yeast OST is
more closely related to the mammalian STT3B isoform. Besides, the Ost1p segment
which would correspond to the cytosolic four-helix bundle of RPN1 is missing in S.
cerevisiae.
Interestingly, all three studies (Braunger et al., 2018; Bai et al., 2018; Wild et al., 2018)
visualized a stably structured, highly conserved N-glycan linked to the catalytic
subunit (to Asn539 in Stt3p/Asn548 in STT3A). The glycan forms interactions with
the lumenal domains of subcomplex III (Wbp1p/Swp1p or OST48/RPN2 respec-
tively) thereby bridging it with the STT3 subunit. The slightly better local resolution
of the S. cerevisiae structures in addition revealed a number of ordered phospholipids
forming the intra-membrane-interfaces between the three subcomplexes.
Within the STT3 subunit, the biggest difference between the yeast and mammalian
models is the position of TMH9, which adopts a more outward oriented confor-
mation in the mammalian STT3A structure (see figure 4.3). Together with STT3
TMHs 6 and 11 it forms a cavity surrounding the proposed dolichol binding site,
hence different degrees of opening might reflect different states in the LLO binding
cycle. As previously mentioned, the yeast structures represent the apo-state of OST
without any bound substrates. The functional state of our mammalian STT3A-OST
is less well defined. With regard to the peptide substrate, we do not observe any
density in the sequon binding site. This is consistent with the fact that our isolated
biogenesis intermediate reflects a post-glycosylation state, with both sequons in the
opsin NC sucessfully modified according to WB analysis. However, it has to be con-
sidered that according to current models STT3A-OST employs a continuous N- to
C-terminal scanning mode in order to sample nascent peptides for N-glycosylation
sequons (Shrimal and Gilmore, 2013; Cherepanova et al., 2016). Thus, it would be
expected that OST keeps interacting with the opsin NC even post-catalysis in order
to probe for additional sites although the mode and site of these interactions remains
to be characterized. A possible indication for ongoing nascent chain interactions the
cryo-EM structure of the mammalian OP96 biogenesis intermediate is the fairly well
structured conformation of the C-terminal half of EL5, starting from the conserved
SVSE-motif. Though without any substrate density this idea remains rather spec-
ulative. The situation with regard to the LLO-binding state is similarly complex.
We observe clear extra density located in the pyrophosphate binding pocket, but
no densities for either the isoprenoid-carrier or the pre-assembled glycan. Hence,
we cannot distinguish, whether the pyrophosphate density corresponds to the post-
transfer PPi-dolichol species prior to product release or whether the enzyme has
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already recruited a new, fully assembled LLO-precursor, priming it for the next cat-
alytic cycle. N-EL5 appears rather flexible and thus is not suitable to distinguish
these two possibilities. In summary, the yeast and mammalian structures definitely
represent different functional states and it seems plausible that these can be cor-
related to the position of STT3 TMH 9. However, the poorly defined state of the
mammalian intermediate prevented a more detailed mechanistic analysis.
Remarkably, in contrast to both, the mammalian (Braunger et al., 2018) and the fun-
gal models (Bai et al., 2018; Wild et al., 2018), STT3 TMHs 8 and 9 are shifted towards
STT3 TMHs 5 and 7 in the bacterial PglB homolog (see figure 4.4) (Lizak et al., 2011;
Napiórkowska et al., 2017).
Bai and colleagues speculate that the relocation of TMHs 8 and 9 in S. cerevisiae is a
Figure 4.4 – Conformation of TMHs in STT3-type proteins. Comparison between
structural models of metazoan (pdb 6fti, Braunger et al., 2018), fungal (pdb 6ezn, Wild
et al., 2018), archaeal (pdb 3waj, Matsumoto et al., 2013) and bacterial (pdb 3rce/5ogl,
Lizak et al., 2011; Napiórkowska et al., 2017) STT3-type enzymes reveals a highly con-
served conformation except for TMHs 8 and 9 (dashed circle) which are drastically repo-
sitioned in the bacterial structures.
consequence of an altered LLO binding route due to the significantly increased size
of the eukaryotic precursor (14-18 isoprene repeats and 14 sugars in yeast compared
to 11 isoprene units and 7 sugars in most bacteria, see Jones et al., 2009). They for-
mulate the hypothesis that the eukaryotic LLO dimensions prevent it from docking
to the enzyme by diving under or threading in the EL5 loop as proposed for the
bacterial PglB (Napiórkowska et al., 2017). Instead they suggest that it enters the
binding cavity through a 10 Å gap between STT3 TMHs 8 and 9.
Can this model be supported by STT3 structures from the third domain of life? In
crystal structures of the AglB homolog from Archeoglobus fulgidus (Matsumoto et al.,
2013; Matsumoto et al., 2017) the enzyme’s conformation more closely resembles
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the eukaryotic variants (see figure 4.4). However, size-wise archaeal LLOs are more
similar to the bacterial precursors with typically 10-12 isoprene units and short lin-
ear oligosaccharide chains (Jones et al., 2009). Therefore, the archaeal structures do
not support the idea that TMH 8 and 9 repositioning is a direct consequence of LLO
dimensions to allow a for an alternative entry route. Nevertheless, they do not con-
tradict the alternative LLO binding mode proposed by Bai and colleagues per se.
Due to limited local resolution we did not provide any structural models for the
lumenal domains of the non-catalytic subunits in mammalian STT3A-OST. In con-
trast, the better resolved yeast structures also allowed to build the lumenal domains
of Ost1p (RPN1), Wbp1p (OST48) and Swp1p (RPN2) and identified structural ho-
mologs for certain regions.
The lumenal domain of Ost1p contained two structurally similar regions featur-
ing a fold of stacked β-sheets and both groups identified resembling domains in
aminopeptidases and leukotrien hydrolases. The two studies identifed different
structural homologs for the Wbp1p middle domain. While Bai et al. claimed sim-
ilarity to amylase domain N, Wild and colleagues find homologies to protein folds
in factors of the complement system of innate immunity. In addition, Bai and col-
leagues descibe a structural similarity between the Swp1p N-terminal domain and
a lipopolysaccharide- and sugar-binding co-receptor of a Toll-like receptor complex.
The two groups draw different conclusions with respect to the functions of the ex-
tended lumenal domains in non-catalytic OST subunits. Bai and colleagues con-
ceive that the structural homologs which were identified in the Wbp1p and Swp1p
N-terminal domains are sufficient to support their role in LLO recruitment. They do
not propose any functional role for the Ost1p N-terminus. In contrast, Wild and col-
leagues rather favor a role for all three lumenal domain in recruitment of additional
factors such as chaperones or factors acting on nascent glycoproteins.
In summary, despite providing structural information, the S. cerevisiae model can-
not provide conclusive data on the Ost1p, Wbp1p and Swp1p subunits’ function
in the N-glycosylation pathway. It cannot be excluded, that they have evolved to
modulate N-glycoprotein biogenesis in an organism specific manner. This idea is
supported by the fact that apart from few conserved patches, which were identified
by Wild and colleagues and mediate subcomplex interactions, the lumenal domains
display low overall sequence conservation (see figure 4.5).
To the same end, the lumenal domain of mammalian RPN2 harbors approximately
340 residues more than its yeast counterpart Swp1p, resulting in an additional lobe
of electron density in the corresponding cryo-EM structure presented in this thesis
78 Chapter 4. Discussion
Figure 4.5 – Sequence conservation between different eukaryotic OST subunits. Se-
quence conservation among STT3-type and subcomplex III OST subunits of various eu-
karyotic organisms (S. cerevisiae, P. pastoris, C. elegans, A. thaliana, D. melanogaster, D.
rerio, M. musculus and H. sapiens) reveals low overall conservation with few conserved
patches at the substrate binding grove (asterisk) and the subunit interaction interfaces
(dashed circles) ) (Figure adapted from Wild et al., 2018).
(see figure 4.6).
Therefore, the biological roles and mechanisms of function for the non-catalytic OST
lumenal domains remain ill-defined.
Finally, the question remains, whether S. cerevisiae OST is capable of engaging the
RTC similar to the mammalian STT3A-OST depite higher similarity to the STT3B-
type complex. The structures cannot provide an ultimate answer. Unfortunately
the lumenal domain of Ost3p as well as its most N-terminal TMH could not be
resolved in the yeast structures, likely due to conformational flexibility. Bai et al. ob-
serve a weak density corresponding to the Ost3p thioredoxin domain in one of their
classes. However, they use a different class without this extra density for docking
into the CET structure of the mammalian OST-containing translocon which does not
reveal sterical clashes in the membrane region. It is conceivable though, that an ad-
ditional lumenal domain in proximity to the position observed for Ost3p might lead
to clashes with other translocon components such as the TRAP lumenal domain or
the Sec61α hinge region which are in close proximity in the mammalian complex
(see figure 4.6). Furthermore, Ost3p is lacking important structural features which
characterize the Sec61-DC2 interaction in our mammalian model. The loop between
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Figure 4.6 – Superposition of a model for fungal OST and the cryo-EM density of
mammalian STT3A-OST. Model of the S. cerevisiae OST complex (red, pdb 6ezn,Wild
et al., 2018) has been fitted as a rigid body into the cryo-EM density of the translocon
region from the mammalian OST-containing RTC, filtered to 7 Å. Density corresponding
to the mammalian STT3A-OST displays additional segments of density for the lumenal
RPN2 N-terminal and cytoplasmic RPN1 C-terminal domains.
Ost3p TMHs 2 and 3 is shorter and adopts a different fold than the corresponding
L1/2 in DC2. Moreover, the DC2 N-terminal region is replaced by an additional
TM span followed by the lumenal domain. Taken together with the fact that S. cere-
visiae does not contain the cytoplasmic ribosome-interacting domain of RPN1 in its
homolog Ost1p (see figure 4.6), it is highly questionable whether the yeast OST com-
plex is bound to RTCs in vivo. Therefore RTC association which allows immediate
co-translational NC scanning appears to be a metazoan specific feature of STT3A-
type-OST complexes.
4.3 Opsin membrane insertion takes unexpected ways
Three opsin biogenesis intermediates were isolated and analyzed by cryo-
EM (OP96,OP109,OP204). Their anticipated architecture according to current
knowledge on opsin topogenesis and membrane protein insertion in general is
schematically illustrated in figure 4.7.
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We were expecting 80S ribosomes which are programmed with a P-Site tRNA
Figure 4.7 – Expected architecture of opsin biogenesis intermediates. Schematic depic-
tion of the structural features expected in the cryo-EM structures of the OP96, OP109 and
OP204 biogenesis intermediates. Indicated numbers of TMS correspond to the number
of TMS which were expected in the membrane region at a given NC length.
bound to the corresponding nascent chain species. Previous studies have shown
that the CMV stalling peptide which we included in our constructs for generation
of stable, uniform RNC populations can form α-helical secondary structure in
the upper part of the ribosomal tunnel (Matheisl et al., 2015). In the membrane
region we predicted Sec61 in an inserting state with potentially varying degrees
of lateral gate opening as well as helical extra densities for the inserting substrate
TMHs intercalated into or in proximity of the gate. This assumption was based on
available structures of inserting Sec61 (Gogala et al., 2014; Voorhees and Hegde,
2016) and the findings that opsin TMHs 1-3 form a PCC-proximal bundle prior to
full release into the lipid bilayer (Ismail et al., 2006).
In the actual cryo-EM reconstructions a major class containing Sec61-bound RNCs
with a P-site peptidyl tRNA and varying amounts of OST could be sorted out in
silico. We did not detect a stable α-helical conformation of the CMV peptide in
the ribosomal tunnel. In this context it is important to point out that the CMV
peptide triggers stalling at a stop-codon. Concomitant with that, its structured
conformation was visualized on a translation termination intermediate in complex
with eukaryotic release factor 1 (eRF1, Matheisl et al., 2015). Apart from stable
association with eRF1 the structure also revealed a role of the first nucleotide after
the stop-codon triplett in formation of a stable termination complex. Hence it is
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possible that in the study presented here, truncation of the mRNA immediately af-
ter the CMV STOP-codon, led to an altered PTC geometry which in turn influenced
the conformation of the NC. Nevertheless, we visualized NC density in the entire
ribosomal tunnel although local resolution did not allow to build an atomic NC
model and unambiguously determine its conformation. Contrary to expectations,
we did not observe any rod-like extra densities for the insertion substrate near
the Sec61 lateral gate. Moreover, the PCC was in a non-inserting state, closely
resembling the primed coformation for all reconstructions. Since all of the samples
were sucessfully glycosylated according to the MW observed in WB detection of
NCs it can be ruled out that Sec61 conformation is a result of unspecific membrane
binding and/or improper PCC engagement.
Extended cryo-EM analysis of the OP96 biogenesis intermediate revealed an
unassigned rod-like density intercalated between Sec61 and OST. We provision-
ally identified the additional helical segment as the TMH of the opsin in vitro
insertion/N-glycosylation substrate. This positioning was highly unexpected since
it is almost on the opposite side of the PCC than the lateral gate, in vicinity of Sec61α
TMH 1 and Sec61β. However, it is consistent with existing crosslinking studies
which described interactions between Sec61β and the first opsin TMH until a NC
length of 150 aa (Meacock et al., 2002; Ismail et al., 2006). Due to distance restraints
these crosslinks are incompatible with positioning of TMH1 at the lateral gate.
Assuming our assignment is valid, there are two possibilities how the TMH has
reached its position. Following the canonical in-out model of membrane insertion,
the TMS would have to first engage the central cavity of Sec61, subsequently
partition into the membrane through the lateral gate and finally relocate around
the PCC. The sliding model provides an alternative explanation. Here, Sec61 might
simply facilitate initial contact between the hydrophobic TMS and the lipid phase.
Thermodynamically, it is then favorable for the TMH to insert directly into the
membrane without sampling the hydrophilic central cavity of Sec61 beforehand.
This spontaneous insertion could occur anywhere in proximity to the PCC, possibly
depending on requirements of additional translocon components for topogenesis
of the respective substrate.
Which explanation seems more likely for the OP96 biogenesis intermediate? The
very short linker between the TMH C-terminus and the PCC (32 aa) greatly reduced
the NCs mobility, arguing against the classical in-out model. In contrast, it is in
favor of TMH sliding along the outer surface of Sec61 in direct vicinity of the OST in
order to allow for sucessful glycosylation of the N15 which is only 20 aa N-terminal
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of TMH1. Spontaneous insertion is furthermore supported by the fact that TMH1
is the most hydrophobic of all TMHs according to ΔG prediction (-2.44 kcal/mol)
(Hessa et al., 2007). The conformation appears to be stable also with longer NC as
indicated by the extended analysis of the OP109 intermediate. Therefore it must
be taken into consideration that our cryo-EM structure represents an equilibrium
state. Consequently, the observed positioning does not necessarily correspond
to a kinetically relevant on-pathway intermediate in vivo but might rather reflect
accomodation of the TMH at the thermodynamically most stable position.
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Future perspectives
The results presented in this dissertation provide the first high resolution structure
of a mammalian co-translational membrane insertion/N-glycosylation intermedi-
ate. They yield important insights in particular with respect to the composition
and architecture of translocon-bound OST complexes and form the base for a model
which can explain the selective integration of STT3A-OST into the RTC of higher
eukaryotes.
Nevertheless many open questions remain regarding the vital process of N-
glycosylation. First, what are the mechanisms involved in sequon recognition for
STT3A- and STT3B-OST? Available data suggest that the two complexes engage
glycosylation substrates in fundamentally different ways (Cherepanova et al., 2016).
As shown in this work, STT3A-OST is directly coupled to the protein synthesis and
translocation machinery and is proposed to generically sample nascent chains by
continuous scanning. In contrast, STT3B-OST is thought to selectively recruit its
target peptides via a mechanism involving the thioredoxin domain of its paralog
specific subunit in order to maximise N-glycan coverage.
Second, what is the role of the paralog-independent non-catalytic subunits,
especially the large lumenal domains of Ost1p/RPN1, Wbp1p/OST48 and
Swp1p/RPN2? There are indications that they contribute to complex stability, sub-
strate binding and selectivity. However, how these functions are distributed among
subunits and how they accomplish these tasks remains to be clarified. One impor-
tant step in this direction would be to complement the recent structural models of
the S. cerevisiae proteins (Bai et al., 2018; Wild et al., 2018) with high resolution struc-
tures of their metazoan counterparts. To address this issue, recent developments
in cryo-EM data processing software (Zivanov et al., 2018) such as CTF-refinement
including various per-particle corrections and multi-body refinement might help to
further increase the local resolution in the translocon region of the mammalian opsin
biogenesis intermediates presented in this work.
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Another objective of future research will be to characterize the substrate recruit-
ment process in OST enzymes of the three kingdoms of life. On the one hand, all
STT3-type proteins appear to share a common catalytic mechanism and have high
structural similarity. On the other hand, certain properties especially concerning
the size and structure of the LLO-precursor hint to potential differences in its deliv-
ery to the active site (Jones et al., 2009; Napiórkowska et al., 2017; Bai et al., 2018).
The LLO-entry route and binding mode might also be clarified by further analysis
regarding the different observed conformations of the EL5-loop. What is the func-
tional importance of these conformational changes? Here, it is known that presence
of LLO or peptide substrates induces stable conformations of either N-EL5 or C-EL5
respectively but the order of events and the exact triggers of conformational stabi-
lization are unclear. Thus, it would be desirable to generate more defined eukaryotic
N-glycosylation intermediates in different stages of the catalytic cycle for extended
structural studies.
Aside from contributing valuable insights into the process of N-glycosylation, this
thesis led to a number of unexpected findings with regard to the membrane inser-
tion procedure of bovine opsin. How can the near-primed conformation of Sec61
be explained, which was observed for all three biogenesis intermediates presented
in this work? Is the additional density at the Sec61-OST interface in the high res-
olution cryo-EM structures of OP96 and OP109 indeed representing the inserting
substrate? If so, how did it reach this position? In order to adress these questions,
it is crucial to obtain proof of the tentative assignment and positioning of the in-
sertion substrate. As mentioned above, a processing routine including the latest
algorithmic developments might lead to improved definition of density features
in the translocon region. Thus, it will potentially allow to confirm the identity of
the tentatively assigned opsin TMS. An alternative approach would be targeted NC
modifications such as additional bulky side chains or the incorporation of unnatu-
ral aa at defined positions to allow site specific crosslinking to proximal translocon
components. In contrast to existing crosslinking studies the experiments could be
coupled with mass spectrometry in order to reveal not only the identity of the NC
interaction partner but also provide information on the interacting region. Further-
more, it will be particularly interesting to evaluate whether intermediates with a
higher number of inserted TMS reside at the same position as provisionally shown
for OP96 and OP109. To that end, extended analysis of insertion intermediates re-
flecting later stages during opsin biogenesis, such as the OP204 intermediate should
be performed. Additionally, structural analysis of biogenesis intermediates from
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other polytopic insertion substrates could help to reveal determinants for certain in-
sertion trajectories.
Finally, the role of many accessory translocon factors remains in the dark. Until
now, they evade structural analysis since they seem to dissociate during the sample
preparation process. In our analysis TRAP, TRAM as well as the majority of EMC
proteins were identified in the sample but could not be visualized at all or at suffi-
ciently high resolution to draw any conclusions. Therefore, another future challenge
lies in experimental stabilization of these transient assemblies to make them acces-
sible for cryo-EM analysis.
In summary, this study once again demonstrates that the biogenesis of α-helical
TMPs is a multi-dimensional problem with many remaining experimental chal-
lenges, especially, but not only considering polytopic substrates. It requires a dy-
namic network of PCC-associated factors, some of which might form only very
transient interactions or perform their function in a highly substrate specific man-
ner. Considering the tremendous biological significance of the inserted substrates,
representing up to 30% of an organism’s protein encoding genes (Von Heijne, 2011)
membrane protein insertion and topogenesis continues to be a highly relevant field
of study.
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Appendix A
MS analysis of the solubilized OP96
biogenesis intermediate
A.1 Hits from the canis lupus familaris database
Table A.1 – MS analysis of the solubilized OP96 sample - Hits from canis lupus fa-
miliaris (dog). Mass spectrometry analysis was performed by Thomas Fröhlich (Gene
Center, LMU), hits are sorted according to their abundance as quantified by the emPAI
value. All subunits from mammalian OST are highlighted in grey. Short names are
given for all identified protein factors involved in translocation processes. The database
from canis lupus familiaris was used for the identification of membrane components due
to the use of dog PKRM in the translation reaction. Hits from soluble components
arise from high similarity between canis lupus familaris (PKRM) and oryctolagus cuniculus
(RRL).
Accession emPAI Description Short Name
gi|545488327 8.91  PREDICTED: 40S ribosomal protein S19 [Canis lupus familiaris]
gi|73987191 8.19  PREDICTED: 40S ribosomal protein S28 [Canis lupus familiaris]
gi|187609320 5.71  Chain u, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|55956952 4.70  ribosomal protein S18 [Canis lupus familiaris]
gi|356582340 4.42  ubiquitin-40S ribosomal protein S27a [Canis lupus familiaris]
gi|57113163 4.14  PREDICTED: 60S ribosomal protein L30 [Canis lupus familiaris]
gi|187609309 4.13  Chain k, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|928169639 3.98  PREDICTED: 40S ribosomal protein S21 [Canis lupus familiaris]
gi|545524789 3.80  PREDICTED: 40S ribosomal protein S3a [Canis lupus familiaris]
gi|187609255 3.56  Chain a, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|187609317 3.23  Chain r, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|187609307 2.96  Chain i, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|187609304 2.91  Chain f, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|73984484 2.88  PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 [Canis lupus familiaris] RPN1
gi|57101324 2.78  PREDICTED: 60S ribosomal protein L18a [Canis lupus familiaris]
gi|187609264 2.71  Chain k, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|325530283 2.62  RecName: Full=40S ribosomal protein S3
gi|73988614 2.51  PREDICTED: 40S ribosomal protein S13 [Canis lupus familiaris]
gi|73974792 2.42  PREDICTED: 60S ribosomal protein L8 [Canis lupus familiaris]
gi|984114 2.31  ribosome receptor [Canis lupus familiaris]
gi|545497049 2.24  PREDICTED: heat shock cognate 71 kDa protein [Canis lupus familiaris]
gi|187609269 2.22  Chain q, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|354725920 2.20  60S ribosomal protein L21 [Canis lupus familiaris]
gi|345806081 2.17  PREDICTED: 78 kDa glucose-regulated protein [Canis lupus familiaris]
gi|345780888 2.17  PREDICTED: 40S ribosomal protein S8 [Canis lupus familiaris]
gi|44888811 2.15  RecName: Full=Hemoglobin subunit beta; AltName: Full=Beta-globin; AltName: Full=Hemoglobin beta chain
gi|73999396 2.11  PREDICTED: 40S ribosomal protein S20 [Canis lupus familiaris]
gi|187609262 2.06  Chain i, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|73969959 1.93  PREDICTED: cytoskeleton-associated protein 4 [Canis lupus familiaris]
gi|73945531 1.80  PREDICTED: 40S ribosomal protein S12 [Canis lupus familiaris]
gi|345805550 1.69  PREDICTED: LOW QUALITY PROTEIN: leucine-rich repeat-containing protein 59 [Canis lupus familiaris]
gi|545545654 1.63  PREDICTED: peptidyl-prolyl cis-trans isomerase FKBP11 [Canis lupus familiaris]
gi|356582337 1.63  60S ribosomal protein L7 [Canis lupus familiaris]
gi|356991214 1.56  60S ribosomal protein L4 [Canis lupus familiaris]
gi|187609314 1.54  Chain p, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|74010186 1.52  PREDICTED: pancreatic alpha-amylase [Canis lupus familiaris]
gi|356582485 1.49  40S ribosomal protein S27 [Canis lupus familiaris]
gi|545502625 1.46  PREDICTED: 40S ribosomal protein S2 isoform X1 [Canis lupus familiaris]
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gi|57086947 1.46  PREDICTED: 60S ribosomal protein L13 [Canis lupus familiaris]
gi|345799858 1.43  PREDICTED: 40S ribosomal protein S25 [Canis lupus familiaris]
gi|73956649 1.29  PREDICTED: 60S ribosomal protein L22 [Canis lupus familiaris]
gi|89573885 1.28  ribosomal protein L18, partial [Canis lupus familiaris]
gi|187609261 1.27  Chain h, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|545535830 1.25  PREDICTED: 60S ribosomal protein L27a isoform X1 [Canis lupus familiaris]
gi|5441527 1.23  ribosomal protein L27 [Canis lupus familiaris]
gi|545503787 1.19  PREDICTED: 60S ribosomal protein L5 [Canis lupus familiaris]
gi|356460872 1.15  40S ribosomal protein S6 [Canis lupus familiaris]
gi|73957688 1.13  PREDICTED: transducin beta-like protein 2 [Canis lupus familiaris]
gi|928184673 1.12  PREDICTED: 60S ribosomal protein L10 isoform X1 [Canis lupus familiaris]
gi|356460978 1.12  60S ribosomal protein L10a [Canis lupus familiaris]
gi|928143153 1.10  PREDICTED: 60S ribosomal protein L38 [Canis lupus familiaris]
gi|57109594 1.06  PREDICTED: 60S ribosomal protein L35a [Canis lupus familiaris]
gi|136406 1.02  RecName: Full=Cationic trypsin; Flags: Precursor
gi|545557165 1.02  PREDICTED: translocon-associated protein subunit delta isoform X1 [Canis lupus familiaris] TRAPδ
gi|545543878 0.97  PREDICTED: 60S ribosomal protein L6 isoform X1 [Canis lupus familiaris]
gi|187609256 0.96  Chain b, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|545542114 0.96  PREDICTED: 60S ribosomal protein L34 [Canis lupus familiaris]
gi|34979905 0.94  epithelial keratin 10 [Canis lupus familiaris]
gi|354725914 0.88  40S ribosomal protein S4, X isoform [Canis lupus familiaris]
gi|187609321 0.88  Chain v, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|73963665 0.87  PREDICTED: transmembrane emp24 domain-containing protein 10 [Canis lupus familiaris]
gi|356640165 0.84  40S ribosomal protein S24 isoform 1 [Canis lupus familiaris]
gi|459746 0.82  protein translocation complex beta subunit [Canis lupus familiaris] Sec61β
gi|73990466 0.81  PREDICTED: translocon-associated protein subunit gamma [Canis lupus familiaris] TRAPγ
gi|5441541 0.81  Ribosomal protein [Canis lupus familiaris]
gi|345799231 0.79  PREDICTED: annexin A11 [Canis lupus familiaris]
gi|545487328 0.79  PREDICTED: 40S ribosomal protein S9 [Canis lupus familiaris]
gi|187609265 0.78  Chain l, Structure Of A Mammalian Ribosomal 40s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|57048082 0.76  PREDICTED: 60S ribosomal protein L9 [Canis lupus familiaris]
gi|187609327 0.76  Chain z, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|172046690 0.73  RecName: Full=DnaJ homolog subfamily B member 11; AltName: Full=ER-associated DNAJ; AltName: Full=ER-associated Hsp40 co-chaperone; 
gi|187609300 0.73  Chain b, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|560891938 0.71  ATP synthase subunit alpha, mitochondrial [Canis lupus familiaris]
gi|73991617 0.71  PREDICTED: 60S ribosomal protein L26 [Canis lupus familiaris]
gi|545539003 0.69  PREDICTED: signal recognition particle receptor subunit beta [Canis lupus familiaris] SRβ
gi|187609318 0.69  Chain s, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|73966629 0.68  PREDICTED: clathrin heavy chain 1 isoform X2 [Canis lupus familiaris]
gi|545498051 0.61  PREDICTED: vesicle-associated membrane protein 2 [Canis lupus familiaris]
gi|73962567 0.61  PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 [Canis lupus familiaris] DAD1
gi|73982080 0.58  PREDICTED: very-long-chain 3-oxoacyl-CoA reductase [Canis lupus familiaris]
A.1. Hits from the canis lupus familaris database 89
gi|187609302 0.58  Chain d, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|34979907 0.57  epithelial keratin 1 [Canis lupus familiaris]
gi|359322142 0.54  PREDICTED: elongation factor 2 [Canis lupus familiaris]
gi|545500190 0.54  PREDICTED: chymotrypsin-like protease CTRL-1 isoform X2 [Canis lupus familiaris]
gi|187609313 0.54  Chain o, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|74003143 0.54  PREDICTED: programmed cell death protein 6 isoform X1 [Canis lupus familiaris]
gi|359322420 0.53  PREDICTED: eukaryotic translation initiation factor 3 subunit F [Canis lupus familiaris]
gi|74003749 0.53  PREDICTED: 60S ribosomal protein L22-like 1 [Canis lupus familiaris]
gi|187609324 0.53  Chain x, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|545530860 0.53  PREDICTED: ubiquitin-like protein fubi and ribosomal protein S30 [Canis lupus familiaris]
gi|73991908 0.52  PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X2 [Canis lupus familiaris] RPN2
gi|73963693 0.52  PREDICTED: 40S ribosomal protein S29 [Canis lupus familiaris]
gi|57036143 0.50  PREDICTED: 40S ribosomal protein S5 [Canis lupus familiaris]
gi|356991221 0.50  60S ribosomal protein L14 [Canis lupus familiaris]
gi|325530312 0.49  RecName: Full=60S ribosomal protein L13a
gi|44888810 0.49  RecName: Full=Hemoglobin subunit alpha; AltName: Full=Alpha-globin; AltName: Full=Hemoglobin alpha chain
gi|359320346 0.48  PREDICTED: CDK5 regulatory subunit-associated protein 3 [Canis lupus familiaris]
gi|345790954 0.48  PREDICTED: malectin isoform X1 [Canis lupus familiaris] Malectin
gi|73971644 0.48  PREDICTED: ras-related protein Rab-14 [Canis lupus familiaris]
gi|131797 0.48  RecName: Full=Ras-related protein Rab-7a
gi|73989982 0.47  PREDICTED: 60S ribosomal protein L15 isoform X1 [Canis lupus familiaris]
gi|187609325 0.47  Chain y, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|924442847 0.46  actin, cytoplasmic 2 [Canis lupus familiaris]
gi|848 0.46  glycoprotein 25L [Canis lupus familiaris]
gi|73958588 0.44  PREDICTED: eukaryotic translation initiation factor 3 subunit C [Canis lupus familiaris]
gi|129505 0.44  RecName: Full=Phospholipase A2; AltName: Full=Group IB phospholipase A2; AltName: Full=Phosphatidylcholine 2-acylhydrolase 1B; Flags: Precursor
gi|545541162 0.44  PREDICTED: RNA-binding protein 38 [Canis lupus familiaris]
gi|545496900 0.43  PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A [Canis lupus familiaris] STT3A
gi|73969188 0.42  PREDICTED: eukaryotic translation initiation factor 3 subunit D [Canis lupus familiaris]
gi|136411 0.42  RecName: Full=Anionic trypsin; Flags: Precursor
gi|73968432 0.41  PREDICTED: ATP synthase subunit beta, mitochondrial [Canis lupus familiaris]
gi|545537816 0.41  PREDICTED: dnaJ homolog subfamily C member 3 [Canis lupus familiaris]
gi|354721202 0.39  40S ribosomal protein S10 [Canis lupus familiaris]
gi|164038 0.38  oligosaccharyltransferase 48 kDa subunit [Canis lupus familiaris] OST48
gi|73950876 0.38  PREDICTED: chymotrypsin-C [Canis lupus familiaris]
gi|345783280 0.38  PREDICTED: transmembrane protein 258 [Canis lupus familiaris] TMEM258
gi|73983414 0.37  PREDICTED: elongation factor 1-gamma [Canis lupus familiaris]
gi|73974130 0.37  PREDICTED: polyadenylate-binding protein 1 [Canis lupus familiaris]
gi|73998882 0.36  PREDICTED: pancreatic triacylglycerol lipase [Canis lupus familiaris]
gi|57085107 0.35  PREDICTED: annexin A7 isoform X1 [Canis lupus familiaris]
gi|935 0.35  unnamed protein product [Canis lupus familiaris]
gi|545526854 0.33  PREDICTED: 40S ribosomal protein S7 [Canis lupus familiaris]
gi|57095966 0.33  PREDICTED: sorcin isoform X2 [Canis lupus familiaris]
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gi|187609305 0.32  Chain g, Structure Of A Mammalian Ribosomal 60s Subunit Within An 80s Complex Obtained By Docking Homology Models Of The Rna And Proteins Into An 8.7 A Cryo-em Map
gi|915 0.32  rab10 [Canis lupus familiaris]
gi|341865609 0.31  pancreatic secretory granule membrane major glycoprotein GP2 precursor [Canis lupus familiaris]
gi|545555828 0.31  PREDICTED: NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 [Canis lupus familiaris]
gi|5731788 0.31  phospholipid hydroperoxide glutathione peroxidase, partial [Canis lupus familiaris]
gi|73980394 0.30  PREDICTED: protein disulfide-isomerase A6 [Canis lupus familiaris]
gi|74000476 0.30  PREDICTED: peptidyl-prolyl cis-trans isomerase B [Canis lupus familiaris]
gi|345780758 0.30  PREDICTED: nuclease-sensitive element-binding protein 1 isoform X1 [Canis lupus familiaris]
gi|73983454 0.30  PREDICTED: 60S acidic ribosomal protein P2 [Canis lupus familiaris]
gi|359320835 0.30  PREDICTED: clathrin light chain A isoform X4 [Canis lupus familiaris]
gi|73973426 0.30  PREDICTED: BAG family molecular chaperone regulator 2 [Canis lupus familiaris]
gi|359320857 0.29  PREDICTED: E3 UFM1-protein ligase 1 [Canis lupus familiaris]
gi|928152172 0.29  PREDICTED: LOW QUALITY PROTEIN: 60S acidic ribosomal protein P1-like [Canis lupus familiaris]
gi|74008235 0.29  PREDICTED: uncharacterized protein LOC480987 [Canis lupus familiaris]
gi|73971210 0.28  PREDICTED: transitional endoplasmic reticulum ATPase [Canis lupus familiaris]
gi|16607669 0.28  unnamed protein product [Canis lupus familiaris]
gi|359323342 0.28  PREDICTED: protein LYRIC isoform X3 [Canis lupus familiaris]
gi|73957259 0.27  PREDICTED: ran-binding protein 10 [Canis lupus familiaris]
gi|73998665 0.27  PREDICTED: eukaryotic translation initiation factor 3 subunit A isoform X1 [Canis lupus familiaris]
gi|73974299 0.27  PREDICTED: eukaryotic translation initiation factor 3 subunit E [Canis lupus familiaris]
gi|17298186 0.26  heat shock protein 70 [Canis lupus familiaris]
gi|928168898 0.26  PREDICTED: eukaryotic translation initiation factor 6 isoform X2 [Canis lupus familiaris]
gi|57092393 0.26  PREDICTED: 40S ribosomal protein S26 [Canis lupus familiaris]
gi|545523499 0.25  PREDICTED: polyadenylate-binding protein 4 isoform X1 [Canis lupus familiaris]
gi|73969600 0.25  PREDICTED: endoplasmic reticulum lectin 1 isoform X2 [Canis lupus familiaris]
gi|73957446 0.25  PREDICTED: transmembrane emp24 domain-containing protein 6 isoform X1 [Canis lupus familiaris]
gi|345800374 0.25  PREDICTED: plasminogen activator inhibitor 1 RNA-binding protein isoform X4 [Canis lupus familiaris]
gi|928136876 0.24  PREDICTED: eukaryotic translation initiation factor 3 subunit B [Canis lupus familiaris]
gi|359279916 0.24  keratin, type I cytoskeletal 19 [Canis lupus familiaris]
gi|359324135 0.24  PREDICTED: peroxiredoxin-4 isoform X4 [Canis lupus familiaris]
gi|158442066 0.24  prohibitin [Canis lupus familiaris]
gi|928143386 0.23  PREDICTED: E2/E3 hybrid ubiquitin-protein ligase UBE2O [Canis lupus familiaris]
gi|73990231 0.23  PREDICTED: armadillo repeat-containing protein 8 isoform X2 [Canis lupus familiaris]
gi|73980965 0.23  PREDICTED: mannosyl-oligosaccharide glucosidase [Canis lupus familiaris]
gi|545522024 0.23  PREDICTED: carboxypeptidase A1 [Canis lupus familiaris]
gi|226732647 0.23  RecName: Full=Keratinocyte-associated protein 2; Short=KCP-2 KCP2
gi|73948370 0.23  PREDICTED: syncollin [Canis lupus familiaris]
gi|354459407 0.23  voltage-dependent anion-selective channel protein 3 isoform 2 [Canis lupus familiaris]
gi|74009006 0.23  PREDICTED: membrane magnesium transporter 1 [Canis lupus familiaris] EMC5
gi|928147174 0.23  PREDICTED: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6 [Canis lupus familiaris]
gi|57087967 0.22  PREDICTED: cytochrome b-c1 complex subunit 2, mitochondrial [Canis lupus familiaris]
gi|73975552 0.22  PREDICTED: carboxypeptidase A2 [Canis lupus familiaris]
gi|16975342 0.22  Chain A, Crystal Structure Of The Lumenal Domain Of Calnexin
gi|34979903 0.22  epithelial keratin 2e [Canis lupus familiaris]
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gi|545492518 0.22  PREDICTED: receptor expression-enhancing protein 5, partial [Canis lupus familiaris]
gi|40313536 0.22  deoxyribonuclease I [Canis lupus familiaris]
gi|73983273 0.22  PREDICTED: peptidyl-prolyl cis-trans isomerase FKBP2 isoform X2 [Canis lupus familiaris]
gi|345785949 0.22  PREDICTED: 60S ribosomal protein L28 [Canis lupus familiaris]
gi|359323129 0.21  PREDICTED: tubulin alpha-1C chain [Canis lupus familiaris]
gi|308199425 0.21  elongation factor 1-alpha 1 [Canis lupus familiaris]
gi|73979580 0.21  PREDICTED: ADP/ATP translocase 1 [Canis lupus familiaris]
gi|74008194 0.21  PREDICTED: ADP/ATP translocase 2 [Canis lupus familiaris]
gi|545541681 0.21  PREDICTED: ubiquitin-fold modifier 1 isoform X1 [Canis lupus familiaris]
gi|545521108 0.20  PREDICTED: elongation factor 1-delta isoform X1 [Canis lupus familiaris]
gi|206984847 0.20  unnamed protein product [Canis lupus familiaris]
gi|126316 0.20  RecName: Full=Inactive pancreatic lipase-related protein 1; Short=PL-RP1; Flags: Precursor
gi|226739213 0.20  RecName: Full=Oligosaccharyltransferase complex subunit OSTC DC2/OSTC
gi|545534022 0.20  PREDICTED: NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 [Canis lupus familiaris]
gi|73956140 0.19  PREDICTED: fatty aldehyde dehydrogenase isoform X2 [Canis lupus familiaris]
gi|545503669 0.19  PREDICTED: nodal modulator 1 [Canis lupus familiaris]
gi|928128521 0.19  PREDICTED: eukaryotic translation initiation factor 3 subunit I [Canis lupus familiaris]
gi|928183240 0.19  PREDICTED: transmembrane and coiled-coil domain-containing protein 1 isoform X1 [Canis lupus familiaris] TMCO1
gi|359319817 0.18  PREDICTED: protein disulfide-isomerase A2 isoform X2 [Canis lupus familiaris]
gi|73979213 0.18  PREDICTED: erlin-2 isoform X2 [Canis lupus familiaris]
gi|545501397 0.18  PREDICTED: vitamin K epoxide reductase complex subunit 1 [Canis lupus familiaris]
gi|57093423 0.18  PREDICTED: poly(rC)-binding protein 1 [Canis lupus familiaris]
gi|74003099 0.18  PREDICTED: ubiquitin-conjugating enzyme E2Q-like protein 1 [Canis lupus familiaris]
gi|928167632 0.17  PREDICTED: serotransferrin [Canis lupus familiaris]
gi|1333622 0.17  paraoxonase 2 [Canis lupus familiaris]
gi|57111763 0.17  PREDICTED: PRA1 family protein 2 [Canis lupus familiaris]
gi|475062 0.17  VIP36 (vesicular integral-membrane protein) [Canis lupus familiaris]
gi|345791839 0.16  PREDICTED: keratin, type II cytoskeletal 6A isoform X2 [Canis lupus familiaris]
gi|10946310 0.16  transferrin receptor [Canis lupus familiaris]
gi|545514391 0.16  PREDICTED: cysteine-rich with EGF-like domain protein 2 [Canis lupus familiaris]
gi|345807587 0.16  PREDICTED: magnesium transporter protein 1 isoform X1 [Canis lupus familiaris] MAGT1
gi|134792 0.16  RecName: Full=Signal peptidase complex catalytic subunit SEC11C; AltName: Full=Microsomal signal peptidase 21 kDa subunit; Short=SPase 21 kDa subunit; Sec11
gi|73998777 0.15  PREDICTED: CUB and zona pellucida-like domain-containing protein 1 [Canis lupus familiaris]
gi|345799449 0.15  PREDICTED: clathrin interactor 1 isoform X1 [Canis lupus familiaris]
gi|73989883 0.15  PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B [Canis lupus familiaris] STT3B
gi|353731063 0.15  eukaryotic translation initiation factor 3 subunit L [Canis lupus familiaris]
gi|345796543 0.15  PREDICTED: translocation protein SEC62 [Canis lupus familiaris] Sec62
gi|345777399 0.15  PREDICTED: AP-3 complex subunit sigma-1 isoform X1 [Canis lupus familiaris]
gi|73980315 0.15  PREDICTED: protein RMD5 homolog A [Canis lupus familiaris]
gi|73985044 0.15  PREDICTED: ADP-ribosylation factor-like protein 8B [Canis lupus familiaris]
gi|345791445 0.14  PREDICTED: stromal cell-derived factor 2-like protein 1 [Canis lupus familiaris]
gi|356460984 0.14  eukaryotic peptide chain release factor subunit 1 [Canis lupus familiaris]
gi|415377 0.14  Rab5c protein [Canis lupus familiaris]
gi|545551111 0.14  PREDICTED: ATP synthase subunit O, mitochondrial [Canis lupus familiaris]
gi|57106334 0.14  PREDICTED: keratin, type I cytoskeletal 18 [Canis lupus familiaris]
gi|57110955 0.13  PREDICTED: elongation factor 1-beta [Canis lupus familiaris]
gi|545533839 0.13  PREDICTED: cytochrome b-c1 complex subunit 1, mitochondrial isoform X1 [Canis lupus familiaris]
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gi|57110953 0.13  PREDICTED: NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial [Canis lupus familiaris]
gi|57098751 0.13  PREDICTED: vesicle-trafficking protein SEC22b [Canis lupus familiaris]
gi|359320233 0.13  PREDICTED: serine/arginine-rich splicing factor 2 [Canis lupus familiaris]
gi|164070 0.13  homologue to sec61 [Canis lupus familiaris] Sec61α
gi|57036583 0.13  PREDICTED: eukaryotic translation initiation factor 3 subunit K [Canis lupus familiaris]
gi|533111 0.13  signal peptidase complex 25 kDa subunit [Canis lupus familiaris] SPase 25 kDa
gi|545549261 0.13  PREDICTED: ER membrane protein complex subunit 7 [Canis lupus familiaris] EMC7
gi|73993818 0.12  PREDICTED: V-type proton ATPase subunit B, brain isoform [Canis lupus familiaris]
gi|345779293 0.12  PREDICTED: transmembrane protein 33 [Canis lupus familiaris]
gi|73945930 0.12  PREDICTED: protein ERGIC-53 isoform X1 [Canis lupus familiaris]
gi|374532808 0.12  thioredoxin-dependent peroxide reductase, mitochondrial [Canis lupus familiaris]
gi|345794865 0.12  PREDICTED: protein disulfide-isomerase A3 [Canis lupus familiaris]
gi|117612 0.12  RecName: Full=Chymotrypsinogen 2; Contains: RecName: Full=Chymotrypsin 2 chain A; Contains: RecName: Full=Chymotrypsin 2 chain B; Flags: Precursor
gi|73980752 0.12  PREDICTED: serine/arginine-rich splicing factor 7 isoform X1 [Canis lupus familiaris]
gi|73992430 0.12  PREDICTED: glucose-induced degradation protein 8 homolog [Canis lupus familiaris]
gi|73946982 0.12  PREDICTED: ER membrane protein complex subunit 10 isoform X2 [Canis lupus familiaris] EMC10
gi|73962198 0.12  PREDICTED: NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial [Canis lupus familiaris]
gi|73964749 0.12  PREDICTED: protein disulfide-isomerase [Canis lupus familiaris]
gi|73992635 0.12  PREDICTED: vesicle-associated membrane protein-associated protein B/C isoform X2 [Canis lupus familiaris]
gi|345792055 0.12  PREDICTED: methyltransferase-like protein 7A [Canis lupus familiaris]
gi|345777664 0.12  PREDICTED: protein NipSnap homolog 3A [Canis lupus familiaris]
gi|345800975 0.11  PREDICTED: enhancer of mRNA-decapping protein 4 [Canis lupus familiaris]
gi|345791833 0.11  PREDICTED: keratin, type II cytoskeletal 3 [Canis lupus familiaris]
gi|57043329 0.11  PREDICTED: proproteinase E [Canis lupus familiaris]
gi|928180988 0.11  PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC488260 [Canis lupus familiaris]
gi|73983298 0.11  PREDICTED: NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [Canis lupus familiaris]
gi|57100904 0.11  PREDICTED: ER membrane protein complex subunit 3 [Canis lupus familiaris] EMC3
gi|545525725 0.11  PREDICTED: transmembrane and ubiquitin-like domain-containing protein 1 [Canis lupus familiaris]
gi|73986020 0.10  PREDICTED: manganese-transporting ATPase 13A1 [Canis lupus familiaris]
gi|134891 0.10  RecName: Full=Signal recognition particle receptor subunit alpha; Short=SR-alpha; AltName: Full=Docking protein alpha; Short=DP-alpha SRα
gi|345780013 0.10  PREDICTED: staphylococcal nuclease domain-containing protein 1 [Canis lupus familiaris]
gi|73953093 0.10  PREDICTED: voltage-dependent anion-selective channel protein 2 [Canis lupus familiaris]
gi|74006309 0.10  PREDICTED: DDB1- and CUL4-associated factor 8 [Canis lupus familiaris]
gi|57109638 0.10  PREDICTED: V-type proton ATPase catalytic subunit A [Canis lupus familiaris]
gi|928161789 0.10  PREDICTED: membrane-associated progesterone receptor component 2, partial [Canis lupus familiaris]
gi|928159936 0.10  PREDICTED: AP-2 complex subunit alpha-2 [Canis lupus familiaris]
gi|73965738 0.10  PREDICTED: V-type proton ATPase 116 kDa subunit a isoform 1 isoform X6 [Canis lupus familiaris]
gi|345791621 0.10  PREDICTED: prohibitin-2 [Canis lupus familiaris]
gi|2853285 0.09  sarcoplasmic reticulum Ca2+-transport ATPase isoform [Canis lupus familiaris]
gi|359321459 0.09  PREDICTED: protein disulfide-isomerase A4 [Canis lupus familiaris]
gi|73960960 0.09  PREDICTED: secretory carrier-associated membrane protein 3 isoform X1 [Canis lupus familiaris]
gi|545513876 0.09  PREDICTED: protein OS-9 isoform X1 [Canis lupus familiaris]
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gi|73974479 0.09  PREDICTED: ER membrane protein complex subunit 2 [Canis lupus familiaris] EMC2
gi|73978790 0.09  PREDICTED: dnaJ homolog subfamily B member 6 isoform X1 [Canis lupus familiaris]
gi|73986278 0.09  PREDICTED: dnaJ homolog subfamily B member 1 isoform X1 [Canis lupus familiaris]
gi|545537385 0.08  PREDICTED: fibronectin type-III domain-containing protein 3A isoform X1 [Canis lupus familiaris]
gi|73983859 0.08  PREDICTED: DNA damage-binding protein 1 [Canis lupus familiaris]
gi|928176123 0.08  PREDICTED: aspartyl/asparaginyl beta-hydroxylase isoform X2 [Canis lupus familiaris]
gi|928157470 0.08  PREDICTED: transmembrane protein 214 [Canis lupus familiaris]
gi|73957263 0.08  PREDICTED: V-type proton ATPase subunit d 1 [Canis lupus familiaris]
gi|345794639 0.08  PREDICTED: thrombospondin-1 [Canis lupus familiaris]
gi|73979498 0.08  PREDICTED: long-chain-fatty-acid--CoA ligase 1 isoform X1 [Canis lupus familiaris]
gi|24021296 0.08  glutamine synthetase [Canis lupus familiaris]
gi|359322750 0.08  PREDICTED: serine/arginine-rich splicing factor 6 isoform X1 [Canis lupus familiaris]
gi|73991533 0.08  PREDICTED: minor histocompatibility antigen H13 isoform X4 [Canis lupus familiaris]
gi|942 0.08  TRAM-protein [Canis lupus familiaris] TRAM
gi|219772678 0.07  unnamed protein product [Canis lupus familiaris]
gi|359320880 0.07  PREDICTED: valine--tRNA ligase isoform X2 [Canis lupus familiaris]
gi|928130713 0.07  PREDICTED: macrophage erythroblast attacher isoform X1 [Canis lupus familiaris]
gi|345796421 0.07  PREDICTED: eukaryotic initiation factor 4A-II [Canis lupus familiaris]
gi|545488118 0.07  PREDICTED: glutaminyl-peptide cyclotransferase-like protein isoform X2 [Canis lupus familiaris]
gi|73979922 0.07  PREDICTED: prolactin regulatory element-binding protein [Canis lupus familiaris]
gi|545531873 0.06  PREDICTED: UDP-glucose:glycoprotein glucosyltransferase 1 [Canis lupus familiaris]
gi|345793750 0.06  PREDICTED: ER membrane protein complex subunit 1 isoform X6 [Canis lupus familiaris] EMC1
gi|359318595 0.06  PREDICTED: AP-2 complex subunit alpha-1 isoform X1 [Canis lupus familiaris]
gi|73960479 0.06  PREDICTED: ER degradation-enhancing alpha-mannosidase-like protein 3 isoform X7 [Canis lupus familiaris]
gi|928131403 0.06  PREDICTED: glutamate dehydrogenase 1, mitochondrial, partial [Canis lupus familiaris]
gi|545499442 0.06  PREDICTED: tubulin beta-3 chain [Canis lupus familiaris]
gi|545521446 0.06  PREDICTED: NF-X1-type zinc finger protein NFXL1 [Canis lupus familiaris]
gi|930 0.06  unnamed protein product [Canis lupus familiaris]
gi|74009203 0.06  PREDICTED: H/ACA ribonucleoprotein complex subunit 4 [Canis lupus familiaris]
gi|359323340 0.06  PREDICTED: phosphatidylserine synthase 1 isoform X1 [Canis lupus familiaris]
gi|345784138 0.06  PREDICTED: metalloreductase STEAP3 isoform X2 [Canis lupus familiaris]
gi|73979871 0.06  PREDICTED: trifunctional enzyme subunit beta, mitochondrial [Canis lupus familiaris]
gi|928142969 0.05  PREDICTED: heat shock protein HSP 90-alpha [Canis lupus familiaris]
gi|928181018 0.05  PREDICTED: LOW QUALITY PROTEIN: tripartite motif-containing protein 10 [Canis lupus familiaris]
gi|57098645 0.05  PREDICTED: all-trans-retinol 13,14-reductase isoform X1 [Canis lupus familiaris]
gi|345793181 0.05  PREDICTED: copine-3 [Canis lupus familiaris]
gi|345781155 0.05  PREDICTED: ATP-binding cassette sub-family E member 1 isoform X1 [Canis lupus familiaris]
gi|57092243 0.04  PREDICTED: bile salt-activated lipase [Canis lupus familiaris]
gi|403497 0.04  GRP94 [Canis lupus familiaris]
gi|74003954 0.04  PREDICTED: phosphatidylinositol-glycan-specific phospholipase D isoform X2 [Canis lupus familiaris]
gi|73980337 0.04  PREDICTED: MICOS complex subunit MIC60 isoform X1 [Canis lupus familiaris]
gi|359320614 0.04  PREDICTED: LOW QUALITY PROTEIN: lipase maturation factor 2 [Canis lupus familiaris]
gi|73964368 0.04  PREDICTED: protein sel-1 homolog 1 isoform X1 [Canis lupus familiaris]
gi|545500961 0.04  PREDICTED: pentatricopeptide repeat-containing protein 1, mitochondrial isoform X4 [Canis lupus familiaris]
gi|359318618 0.04  PREDICTED: LOW QUALITY PROTEIN: glycogen [starch] synthase, muscle [Canis lupus familiaris]
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gi|545556290 0.03  PREDICTED: ATP-binding cassette sub-family B member 6, mitochondrial [Canis lupus familiaris]
gi|33413904 0.03  adaptor-related protein complex AP3 beta 1 subunit [Canis lupus familiaris]
gi|73982653 0.03  PREDICTED: cysteine--tRNA ligase, cytoplasmic isoform X1 [Canis lupus familiaris]
gi|73966186 0.03  PREDICTED: importin subunit beta-1 [Canis lupus familiaris]
gi|545495990 0.03  PREDICTED: la-related protein 1 [Canis lupus familiaris]
gi|73964198 0.03  PREDICTED: C-1-tetrahydrofolate synthase, cytoplasmic isoform X1 [Canis lupus familiaris]
gi|545503813 0.03  PREDICTED: glutamate-rich protein 3 [Canis lupus familiaris]
gi|928146436 0.02  PREDICTED: extended synaptotagmin-1 [Canis lupus familiaris]
gi|545543200 0.02  PREDICTED: vigilin [Canis lupus familiaris]
gi|928156856 0.02  PREDICTED: ankyrin-1 isoform X1 [Canis lupus familiaris]
gi|359319316 0.02  PREDICTED: zinc finger SWIM domain-containing protein 8 isoform X3 [Canis lupus familiaris]
gi|928129726 0.02  PREDICTED: putative ankyrin repeat domain-containing protein 31 isoform X1 [Canis lupus familiaris]
gi|333805632 0.01  spectrin beta chain, erythrocytic [Canis lupus familiaris]
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A.2 Hits from the oryctolagus cuniculus database
Table A.2 – MS analysis of the solubilized OP96 sample - Hits from oryctolagus cu-
niculus (rabbit).Mass spectrometry analysis was performed by Thomas Fröhlich (Gene
Center, LMU), hits are sorted according to their abundance as quantified by the em-
PAI value. The database from oryctolagus cuniculus was used for the identification of
soluble components due to the use of rabbit reticulocyte lysate in the translation reac-
tion. Hits from membrane components arise from high similarity between canis lupus
familaris (PKRM) and oryctolagus cuniculus (RRL).
Accession emPAI Description
gi|529281378 8.19 Chain c, Rabbit 40s Ribosomal Subunit In Complex With Eif1.
gi|291390048 7.47 PREDICTED: 60S ribosomal protein L38 [Oryctolagus cuniculus]
gi|665764245 5.76 Chain T, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291388327 5.49 PREDICTED: 60S ribosomal protein L30 [Oryctolagus cuniculus]
gi|291396021 4.70 PREDICTED: 40S ribosomal protein S18 [Oryctolagus cuniculus]
gi|291400758 4.64 PREDICTED: 60S ribosomal protein L24 [Oryctolagus cuniculus]
gi|665764286 4.14 Chain c, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|665764247 3.98 Chain V, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291389960 3.80 PREDICTED: 40S ribosomal protein S3a [Oryctolagus cuniculus]
gi|291416370 3.58 PREDICTED: ubiquitin-40S ribosomal protein S27a [Oryctolagus cuniculus]
gi|1485 3.57 unnamed protein product [Oryctolagus cuniculus]
gi|291408313 2.96 PREDICTED: 60S ribosomal protein L12 [Oryctolagus cuniculus]
gi|89573875 2.75 ribosomal protein L18, partial [Oryctolagus cuniculus]
gi|291387632 2.71 PREDICTED: 40S ribosomal protein S14 [Oryctolagus cuniculus]
gi|291394359 2.66 PREDICTED: 60S ribosomal protein L17 [Oryctolagus cuniculus]
gi|291397006 2.44 PREDICTED: 40S ribosomal protein S12 [Oryctolagus cuniculus]
gi|291414539 2.42 PREDICTED: 60S ribosomal protein L8 [Oryctolagus cuniculus]
gi|291400487 2.31 PREDICTED: transferrin receptor protein 1 [Oryctolagus cuniculus]
gi|291384249 2.22 PREDICTED: 40S ribosomal protein S3 [Oryctolagus cuniculus]
gi|291386783 2.22 PREDICTED: 40S ribosomal protein S11 [Oryctolagus cuniculus]
gi|291388155 2.20 PREDICTED: 60S ribosomal protein L21 [Oryctolagus cuniculus]
gi|529281382 2.19 Chain g, Rabbit 40s Ribosomal Subunit In Complex With Eif1.
gi|291383687 2.17 PREDICTED: 40S ribosomal protein S8 [Oryctolagus cuniculus]
gi|665764265 2.16 Chain G, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|1483 2.12 beta-globin [Oryctolagus cuniculus]
gi|291389987 2.06 PREDICTED: 40S ribosomal protein S16 [Oryctolagus cuniculus]
gi|655878299 2.03 PREDICTED: 78 kDa glucose-regulated protein [Oryctolagus cuniculus]
gi|307775447 1.91 60S ribosomal protein L4 [Oryctolagus cuniculus]
gi|1751 1.89 liver transferrin [Oryctolagus cuniculus]
gi|665764276 1.83 Chain S, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291388052 1.80 PREDICTED: 60S ribosomal protein L13 [Oryctolagus cuniculus]
gi|655870993 1.75 PREDICTED: 60S ribosomal protein L23 [Oryctolagus cuniculus]
gi|291403978 1.73 PREDICTED: 60S ribosomal protein L5 [Oryctolagus cuniculus]
gi|291383777 1.70 PREDICTED: heat shock cognate 71 kDa protein [Oryctolagus cuniculus]
gi|365177544 1.67 alpha-globin 1 [Oryctolagus cuniculus]
gi|122475 1.67 RecName: Full=Hemoglobin subunit alpha-1/2; AltName: Full=Alpha-1/2-globin; AltName: Full=Hemoglobin alpha-1/2 chain
gi|291388125 1.64 PREDICTED: 60S ribosomal protein L7 [Oryctolagus cuniculus]
gi|665764275 1.54 Chain R, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291383303 1.48 PREDICTED: 40S ribosomal protein S20 [Oryctolagus cuniculus]
gi|291410235 1.45 PREDICTED: 40S ribosomal protein S13 [Oryctolagus cuniculus]
gi|291412982 1.43 PREDICTED: 40S ribosomal protein S25 [Oryctolagus cuniculus]
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gi|461517 1.42 RecName: Full=Annexin A11; AltName: Full=Annexin XI; AltName: Full=Annexin-11; 
gi|217418273 1.41 ribosomal protein L10 (predicted) [Oryctolagus cuniculus]
gi|291383209 1.40 PREDICTED: 40S ribosomal protein S6 [Oryctolagus cuniculus]
gi|291407689 1.33 PREDICTED: 40S ribosomal protein S4, X isoform [Oryctolagus cuniculus]
gi|665764278 1.28 Chain U, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|529281372 1.27 Chain W, Rabbit 40s Ribosomal Subunit In Complex With Eif1.
gi|217418260 1.24 signal sequence receptor, delta (predicted) [Oryctolagus cuniculus]
gi|665764228 1.22 Chain C, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291393273 1.20 PREDICTED: 60S ribosomal protein L14 [Oryctolagus cuniculus]
gi|655602744 1.14 PREDICTED: 60S ribosomal protein L27a isoform X1 [Oryctolagus cuniculus]
gi|291396081 1.12 PREDICTED: 60S ribosomal protein L10a [Oryctolagus cuniculus]
gi|665764274 1.05 Chain Q, Regulation Of The Mammalian Elongation Cycle By 40s Subunit Rolling: A Eukaryotic-specific Ribosome Rearrangement
gi|291394855 1.04 PREDICTED: sorcin isoform X1 [Oryctolagus cuniculus]
gi|291385667 1.03 PREDICTED: 60S ribosomal protein L9 [Oryctolagus cuniculus]
gi|291389071 1.00 PREDICTED: peptidyl-prolyl cis-trans isomerase FKBP11 [Oryctolagus cuniculus]
gi|291408688 1.00 PREDICTED: 60S ribosomal protein L18a [Oryctolagus cuniculus]
gi|217418300 0.99 ribosomal protein S9 (predicted) [Oryctolagus cuniculus]
gi|655899014 0.94 PREDICTED: 60S ribosomal protein L13a [Oryctolagus cuniculus]
gi|146674796 0.93 laminin receptor precursor, partial [Oryctolagus cuniculus]
gi|291393348 0.92 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 [Oryctolagus cuniculus]
gi|655878391 0.88 PREDICTED: 60S ribosomal protein L35 [Oryctolagus cuniculus]
gi|1370279 0.87 transmembrane protein [Oryctolagus cuniculus]
gi|291389862 0.86 PREDICTED: 60S ribosomal protein L3 [Oryctolagus cuniculus]
gi|291383381 0.84 PREDICTED: 40S ribosomal protein S27 [Oryctolagus cuniculus]
gi|291404117 0.83 PREDICTED: 40S ribosomal protein S24 isoform X3 [Oryctolagus cuniculus]
gi|291382907 0.82 PREDICTED: protein transport protein Sec61 subunit beta [Oryctolagus cuniculus]
gi|291400056 0.81 PREDICTED: translocon-associated protein subunit gamma [Oryctolagus cuniculus]
gi|291394851 0.81 PREDICTED: 40S ribosomal protein S17 [Oryctolagus cuniculus]
gi|291395525 0.79 PREDICTED: 60S ribosomal protein L27 [Oryctolagus cuniculus]
gi|291393699 0.79 PREDICTED: 60S ribosomal protein L28 [Oryctolagus cuniculus]
gi|291406014 0.78 PREDICTED: keratin, type I cytoskeletal 10 isoform X1 [Oryctolagus cuniculus]
gi|291406991 0.78 PREDICTED: 60S ribosomal protein L6 [Oryctolagus cuniculus]
gi|291394968 0.78 PREDICTED: 40S ribosomal protein S23 [Oryctolagus cuniculus]
gi|1553 0.77 elongation factor 1 gamma [Oryctolagus cuniculus]
gi|291411482 0.77 PREDICTED: transducin beta-like protein 2 [Oryctolagus cuniculus]
gi|291403291 0.75 PREDICTED: putative 60S ribosomal protein L37a [Oryctolagus cuniculus]
gi|655895819 0.71 PREDICTED: tripartite motif-containing protein 58 [Oryctolagus cuniculus]
gi|291405068 0.71 PREDICTED: 60S ribosomal protein L26 [Oryctolagus cuniculus]
gi|655852411 0.69 PREDICTED: signal recognition particle receptor subunit beta [Oryctolagus cuniculus]
gi|655851870 0.69 PREDICTED: vesicle-associated membrane protein 3 [Oryctolagus cuniculus]
gi|291386554 0.69 PREDICTED: 60S ribosomal protein L23a [Oryctolagus cuniculus]
gi|291395920 0.67 PREDICTED: tripartite motif-containing protein 10 isoform X1 [Oryctolagus cuniculus]
gi|655871198 0.67 PREDICTED: keratin, type I cytoskeletal 15 [Oryctolagus cuniculus]
gi|655870340 0.62 PREDICTED: clathrin heavy chain 1 isoform X1 [Oryctolagus cuniculus]
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gi|291383906 0.61 PREDICTED: 60S ribosomal protein L36a [Oryctolagus cuniculus]
gi|327315387 0.61 60S ribosomal protein L35a [Oryctolagus cuniculus]
gi|291400281 0.60 PREDICTED: dnaJ homolog subfamily B member 11 [Oryctolagus cuniculus]
gi|291407056 0.58 PREDICTED: 60S acidic ribosomal protein P0 [Oryctolagus cuniculus]
gi|291403718 0.57 PREDICTED: 60S ribosomal protein L34 [Oryctolagus cuniculus]
gi|291413981 0.53 PREDICTED: programmed cell death protein 6 isoform X1 [Oryctolagus cuniculus]
gi|291386196 0.53 PREDICTED: 60S ribosomal protein L31 [Oryctolagus cuniculus]
gi|89574025 0.52 mitochondrial ATP synthase, H+ transporting F1 complex beta subunit, partial [Oryctolagus cuniculus]
gi|291400180 0.52 PREDICTED: 60S ribosomal protein L22-like 1 [Oryctolagus cuniculus]
gi|291414405 0.52 PREDICTED: ubiquitin-like protein fubi and ribosomal protein S30 [Oryctolagus cuniculus]
gi|291388310 0.52 PREDICTED: 40S ribosomal protein S29 [Oryctolagus cuniculus]
gi|291411397 0.50 PREDICTED: 40S ribosomal protein S5 [Oryctolagus cuniculus]
gi|1203894 0.50 elongation factor 1 delta [Oryctolagus cuniculus]
gi|291408446 0.48 PREDICTED: ras-related protein Rab-14 [Oryctolagus cuniculus]
gi|655870908 0.48 PREDICTED: CDK5 regulatory subunit-associated protein 3 [Oryctolagus cuniculus]
gi|291396428 0.48 PREDICTED: BAG family molecular chaperone regulator 2 [Oryctolagus cuniculus]
gi|291399716 0.47 PREDICTED: 60S ribosomal protein L15 [Oryctolagus cuniculus]
gi|655863889 0.47 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 [Oryctolagus cuniculus]
gi|655721756 0.46 PREDICTED: LOW QUALITY PROTEIN: ribosome-binding protein 1 [Oryctolagus cuniculus]
gi|655791666 0.46 PREDICTED: ran-binding protein 10 [Oryctolagus cuniculus]
gi|291390868 0.44 PREDICTED: eukaryotic translation initiation factor 3 subunit C [Oryctolagus cuniculus]
gi|291404166 0.44 PREDICTED: annexin A7 isoform X1 [Oryctolagus cuniculus]
gi|291405799 0.43 PREDICTED: leucine-rich repeat-containing protein 59 [Oryctolagus cuniculus]
gi|291389904 0.42 PREDICTED: eukaryotic translation initiation factor 3 subunit D [Oryctolagus cuniculus]
gi|655893183 0.41 PREDICTED: LOW QUALITY PROTEIN: ubiquitin-conjugating enzyme E2 O [Oryctolagus cuniculus]
gi|655708163 0.41 PREDICTED: eukaryotic translation initiation factor 6 [Oryctolagus cuniculus]
gi|655602713 0.40 PREDICTED: eukaryotic translation initiation factor 3 subunit F [Oryctolagus cuniculus]
gi|291396063 0.39 PREDICTED: 40S ribosomal protein S10 [Oryctolagus cuniculus]
gi|291394323 0.38 PREDICTED: ATP synthase subunit alpha, mitochondrial [Oryctolagus cuniculus]
gi|291383033 0.38 PREDICTED: transitional endoplasmic reticulum ATPase [Oryctolagus cuniculus]
gi|291409694 0.38 PREDICTED: ubiquitin-fold modifier 1 [Oryctolagus cuniculus]
gi|655602634 0.37 PREDICTED: interferon-induced very large GTPase 1-like isoform X1 [Oryctolagus cuniculus]
gi|655688285 0.37 PREDICTED: polyadenylate-binding protein 1 [Oryctolagus cuniculus]
gi|655870053 0.36 PREDICTED: schlafen family member 14 [Oryctolagus cuniculus]
gi|655850868 0.36 PREDICTED: 60S ribosomal protein L11 [Oryctolagus cuniculus]
gi|291407031 0.35 PREDICTED: malectin [Oryctolagus cuniculus]
gi|655852467 0.34 PREDICTED: armadillo repeat-containing protein 8 isoform X1 [Oryctolagus cuniculus]
gi|291397946 0.34 PREDICTED: protein S100-A8 [Oryctolagus cuniculus]
gi|655868457 0.33 PREDICTED: arachidonate 15-lipoxygenase isoform X1 [Oryctolagus cuniculus]
gi|529281357 0.33 Chain H, Rabbit 40s Ribosomal Subunit In Complex With Eif1.
gi|291407802 0.33 PREDICTED: ADP/ATP translocase 2 [Oryctolagus cuniculus]
gi|655869751 0.32 PREDICTED: galectin-9 isoform X1 [Oryctolagus cuniculus]
gi|291383631 0.32 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A [Oryctolagus cuniculus]
gi|291387085 0.32 PREDICTED: ras-related protein Rab-10 isoform X1 [Oryctolagus cuniculus]
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gi|291402876 0.30 PREDICTED: LOW QUALITY PROTEIN: peptidyl-prolyl cis-trans isomerase B [Oryctolagus cuniculus]
gi|608518 0.30 p50 [Oryctolagus cuniculus]
gi|4105817 0.30 Rab7 [Oryctolagus cuniculus]
gi|291382979 0.30 PREDICTED: clathrin light chain A isoform X4 [Oryctolagus cuniculus]
gi|291412313 0.30 PREDICTED: 60S acidic ribosomal protein P1 [Oryctolagus cuniculus]
gi|655606069 0.30 PREDICTED: vesicle-associated membrane protein 8 [Oryctolagus cuniculus]
gi|655881271 0.29 PREDICTED: RNA-binding protein 24 [Oryctolagus cuniculus]
gi|655846321 0.28 PREDICTED: secretory carrier-associated membrane protein 3 [Oryctolagus cuniculus]
gi|291383133 0.28 PREDICTED: 60S ribosomal protein L29-like [Oryctolagus cuniculus]
gi|291384176 0.28 PREDICTED: 60S ribosomal protein L36 [Oryctolagus cuniculus]
gi|655868267 0.27 PREDICTED: eukaryotic translation initiation factor 3 subunit A [Oryctolagus cuniculus]
gi|3108211 0.27 histone H2A.F/Z variant [Oryctolagus cuniculus]
gi|655840227 0.26 PREDICTED: valine--tRNA ligase [Oryctolagus cuniculus]
gi|655842765 0.26 PREDICTED: keratinocyte-associated protein 2-like [Oryctolagus cuniculus]
gi|655736937 0.26 PREDICTED: 40S ribosomal protein S26 [Oryctolagus cuniculus]
gi|291399204 0.25 PREDICTED: polyadenylate-binding protein 4 isoform X2 [Oryctolagus cuniculus]
gi|291398395 0.25 PREDICTED: pancreatic alpha-amylase-like [Oryctolagus cuniculus]
gi|655832614 0.25 PREDICTED: LOW QUALITY PROTEIN: dnaJ homolog subfamily C member 3 [Oryctolagus cuniculus]
gi|291398727 0.25 PREDICTED: plasminogen activator inhibitor 1 RNA-binding protein isoform X4 [Oryctolagus cuniculus]
gi|291396648 0.24 PREDICTED: E3 UFM1-protein ligase 1 isoform X1 [Oryctolagus cuniculus]
gi|655769425 0.24 PREDICTED: cytoskeleton-associated protein 4 [Oryctolagus cuniculus]
gi|217038304 0.24 SEC63-like protein (predicted) [Oryctolagus cuniculus]
gi|291405834 0.24 PREDICTED: prohibitin [Oryctolagus cuniculus]
gi|655899077 0.23 PREDICTED: eukaryotic translation initiation factor 3 subunit B [Oryctolagus cuniculus]
gi|6653665 0.23 voltage-dependent anion channel 3 [Oryctolagus cuniculus]
gi|291404134 0.22 PREDICTED: AP-3 complex subunit mu-1 [Oryctolagus cuniculus]
gi|291390734 0.22 PREDICTED: cytochrome b-c1 complex subunit 2, mitochondrial [Oryctolagus cuniculus]
gi|1256242 0.22 translocon associated protein alpha [Oryctolagus cuniculus]
gi|291389971 0.22 PREDICTED: keratin, type I cytoskeletal 18 [Oryctolagus cuniculus]
gi|291395187 0.21 PREDICTED: tubulin alpha-1B chain-like [Oryctolagus cuniculus]
gi|655730654 0.21 PREDICTED: LOW QUALITY PROTEIN: keratin, type II cytoskeletal 2 epidermal [Oryctolagus cuniculus]
gi|1551 0.21 elongation factor 1 alpha [Oryctolagus cuniculus]
gi|291395799 0.20 PREDICTED: heat shock 70 kDa protein 1B [Oryctolagus cuniculus]
gi|291388413 0.20 PREDICTED: eukaryotic translation initiation factor 3 subunit E [Oryctolagus cuniculus]
gi|291384874 0.20 PREDICTED: estradiol 17-beta-dehydrogenase 12 [Oryctolagus cuniculus]
gi|14701788 0.20 proteolipid protein 2 [Oryctolagus cuniculus]
gi|655855843 0.19 PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC100358804 [Oryctolagus cuniculus]
gi|291386789 0.19 PREDICTED: endoplasmic reticulum lectin 1 [Oryctolagus cuniculus]
gi|291409112 0.18 PREDICTED: erlin-2 [Oryctolagus cuniculus]
gi|56718852 0.18 eukaryotic translation initiation factor 3 subunit 2 beta [Oryctolagus cuniculus]
gi|291411017 0.18 PREDICTED: vitamin K epoxide reductase complex subunit 1 isoform X1 [Oryctolagus cuniculus]
gi|2644966 0.18 hnRNP-E1 protein [Oryctolagus cuniculus]
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gi|655856832 0.18 PREDICTED: oligosaccharyltransferase complex subunit OSTC [Oryctolagus cuniculus]
gi|655877060 0.18 PREDICTED: magnesium transporter protein 1 [Oryctolagus cuniculus]
gi|655901920 0.18 PREDICTED: AP-2 complex subunit alpha-2 [Oryctolagus cuniculus]
gi|291387898 0.17 PREDICTED: vesicular integral-membrane protein VIP36 [Oryctolagus cuniculus]
gi|655779421 0.17 PREDICTED: LOW QUALITY PROTEIN: peptidyl-prolyl cis-trans isomerase FKBP2 [Oryctolagus cuniculus]
gi|291389217 0.16 PREDICTED: keratin, type II cytoskeletal 1 [Oryctolagus cuniculus]
gi|1703 0.16 gamma non-muscle actin [Oryctolagus cuniculus]
gi|655900781 0.16 PREDICTED: glutamine synthetase [Oryctolagus cuniculus]
gi|655901923 0.16 PREDICTED: AP-2 complex subunit alpha-2-like, partial [Oryctolagus cuniculus]
gi|291391538 0.16 PREDICTED: LOW QUALITY PROTEIN: actin, cytoplasmic 1 [Oryctolagus cuniculus]
gi|291394422 0.16 PREDICTED: signal peptidase complex catalytic subunit SEC11C [Oryctolagus cuniculus]
gi|655879413 0.16 PREDICTED: ADP-ribosylation factor-like protein 8B [Oryctolagus cuniculus]
gi|655705917 0.15 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 isoform X1 [Oryctolagus cuniculus]
gi|655655071 0.15 PREDICTED: clathrin interactor 1 isoform X1 [Oryctolagus cuniculus]
gi|655632699 0.15 PREDICTED: AP-3 complex subunit sigma-1 [Oryctolagus cuniculus]
gi|291414663 0.15 PREDICTED: eukaryotic translation initiation factor 3 subunit L [Oryctolagus cuniculus]
gi|655853277 0.15 PREDICTED: translocation protein SEC62 [Oryctolagus cuniculus]
gi|291386382 0.15 PREDICTED: protein RMD5 homolog A [Oryctolagus cuniculus]
gi|655851123 0.14 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit [Oryctolagus cuniculus]
gi|291406117 0.14 PREDICTED: ras-related protein Rab-5C [Oryctolagus cuniculus]
gi|6070211 0.14 eukaryotic polypeptide chain release factor 1 [Oryctolagus cuniculus]
gi|218456212 0.14 ATP synthase subunit O, mitochondrial (predicted) [Oryctolagus cuniculus]
gi|291401874 0.14 PREDICTED: membrane-associated progesterone receptor component 2 [Oryctolagus cuniculus]
gi|512125535 0.14 Chain L, Human Tweak In Complex With The Fab Fragment Of A Neutralizing Antibody
gi|398395 0.13 elongation factor 1 beta [Oryctolagus cuniculus]
gi|291393631 0.13 PREDICTED: cytochrome b-c1 complex subunit 1, mitochondrial [Oryctolagus cuniculus]
gi|655852190 0.13 PREDICTED: dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3B [Oryctolagus cuniculus]
gi|291398127 0.13 PREDICTED: vesicle-trafficking protein SEC22b [Oryctolagus cuniculus]
gi|291404870 0.13 PREDICTED: inactive pancreatic lipase-related protein 1 [Oryctolagus cuniculus]
gi|655893116 0.13 PREDICTED: serine/arginine-rich splicing factor 2 [Oryctolagus cuniculus]
gi|291390078 0.13 PREDICTED: eukaryotic translation initiation factor 3 subunit K [Oryctolagus cuniculus]
gi|291384261 0.13 PREDICTED: signal peptidase complex subunit 2 [Oryctolagus cuniculus]
gi|655863531 0.13 PREDICTED: ER membrane protein complex subunit 7 isoform X1 [Oryctolagus cuniculus]
gi|291394621 0.12 PREDICTED: aquaporin-1 [Oryctolagus cuniculus]
gi|291401067 0.12 PREDICTED: V-type proton ATPase subunit B, brain isoform [Oryctolagus cuniculus]
gi|291385707 0.12 PREDICTED: transmembrane protein 33 isoform X1 [Oryctolagus cuniculus]
gi|129730 0.12 RecName: Full=Protein disulfide-isomerase; Short=PDI; AltName: Full=Cellular thyroid hormone-binding protein; 
gi|291404901 0.12 PREDICTED: thioredoxin-dependent peroxide reductase, mitochondrial [Oryctolagus cuniculus]
gi|217030873 0.12 protein disulfide isomerase-associated 3 precursor (predicted) [Oryctolagus cuniculus]
gi|655614831 0.12 PREDICTED: serine/arginine-rich splicing factor 7 isoform X1 [Oryctolagus cuniculus]
gi|291394118 0.12 PREDICTED: NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial [Oryctolagus cuniculus]
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gi|291396950 0.12 PREDICTED: dnaJ homolog subfamily B member 6 [Oryctolagus cuniculus]
gi|655845589 0.12 PREDICTED: LOW QUALITY PROTEIN: transmembrane and coiled-coil domain-containing protein 1 [Oryctolagus cuniculus]
gi|655886940 0.12 PREDICTED: ATP synthase subunit f, mitochondrial [Oryctolagus cuniculus]
gi|291389142 0.12 PREDICTED: methyltransferase-like protein 7A [Oryctolagus cuniculus]
gi|291391293 0.12 PREDICTED: synaptophysin-like protein 1 [Oryctolagus cuniculus]
gi|291390349 0.11 PREDICTED: enhancer of mRNA-decapping protein 4 isoform X2 [Oryctolagus cuniculus]
gi|291389209 0.11 PREDICTED: keratin, type II cytoskeletal 5 isoform X1 [Oryctolagus cuniculus]
gi|655805242 0.11 PREDICTED: nodal modulator 1 [Oryctolagus cuniculus]
gi|655891744 0.11 PREDICTED: AP-3 complex subunit beta-1 [Oryctolagus cuniculus]
gi|291388238 0.11 PREDICTED: copine-3 [Oryctolagus cuniculus]
gi|291384976 0.11 PREDICTED: NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial [Oryctolagus cuniculus]
gi|291407221 0.11 PREDICTED: peroxiredoxin-4 isoform X3 [Oryctolagus cuniculus]
gi|655890232 0.11 PREDICTED: ER membrane protein complex subunit 3 [Oryctolagus cuniculus]
gi|655897861 0.11 PREDICTED: LOW QUALITY PROTEIN: toll-interacting protein [Oryctolagus cuniculus]
gi|291383611 0.10 PREDICTED: signal recognition particle receptor subunit alpha [Oryctolagus cuniculus]
gi|291391168 0.10 PREDICTED: staphylococcal nuclease domain-containing protein 1 [Oryctolagus cuniculus]
gi|291410136 0.10 PREDICTED: calnexin isoform X3 [Oryctolagus cuniculus]
gi|6653663 0.10 voltage-dependent anion channel 2 [Oryctolagus cuniculus]
gi|655854861 0.10 PREDICTED: V-type proton ATPase catalytic subunit A [Oryctolagus cuniculus]
gi|291403258 0.10 PREDICTED: thrombospondin-1 [Oryctolagus cuniculus]
gi|291413344 0.10 PREDICTED: alpha-soluble NSF attachment protein [Oryctolagus cuniculus]
gi|655840030 0.10 PREDICTED: LOW QUALITY PROTEIN: uncharacterized protein LOC100343399 [Oryctolagus cuniculus]
gi|291392793 0.10 PREDICTED: prohibitin-2 [Oryctolagus cuniculus]
gi|291388415 0.09 PREDICTED: ER membrane protein complex subunit 2 [Oryctolagus cuniculus]
gi|676873107 0.09 immunoglobulin gamma heavy chain constant region, partial [Oryctolagus cuniculus cuniculus]
gi|655894769 0.09 PREDICTED: dnaJ homolog subfamily B member 1 [Oryctolagus cuniculus]
gi|655865611 0.09 PREDICTED: eukaryotic initiation factor 4A-I-like [Oryctolagus cuniculus]
gi|291409601 0.08 PREDICTED: DNA damage-binding protein 1 [Oryctolagus cuniculus]
gi|291410132 0.08 PREDICTED: RUN and FYVE domain-containing protein 1 [Oryctolagus cuniculus]
gi|291388434 0.08 PREDICTED: eukaryotic translation initiation factor 3 subunit H [Oryctolagus cuniculus]
gi|655606040 0.08 PREDICTED: mitochondrial inner membrane protein isoform X1 [Oryctolagus cuniculus]
gi|655882251 0.08 PREDICTED: serine/arginine-rich splicing factor 6 [Oryctolagus cuniculus]
gi|655601210 0.08 PREDICTED: etoposide-induced protein 2.4 homolog [Oryctolagus cuniculus]
gi|291388107 0.08 PREDICTED: translocating chain-associated membrane protein 1 [Oryctolagus cuniculus]
gi|655700678 0.08 PREDICTED: LOW QUALITY PROTEIN: protein LYRIC [Oryctolagus cuniculus]
gi|655887896 0.08 PREDICTED: secretory carrier-associated membrane protein 2 [Oryctolagus cuniculus]
gi|655900241 0.07 PREDICTED: LOW QUALITY PROTEIN: probable cation-transporting ATPase 13A1 [Oryctolagus cuniculus]
gi|655829498 0.07 PREDICTED: LOW QUALITY PROTEIN: ATP-binding cassette sub-family B member 6, mitochondrial [Oryctolagus cuniculus]
gi|655899323 0.07 PREDICTED: LOW QUALITY PROTEIN: cysteine--tRNA ligase, cytoplasmic-like [Oryctolagus cuniculus]
gi|655890200 0.07 PREDICTED: ER degradation-enhancing alpha-mannosidase-like protein 3 [Oryctolagus cuniculus]
gi|655889921 0.07 PREDICTED: protein disulfide-isomerase A6 [Oryctolagus cuniculus]
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gi|291406131 0.07 PREDICTED: V-type proton ATPase 116 kDa subunit a isoform 1 isoform X3 [Oryctolagus cuniculus]
gi|291402056 0.07 PREDICTED: saccharopine dehydrogenase-like oxidoreductase [Oryctolagus cuniculus]
gi|217916954 0.07 dyskerin (predicted), partial [Oryctolagus cuniculus]
gi|291412860 0.06 PREDICTED: fatty aldehyde dehydrogenase isoform X1 [Oryctolagus cuniculus]
gi|291394426 0.06 PREDICTED: protein ERGIC-53 isoform X1 [Oryctolagus cuniculus]
gi|655899696 0.06 PREDICTED: AP-2 complex subunit alpha-1 [Oryctolagus cuniculus]
gi|655845860 0.06 PREDICTED: DDB1- and CUL4-associated factor 8 isoform X1 [Oryctolagus cuniculus]
gi|655827020 0.06 PREDICTED: metalloreductase STEAP3 isoform X1 [Oryctolagus cuniculus]
gi|655892765 0.06 PREDICTED: E3 ubiquitin-protein ligase makorin-1 [Oryctolagus cuniculus]
gi|655605354 0.06 PREDICTED: serine/threonine-protein kinase MARK2-like [Oryctolagus cuniculus]
gi|655898441 0.06 PREDICTED: sorting nexin-8 [Oryctolagus cuniculus]
gi|655896277 0.06 PREDICTED: tubulin beta-3 chain [Oryctolagus cuniculus]
gi|655833400 0.06 PREDICTED: protein transport protein Sec61 subunit alpha isoform 1 [Oryctolagus cuniculus]
gi|291393196 0.05 PREDICTED: tripeptidyl-peptidase 2 isoform X1 [Oryctolagus cuniculus]
gi|655790980 0.05 PREDICTED: V-type proton ATPase subunit d 1 [Oryctolagus cuniculus]
gi|655865898 0.05 PREDICTED: glutamate dehydrogenase 1, mitochondrial [Oryctolagus cuniculus]
gi|655881614 0.05 PREDICTED: protein OS-9 [Oryctolagus cuniculus]
gi|655864474 0.05 PREDICTED: signal recognition particle 54 kDa protein isoform X3 [Oryctolagus cuniculus]
gi|291401168 0.05 PREDICTED: ATP-binding cassette sub-family E member 1 [Oryctolagus cuniculus]
gi|655839976 0.04 PREDICTED: phosphatidylinositol-glycan-specific phospholipase D isoform X1 [Oryctolagus cuniculus]
gi|2581793 0.04 glucose-regulated protein GRP94, partial [Oryctolagus cuniculus]
gi|655841556 0.04 PREDICTED: heat shock protein HSP 90-beta isoform X1 [Oryctolagus cuniculus]
gi|291392087 0.04 PREDICTED: NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial [Oryctolagus cuniculus]
gi|655814551 0.04 PREDICTED: protein disulfide-isomerase A4 [Oryctolagus cuniculus]
gi|2384762 0.04 glycogen synthase [Oryctolagus cuniculus]
gi|655676341 0.03 PREDICTED: aspartyl/asparaginyl beta-hydroxylase [Oryctolagus cuniculus]
gi|655869173 0.03 PREDICTED: sarcoplasmic/endoplasmic reticulum calcium ATPase 3 isoform X1 [Oryctolagus cuniculus]
gi|291403822 0.03 PREDICTED: nuclear export mediator factor NEMF isoform X2 [Oryctolagus cuniculus]
gi|5805341 0.03 glycoprotein IIb [Oryctolagus cuniculus]
gi|655851212 0.03 PREDICTED: ER membrane protein complex subunit 1 isoform X4 [Oryctolagus cuniculus]
gi|655870955 0.03 PREDICTED: importin subunit beta-1 [Oryctolagus cuniculus]
gi|291387698 0.03 PREDICTED: la-related protein 1 [Oryctolagus cuniculus]
gi|291389423 0.03 PREDICTED: extended synaptotagmin-1 [Oryctolagus cuniculus]
gi|655873131 0.03 PREDICTED: C-1-tetrahydrofolate synthase, cytoplasmic [Oryctolagus cuniculus]
gi|655873297 0.03 PREDICTED: protein sel-1 homolog 1 [Oryctolagus cuniculus]
gi|291385746 0.03 PREDICTED: NF-X1-type zinc finger protein NFXL1 [Oryctolagus cuniculus]
gi|291405608 0.03 PREDICTED: AP-2 complex subunit beta isoform X1 [Oryctolagus cuniculus]
gi|291408948 0.02 PREDICTED: fibronectin type-III domain-containing protein 3A isoform X1 [Oryctolagus cuniculus]
gi|291414790 0.02 PREDICTED: vigilin [Oryctolagus cuniculus]
gi|655848769 0.02 PREDICTED: glutamate-rich protein 3 isoform X1 [Oryctolagus cuniculus]
gi|291404146 0.02 PREDICTED: zinc finger SWIM domain-containing protein 8 isoform X4 [Oryctolagus cuniculus]
gi|655875291 0.02 PREDICTED: DNA polymerase alpha catalytic subunit [Oryctolagus cuniculus]
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gi|655862559 0.01 PREDICTED: vacuolar protein sorting-associated protein 13C [Oryctolagus cuniculus]
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List of Abbreviations
Å (unit) Ångstroem
ΔG Gibbs free energy
ΔH Change in enthalpy
ΔS Change in entropy
µg Microgram
µL Microliter
µM Micromolar
3D Three-dimensional
aa Amino acid
aa-tRNA Aminoacyl-transfer ribonucleic acid
A. fulgidus Archeoglobus fulgidus
AglB Archaeal glycosylation B
A-site Aminoacyl-site
CET Cryo-electron tomography
CHX Cycloheximide
C. lari Camphylobacter lari
C-terminal Carboxyterminal
CTF Contrast transfer function
CMV Cytomegalovirus
cryo-EM Cryo-electron microscopy
DAD1 Defender against apoptotic cell-death 1
DC Decoding center
DNA Deoxyribonucleic acid
Dol Dolichol
DTT Dithiothreitol
ECL Electro chemiluminescence
E. coli Escherichia coli
eEF Eukaryotic elongation factor
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eIF Eukaryotic initiation factor
EL External loop
EMC ER membrane protein complex
emPAI Exponentially modified protein abundance index
Endo H Endoglycosidase H
eq (unit) Equivalent
ER Endoplasmic reticulum
eRF1 Eukaryotic release factor 1
E-site Exit-site
F Free (non-membrane bound)
FSC Fourier shell correlation
GIFT domain Gliding/intraflagellar transport domain
GPCR G-protein coupled receptor
GTP Guanosine triphosphate
H. sapiens Homo sapiens
HA Hemagglutinin
HRP Horseradish peroxidase
IAP Implantation-associated protein 1
Kan Kanamycin
KCP2 Keratinocyte associated protein 2
kDa Kilodalton
L Loop
LLO Lipid-linked oligosaccharide
LSU Large ribosomal subunit
MagT1 Magnesium transporter 1
MB Membrane bound
mM Millimolar
mRNA Messenger RNA
MS Mass spectrometry
MW Molecular weight
NC Nascent chain
ng nanogram
N-glycosylation Asparagine-linked glycosylation
N-terminal Aminoterminal
OD Optical density
OP Opsin
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ORF Open reading frame
OST Oligosaccharyltransferase
OST48 Oligosaccharyltransferase subunit of 48 kilodalton
PAA Poly-acrylamide
PAGE Polyacrylamide gel electrophoresis
PAT-10 Protein associated with the ER translocon of 10 kilodalton
PCC Protein conducting channel
PCR Polymerase chain reaction
pdb Protein data bank
PglB Protein glycosylation B
PKRM Puromycin/High-salt treated rough microsomal membranes
PPi Pyrophosphate
P-site Peptidyl-site
PTC Peptidyl transferase center
RF Release factor
RM Rough microsomal membranes
RT Room temperature
RNC Ribosome-nascent chain complex
rpm Revolutions per minute
RPN1 Ribophorin 1
RPN2 Ribophorin 2
RRL Rabbit reticulocyte lysate
rRNA Ribosomal ribonucleic acid
RTC Ribosome-translocon complex
S (unit) Svedberg unit
SA Signal anchor
S. cerevisiae Saccharomyces cerevisiae
SD Shine-Dalgarno
SDS Sodium dodecyl sulfate
SP Signal peptide
SR Signal recognition particle receptor
SRP Signal recognition particle
SS Signal sequence
SSR Signal sequence receptor complex (also: TRAP)
SSU Small ribosomal subunit
STT3 Staurosporin and temperature sensitive mutant 3
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TC Ternary complex
TCA Trichloroacetic acid
TM Transmembrane
TMD Transmembrane domain
TMEM258 Transmembrane protein 258
TMP Transmembrane protein
TMS Transmembrane segment
TRAM Translocating chain-associating membrane protein
TRAP Translocon-associated protein complex
tRNA Transfer ribonucleic acid
TUSC3 Tumor suppressor candidate 3
U units
UTR Untranslated region
WB Western blot
WT Wild type
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